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ABSTRACT 
 
Evaluation of Chloride Intracellular Channels 4 and 1 Functions in Developmental and 
Pathological Angiogenesis 
Jennifer Jean Tung 
 
 Members of the chloride intracellular channel (CLIC) protein family have been 
implicated as regulators of tubulogenesis, a critical step in the formation of new blood 
vessels during angiogenesis. We sought to determine CLIC4 and CLIC1 function in 
angiogenesis. We hypothesized that CLIC4 and CLIC1 act in endothelial lumen 
formation and promote both developmental and pathological angiogenesis. 
 Using in vitro studies, we found that CLIC4 promotes endothelial proliferation, 
network formation, capillary-like sprouting, and lumen formation. In vivo, Clic4 
knockout mice display a mild defect in retinal vascular development and an apparent 
decrease in retinal macrophage content. By implanting murine tumor cells in Clic4 
knockout mice, we discovered that Clic4 affects the establishment of lung metastases. 
Endothelial and smooth muscle cell content of tumors are comparable to wild type, but 
overall vessel architecture is altered. In studying CLIC1, we found that CLIC1 
knockdown results in reduced endothelial proliferation, directed migration, network 
formation, and capillary-like sprouting in vitro. In vivo analysis revealed no apparent 
angiogenic phenotype in the developing retinas of Clic1 knockout mice. 




 double mutant embryos, which were unable to 




 9.5 dpc embryos for 
vasculature revealed an angiogenic defect, most notable along the intersomitic vessels 
and in the brain. Endothelial content is reduced in Clic4;Clic1 double knockout embryos, 





 9.5 dpc embryos suggests altered aortic development, reduced 
proliferation, and increased apoptosis.  
 I conclude that CLIC4 and CLIC1 function in endothelial proliferation and 
morphogenesis and that Clic4 and Clic1 are required for embryonic development. 
Together, our findings indicate that CLIC4 and CLIC1 are important in developmental 
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Chapter One: Introduction 
 
 This chapter contains excerpts from a review that I co-authored with Ian Tattersall 
[1].  
 
1.1 Overview of angiogenesis in development and pathology 
 The processes responsible for blood vasculature development are termed 
vasculogenesis for primary vessel structure growth, and angiogenesis. Angiogenesis is 
the formation of new blood vessels from the sprouting, branching, and pruning of 
preexisting vessels. It is an essential process for mammalian embryonic maturation, 
proper organ development, and tissue growth and repair. Deviations in angiogenic 
regulation are important factors in pathological processes such as malignant growth and 
transformation among many others [2, 3].  
 The basic cellular mechanisms of angiogenesis begin with pro-angiogenic factors 
stimulating endothelial cells to degrade the local basement membrane surrounding an 
existing vessel [4]. Endothelial cells then rearrange, proliferate, and migrate into the 
surrounding stroma. New sprouts form lumens in a process termed tubulogenesis. After 
lumen formation, tubes branch and reconnect to form vascular networks in a process 
termed anastomosis. Pruning of newly formed capillaries and elementary sprouts follows 
anastomosis, and the basement membrane is reformed. Finally, accessory cells such as 
pericytes or smooth muscle cells are recruited to help stabilize the vessel, produce 
extracellular matrix components, and provide control of luminal diameter [5].  
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 When angiogenic regulation is derailed, a number of pathologies such as macular 
degeneration, diabetic retinopathy, and ischemia can occur. With respect to tumor 
development, Judah Folkman first hypothesized in 1971 that without tumor-recruited 
angiogenesis to provide nourishment, waste removal, and a means of escape for tumor 
cells, the tumor would remain localized or become necrotic [6]. Since its inception, a 
number of studies have gathered evidence in support of this tumor angiogenesis 
hypothesis and are well-reviewed [7]. The mechanism driving tumor angiogenesis has 
been termed the “angiogenic switch” and stipulates a pathological shift to a pro-
angiogenic state from the carefully regulated balance of inhibitory and activating 
angiogenic signals in a normal cell environment [8]. With these early studies, the concept 
of targeting angiogenesis in treating pathologies was discovered, and targeting tumor 
angiogenesis is now a well-established goal in anti-cancer drug development [3]. A better 
understanding of the basic mechanisms that drive angiogenesis could provide new 
avenues for drug development and tumor targeting.  
 
1.2 Mechanisms of tubulogenesis 
 Without tubulogenesis, endothelial cords would fail to transport fluid and key 
components of blood. While it is accepted that endothelial tubulogenesis involves the 
establishment of apicobasal polarity, vesicular trafficking, and cytoskeletal reorganization, 
the underlying mechanisms of tubulogenesis remain unclear [9-15]. Recent studies have 
implicated a broad array of cell surface and signaling proteins in tubulogenesis and 
several models have been proposed to explain the mechanics of tubulogenesis.  
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 An initial model for endothelial tubulogenesis, referred to as “cell hollowing,” 
involves the coalescence of pinocytic vesicles to generate lumens (Fig 1.1) [16-20]. This 
model emphasizes the importance of vesicular and vacuolar development and movement 
within the endothelial cell. By cell hollowing, a single endothelial cell creates a de novo 
lumen through the coalescence of vesicles/vacuoles intracellularly while cell invasion 
into the surrounding stroma occurs. These vesicles carry apical markers to distinguish the 
future luminal membrane from the basal membrane of the endothelial cell, and this 
process occurs without cell loss [17]. Once the cell is “hollowed,” the lumen contained 
within the cell opens on either end through intercellular vacuolar fusion by exocytosis to 
form a “seamless vessel” without junctions [20]. Evidence for this model is found most 
notably in vitro and by analysis of zebrafish intersomitic vessel sprouting [16, 18, 20].  
 An alternative model for endothelial tubulogenesis, known as “cord hollowing,” 
emphasizes the importance of endothelial cell-cell junctions and the establishment of 
apicobasal polarity (Fig 1.1) [21-24]. In this model, a polarized multi-cellular endothelial 
cord migrates into the surrounding stroma and loses its apicobasal polarity. During this 
step, cell junctions in the cord break and the cord thickens to roughly two or three cells. 
A de novo lumen is formed extracellularly without cell loss when an external cue signals 
for repolarization, and surfaces in contact with the extracellular matrix accrue basal 
markers while apical markers target endothelial cell-cell junctions at the central axis via 
vesicles. Apical vesicles then fuse at the central axis, separating the cell surfaces with 
fluid-filled pockets of what will ultimately be a lumen continuous within itself and the 
parent vessel. Studies using C. elegans and zebrafish provide notable data supporting this 
model [22-25].  
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 In addition to the cell hollowing and cord hollowing models, other models of 
tubulogenesis have been proposed. Each model has supporting evidence and utility in 
explaining the mechanics behind endothelial tubulogenesis. One recent study of the 
developing mouse aorta proposes a mechanism by which lumens are formed 
extracellularly when VEGF-A activates a chain of events leading to F-actin 
rearrangements, ultimately separating two contacting endothelial cells [26]. This process 
involves Rho-dependent kinase and is not known to invoke vesicular trafficking. Another 
model, termed “selective sprouting”, is supported by studies in the developing zebrafish 
cardinal vein [27]. The selective sprouting model stipulates that venous endothelial cells 
migrate from the dorsal aorta to surround erythrocytes and are retained by VEGF-
A/VEGFR-2 signaling, a process analogous to vasculogenesis during embryogenesis.  
 The fact that several models of endothelial tubulogenesis are supported by a 
variety of observations and experiments suggests that the mechanism utilized for lumen 
formation could be context-dependent. With further research and advancing means for 
studying tubulogenesis, we may find that lumen formation results from a combination of 
proposed models or that the method for tubulogenesis depends on vessel type and caliber. 
 
1.3 Chloride intracellular channels 
 Chloride intracellular channels (CLICs), so named for their homology to p64, are 
putative ion channels belonging to the p64 gene family and are distantly related to 
glutathione S-transferases (GSTs) [28, 29]. CLICs were first discovered by the Al-
Awqati group when they identified a protein while searching for novel chloride ion 
channels [28, 30]. In their studies, they found indanyloxyacetic acid 94 (IAA94), a small 
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molecule inhibitor of ion channel modulator ethacrynic acid, moderately inhibited 
chloride channel activity in bovine kidney cortex membrane vesicles [28]. From this, they 
purified what is now known as p64 and identified it as a bovine chloride channel 
localized to apical and intracellular membranes [29, 31]. CLIC1 and CLIC4 were then 
discovered as homologues of bovine p64, however they differed structurally from p64 in 
that they did not possess an N-terminal extension like p64 [32-34].   
 There are 6 known CLIC paralogues in mammals, named CLIC1-6, and the 
family is defined by a roughly 230 conserved amino acid core sequence at the C-terminus 
and three conserved cysteine residues [35]. CLIC-like proteins are present in 
invertebrates and CLICs are highly conserved in vertebrates [36]. CLICs are not known 
to have a signal peptide, however they do possess a putative transmembrane domain 
(PTM) near the N-terminus responsible for forming the pore of the membrane-bound 
channel [33, 37]. Sequence analysis, crystal structures, and electrophysiological studies 
on CLICs indicate that they form single-pass transmembrane proteins by polymerizing 
[36]. CLIC4 has been observed as a homotrimer [38] while CLIC1 has been observed as 
a homodimer [39]. In addition to being redox-regulated, studies suggest that the dramatic 
transition from cytoplasmic globular state to membrane-bound channel structure of 
CLICs may be influenced by pH [40-42].  
 CLICs have previously been shown to be involved in a variety of processes that 
include secretion, cell division, apoptosis, and cell mobility [43-47]. The CLIC family of 
proteins is widely expressed in multicellular organisms and auto-assemble to form 
intracellular ion channels that auto-insert into specific cellular membranes [36]. Unlike 
other mammalian ion channels, CLICs are present in cells as both soluble cytoplasmic 
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proteins and integral membrane proteins, and this transition appears to be redox-regulated 
[37, 39, 48]. CLIC localization varies according to cell type and its localization appears 
to be specific to its function. In the case of CLIC4, its localization also appears to be 
dependent on its expression level [49]. 
  The CLIC family of proteins has recently been implicated as having a role in this 
tubulogenic process. One study found that CLIC-like protein EXC-4 in C. elegans plays a 
critical role in both the proper development and maintenance of the C. elegans excretory 
canal [50]. Exc-4 mutants presented luminal cysts and other morphological defects at the 
surface of the canal. EXC-4 was also found to be continuously needed for normal tube 
size maintenance.  
 
1.4 Evidence for CLIC function in angiogenesis 
  In both the cell hollowing and cord hollowing models for tubulogenesis, 
vesicular trafficking plays an integral role [13, 16, 18]. The origin and purpose of these 
vesicles remains under contention. Since the C. elegans excretory canal is thought to 
form a lumen by much the same mechanism as human capillaries [20], and CLICs are 
conserved between vertebrates and invertebrates, this suggests a role for CLICs in 
endothelial tubulogenesis.  
 Of the six known mammalian CLICs, only CLIC4 and CLIC1 are reported to be 
highly expressed in endothelial cells [51-57]. CLIC5 levels are found to be low in 
placental endothelial cells [52] and high in glomerular endothelial cells [57]. CLIC1, 
CLIC4, and CLIC5 are also regulated by F-actin when reconstituted in planar lipid 
bilayers [43], suggesting a potential role in cytoskeletal reorganization. Both CLIC4 and 
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CLIC1 have been shown to form single-pass, dimeric channels that have poorly selective, 
redox-regulated chloride channel activity [39, 58]. Crystal structure and functional 
analyses indicate that CLIC4 and CLIC1 possess a putative transmembrane domain 
(PTM) near the N-terminus [59].  
 Potential regulation of CLICs by redox signaling provides an interesting avenue 
by which CLICs may function in angiogenesis. Structural studies on CLIC1 have 
revealed two stable crystal structures: soluble and integral membrane forms [39]. The N-
domain undergoes the most drastic structural transition, lending further credence to the 
N-domain being the transmembrane domain. The two crystal structure states of CLIC1 
observed were a reduced, soluble monomeric form, and an oxidized, non-covalent dimer.  
 As hypoxic or hyperoxic conditions produce oxidative stress, it would seem 
intuitive for redox signaling to be a regulator of angiogenesis. Research on the role of 
reactive oxygen species (ROS) in angiogenesis signaling has been an emerging field, but 
ROS presence has been implicated in a number of vascular and cardiovascular diseases 
such as ischemia and hypertension [60, 61]. Studies have now shown that an increase in 
ROS is often accompanied by induction of angiogenic regulators such as VEGF and Ang-
1 in endothelial cells [62, 63] while antioxidants inhibit angiogenic responses in 
endothelial cells [64, 65]. With the implication that CLIC translocation from the 
cytoplasm to membranes is regulated by redox signaling, and given that redox signaling 
mediates the angiogenic response, one could postulate that the oxidized, membrane-
bound form of CLIC plays a role in hypoxia-induced angiogenesis.  
 Along these lines, studies have noted a correlation between pH and CLIC chloride 
conductivity [40, 42, 59, 66]. Specifically, channel activity increases as pH is reduced, 
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consistent with the proposed redox regulation of stable CLIC tertiary structures. Having 
sensitivity to pH could suggest another means by which CLICs may be regulated in 
functioning during tubulogenesis as cytoplasmic vesicles are often acidic. Alternatively, 
CLICs may play a role in regulating vesicular acidification coupled with a proton pump 
[36].  
 Little attention has been given to CLIC5 and CLIC1 as tubulogenic regulators 
thus far, but there is increasing evidence for a role for CLIC4 in lumen formation. CLIC4 
has been found to be localized to vesicles in human umbilical vein endothelial cells [49] 
and large vacuoles in mouse heart endothelial cells [67]. Analyses of retinal vasculature 
in developing mice and adult mice challenged by an oxygen toxicity assay, reveals 
stunted vascular development in Clic4
-/-
 mice [67]. CLIC4 may also influence vacuolar 
formation in endothelial cells by regulating pH [67]. Furthermore, CLIC4 localizes to the 
midbody and centrosome of cultured bovine aortic endothelial cells and is enriched at 
cell-cell junctions in choriocarcinoma cells [68], suggesting a role in establishing or 
maintaining cell polarization. CLIC4 is also RhoA-regulated in a variety of cells [46]. 
Upon G13-coupled Rho-A activating receptor stimulation, CLIC4 translocates to the 
plasma membrane but does not modulate chloride currents, implying a hitherto unknown 
function of CLIC4 in the cell [46].  
 While not necessarily a regulator of tubulogenesis, CLIC1 may also play a role in 
regulating angiogenesis. The same C. elegans studies on exc-4 found that human Clic1 
fused to the putative transmembrane domain of exc4 was able to rescue the cystic 
disruption phenotype of the exc4 mutant excretory canal [37]. CLIC1 may also affect 
apical membrane recycling as suggested by its localization to the apical domain in several 
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columnar epithelia [54]. In addition, both CLIC1 and CLIC4 have been suggested to 
interact with the actin cytoskeleton [43], implicating them in organelle trafficking.  
 Together, the data described above suggest that CLIC4 may function in 
physiological and pathological angiogenesis, specifically during tubulogenesis. As 
CLIC4 has been more extensively characterized, we have chosen to focus mainly on 
defining a role for CLIC4 in angiogenesis. As we acknowledge the possibility that CLIC1 
may functionally overlap with CLIC4 and note that only CLIC4 and CLIC1 are strongly 
expressed in endothelial cells, we also focus on CLIC1 as a potential angiogenic regulator. 
We tested our hypothesis that CLIC4 and CLIC1 contribute singly and in concert to 
tubulogenesis and angiogenesis. First, we analyzed endothelial cell behavior in a series of 
in vitro assays that mimic individual steps of angiogenesis when CLIC4 or CLIC1 
expression levels are altered. Second, we generated Clic4 knockout mice and acquired 
Clic1 knockout mice for analyses. Third, we analyzed tumor growth on Clic4 mutant 
mice. Finally, we generated Clic4;Clic1 double knockout mice.  
 In chapters 2 and 4, we describe how CLIC4 and CLIC1 were determined to be 
effectors of endothelial cell growth, survival, network formation, and capillary sprouting 
in vitro. We also determined that only CLIC4 affects lumen formation in vitro while only 
CLIC1 affects endothelial cell migration. Chapter 3 describes our analysis of the Clic4 
single knockout mice. We show that loss of Clic4 results in postnatal underrepresentation 
and subtly delayed vascular development in the retina. Surviving Clic4 knockout mice 
are viable and fertile. In chapter 3, we describe our finding that tumors implanted on 
Clic4 knockout mice tend to be larger by weight than controls with more metastases to 
the lungs. Chapter 5 describes our finding that Clic4 and Clic1 are concurrently essential 
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for embryonic development as evidenced by embryonic lethality of Clic4;Clic1 double 
mutants, which is not presented by Clic1 single mutants while Clic4 single mutants 
present embryonic lethality with incomplete penetrance. In addition, we show that 
Clic4;Clic1 double mutants exhibit an angiogenic phenotype at embryonic time of death, 
suggesting that Clic4 and Clic1 overlap functionally in regulating angiogenesis. Finally in 
chapter 6, we discuss possible mechanisms of CLIC4 and CLIC1 function.  
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Figure 1.1 | Cell hollowing and cord hollowing models for tubulogenic mechanisms. 
In this depiction, green shading represents the basal domain of the cell while red shading 
represents the apical domain. (Center panel) Representation of the process of pinocytosis. 
(Left panel) Cell hollowing begins with a cord of endothelial cells undergoing 
pinocytosis. The resultant pinocytic vesicles then fuse intracellularly to form vacuoles, 
which further fuse. Apical markers on the vacuolar membrane target the vacuoles to the 
site of the future lumen while the vacuoles continue to fuse, creating a membrane bound 
lumen. The lumen of this “hollowed cell” then fuses intercellularly with surrounding 
hollowed cells by exocytosis of vacuoles to form a continuous lumen. A cross-section of 
a vessel formed in such a manner would reveal a vessel without cell junctions, or a 
“seamless vessel.” (Right panel) During invasion by an endothelial cord into the 
surrounding extracellular matrix, the endothelial cells lose their apicobasal polarity in the 
cord-hollowing model. An external cue then triggers repolarization and membranes 
contacting the extracellular matrix accumulate basal markers while pinocytic vesicles 
carrying apical markers fuse at the site of the future lumen. Vesicles continue to fuse at 
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Chapter Two: CLIC4 is involved in endothelial cell proliferation and 
morphogenesis in vitro 
 
 Based on previously reported data implicating CLIC4 in tubulogenesis (section 
1.4), we profiled human umbilical vein endothelial cells (HUVEC) for CLIC expression 
by semi-quantitative PCR [69]. We found CLIC4 and 1 to be the most strongly expressed 
of the 6 human CLICs analyzed (Supp Fig 2.1). We initially sought to determine which 
steps of angiogenesis CLIC4 expression affected by using a series of in vitro assays that 
mimic individual steps of angiogenesis. This chapter contains the manuscript I authored 
as published in Angiogenesis (Feb 2009) as well as additional results and discussion. I 
performed all data gathering and analysis for the material in this chapter with technical 
support and guidance from Martin Nakatsu, Christopher Hughes, and Christine Yoon. 
Claire Vech Reeves and Joseph Dufraine contributed ideas and guidance early in the 
project. Dazhi Xiong and Robert Kass performed patch-clamp assessment for chloride 
conductance. Oliver Hobert, Mark Berryman, and Jan Kitajewski participated in 
analyzing results, authoring, and revising the manuscript. In addition, Mark Berryman 
provided an antibody used in analyses of this chapter.  
 
2.1 Abstract 
 New capillaries are formed through angiogenesis and an integral step in this 
process is endothelial tubulogenesis. The molecular mechanisms driving tube formation 
during angiogenesis are not yet delineated. Recently, the chloride intracellular channel 4 
(CLIC4)-orthologue EXC-4 was found to be necessary for proper development and 
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maintenance of the Caenorhabditis elegans excretory canal, implicating CLIC4 as a 
regulator of tubulogenesis. Here, we studied the role of CLIC4 in angiogenesis and 
endothelial tubulogenesis. We report the effects of inhibiting or inducing CLIC4 
expression on distinct aspects of endothelial cell behavior in vitro. Our experiments 
utilized RNA interference to establish cultured human endothelial cell lines with 
significant reduction of CLIC4 expression, and a CLIC4-expressing lentiviral plasmid 
was used to establish CLIC4 overexpression in endothelial cells. We observed no effect 
on cell migration and a modest effect on cell survival. Reduced CLIC4 expression 
decreased cell proliferation, capillary network formation, capillary-like sprouting, and 
lumen formation. This suggests that normal endogenous CLIC4 expression is required for 
angiogenesis and tubulogenesis. Accordingly, increased CLIC4 expression promoted 
proliferation, network formation, capillary-like sprouting, and lumen formation. We 
conclude that CLIC4 functions to promote endothelial cell proliferation and to regulate 
endothelial morphogenesis and is thus involved in multiple steps of in vitro angiogenesis. 
 
2.2 Introduction 
 Angiogenesis entails the formation of new blood vessels from the sprouting, 
branching, and pruning of pre-existing vessels and is essential for embryonic 
development as well as tissue growth and repair. Deviations in the regulation of 
angiogenesis are important factors in pathological processes such as atherosclerosis, 
diabetic retinopathy, and malignant tumor growth. The basic cellular mechanisms of 
angiogenesis begin with pro-angiogenic factors stimulating endothelial cells to degrade 
the local basement membrane surrounding an existing vessel followed by endothelial cell 
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rearrangement, proliferation, and migration into the surrounding stroma [4]. A neo-vessel 
is generated when new sprouts form lumens in a process termed tubulogenesis. 
Anastomosis of tubes occurs after the formation of lumens and involves the branching 
and reconnecting of vessels to form networks. Pruning of elementary sprouts follows and 
the basement membrane is reformed. Finally, accessory cells such as pericytes or smooth 
muscle cells are recruited to help stabilize the vessel and provide control of luminal 
diameter.  
 In endothelial biology, the critical underlying process of endothelial tube 
formation and tube maintenance is still poorly understood. There are several current 
models for mammalian vascular tubulogenesis. One model involves a chain of 
endothelial cells forming vesicles that enlarge, merge, and fuse intra- and intercellularly 
to form contiguous lumens [20]. This process involves the acquisition of cell apicobasal 
polarity, cytoskeletal reorganization, assembly of intercellular junctions, and membrane 
domain specification [9]. The formation of the Caenorhabditis elegans excretory canal 
provides an example of this process [50].  
 Recently, members of the glutathione S-transferase-related chloride intracellular 
channel (CLIC) protein family have been implicated in tubulogenesis. The CLIC family, 
composed of six family members in mammals, is defined by a roughly 230 conserved 
amino acid core sequence at the C-terminus [54]. CLIC family proteins are widely 
expressed in multicellular organisms and are involved in a variety of processes including 
tube formation, secretion, cell division, apoptosis, and cell motility [35]. Several CLIC 
family proteins have been shown to form intracellular ion channels that auto-assemble 
and auto-insert into specific cellular membranes [35]. In addition to their association with 
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membranes, CLIC proteins can also exist as soluble cytosolic and nuclear proteins, 
suggesting that CLICs may have alternate, non-channel functions [42]. Currently, only 
CLIC1 and CLIC4 are reported to be expressed in endothelial cells [49, 52, 54].  
 Among CLIC proteins, CLIC4 has been studied most extensively. CLIC4 has 
been shown to be associated with cytoskeletal proteins such as dynamin I, actin, and 
tubulin suggesting a role in regulating cellular morphology, membrane trafficking, and 
cell signaling [68, 70]. A recent study found that CLIC4-orthologue EXC-4 in C. elegans 
plays a critical role in both the proper development and maintenance of the C. elegans 
excretory canal [50]. Luminal cysts and other morphological defects were observed at the 
surface of the canal in exc-4 mutants, providing the first evidence that CLICs function in 
tubulogenesis. It was also demonstrated that EXC-4 was continuously needed for normal 
tube size maintenance [50].  
 This study investigates human CLIC4 as a regulator of angiogenic processes by 
using in vitro techniques that mimic multiple distinct steps of angiogenesis. Based on the 
EXC-4 precedent, we hypothesized that reducing CLIC4 expression in endothelial cells 
would negatively affect angiogenesis, while increasing CLIC4 expression would promote 
endothelial angiogenesis. Human primary endothelial cells were used to represent their in 
vivo counterpart and are suggested to be better suited for in vitro studies than 
immortalized endothelial lines based upon assessment of gene expression patterns [71]. 
We indeed found that reduced CLIC4 expression levels in endothelial cells inhibited 
endothelial network formation and cell proliferation. CLIC4 knockdown affected 
capillary-like network formation and lumen formation. Reduced CLIC4 expression had 
no effect on cell migration but led to a modest effect on cell survival. CLIC4 
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overexpression promoted proliferation, network formation, capillary-like sprouting, and 
lumen formation in vitro. Together, these results indicate that CLIC4 expression is 
required for multiple steps of angiogenesis.  
 
2.3 Altered CLIC4 expression does not affect endothelial cell migration 
 To assess the function of CLIC4 during individual steps of angiogenesis in vitro, 
we generated HUVEC lines stably infected with lentivirus-based vectors to reduce or 
increase expression of CLIC4. CLIC4 knockdown and overexpression were confirmed at 
the protein level by immunoblotting (Fig 2.1a, b). Immunoblotting for CLIC1 showed 
that Clic4 shRNA did not target Clic1, which is also expressed in endothelial cells, 
indicating that the shRNA treatments were specific for Clic4 (Fig 2.1a). 
 Established knockdown cell lines were referred to as shRNA3 and shRNA5 with 
plko sc (pLKO.1-puro vector containing scrambled shRNA insert) as the control. The 
CLIC4 overexpression cell line was named CLIC4 with pccl (pCCL.pkg.wpre) 
containing GFP as its respective control. The cellular morphology of knockdown and 
overexpression HUVEC lines was qualitatively assessed. For this analysis, equivalent 
numbers of cells from each of the lines were seeded and cell cultures were photographed 
48 h later, when cells were still subconfluent (Fig 2.1c, d). We detected no major changes 
in cellular morphology with the exception of HUVEC shRNA5, which appeared more 
rounded relative to control cells (Fig 2.1c). We noted that both HUVEC shRNA3 and 
HUVEC shRNA5 lines appeared sparser than control or overexpressing cells, indicating 
that CLIC4 knockdown may reduce cell growth. 
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 Previous studies have documented that CLIC4 is associated with cytoskeletal 
proteins in a variety of cells [43, 68, 70] and that CLIC4 expression levels affect cell 
motility in some cell types [72]. To determine whether endothelial cell migration is 
affected by reduced or increased CLIC4 expression, we utilized a migration assay to 
assess effects of CLIC4 on directed cell migration. For this assay, we scraped a line 
through confluent monolayers of the HUVEC CLIC4 knockdown and overexpression 
cultures grown on type I collagen. Endothelial cell migration into the cell-free area was 
then monitored at various time points over a 12 h period. CLIC4 knockdown or 
overexpression resulted in no observable effect on the migration rates of HUVECs when 
compared with control lines. Representative data are shown in Figure 2.2. 
 
2.4 CLIC4 expression promotes endothelial cell proliferation 
 Chloride intracellular channel 4 has been documented to play a role in cell 
proliferation of squamous cancer cell lines and to affect survival of keratinocytes, 
squamous cancer cell lines, and human osteosarcoma lines [47, 51]. To explore the role 
of CLIC4 in endothelial cell proliferation and survival, we utilized WST-8-based survival 
and proliferation assays on our CLIC4 knockdown and overexpressing cell lines. 
Proliferation assays were performed by scoring cells after seeding equal numbers of 
HUVECs on type I collagen-coated plates and culturing in serum free medium (SFM) 
supplemented with epidermal growth factor (EGF) and vascular endothelial growth 
factor-A (VEGF-A) for 96 h. We found that reduction of CLIC4 expression led to 
significant inhibition of endothelial cell proliferation (Fig 2.3a), while overexpression of 
CLIC4 resulted in a significant promotion of endothelial cell proliferation (Fig 2.3b). 
These results indicate that expression of CLIC4 promotes endothelial cell proliferation. 
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 For survival assays, equivalent numbers of knockdown, overexpression, or control 
HUVEC were seeded on type I collagen-coated plates and cultured for 24 or 48 h in SFM 
alone or SFM supplemented with the survival signal EGF. We found that in the absence 
of EGF, CLIC4 knockdown had no significant effect on endothelial cell survival at 24 h 
when compared with control lines (Fig 2.4). At 48 h, knockdown lines display a modest 
but significant increase in cell survival (Fig 2.4a). CLIC4 overexpression significantly 
decreased endothelial cell survival at 48 h, but not at 24 h (Fig 2.4b). Thus, in contrast to 
the pronounced results for proliferation, CLIC4 expression plays a limited role in 
decreasing endothelial cell survival. 
 
2.5 CLIC4 promotes endothelial capillary-like network formation 
 Since CLIC4 has been suggested to function in tubulogenesis, we assessed the 
effect of CLIC4 expression on endothelial cell morphogenesis by determining the ability 
of the various CLIC4 knockdown or overexpressing cell lines to organize into capillary-
like networks. To assess capillary-like network formation, HUVEC were seeded between 
two porcine collagen gel layers and cultured in SFM containing VEGF-A and EGF for 96 
h. As shown in Figure 2.5a, CLIC4 knockdown resulted in a dramatic reduction in cord 
formation, network formation, and branching, whereas overexpression resulted in a 
modest but significant increase in capillary-like network formation. Quantification of 
surface area occupied by network structures confirmed that CLIC4 knockdown results in 
a significant decrease in surface area occupation by endothelial cells: HUVEC shRNA3 
and HUVEC shRNA5 covered only 72.7 and 70.2% of the surface area relative to 
HUVEC plko sc set at 100% (Fig 2.5b). By comparison, HUVEC CLIC4 overexpression 
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covered 112.4% of the surface area relative to HUVEC pccl set at 100%, indicating a 
significant increase in endothelial surface area occupation by endothelial networks. 
 Results from quantifying the number of branch points per field of view also 
indicate that CLIC4 expression affects endothelial network formation. One branch point 
was considered any focal intersection of two or more cords. Knockdown cell lines 
exhibited a significant reduction in the number of branch points per field of vision when 
compared with plko sc control (Fig 2.5c). Consistently, a significant increase in branch 
point numbers was found in CLIC4-overexpressing lines compared with control pccl (Fig 
2.5d). These results indicate that CLIC4 expression promotes endothelial network 
formation and branching. 
 It has been reported that the network formation assay we utilize here is dependent 
to some extent on cell proliferation [73]. Thus, we included an additional control group to 
help distinguish potential effects of CLIC4 knockdown on proliferation versus network 
formation. This control group consisted of plko sc cells treated with mitomycin C (mmc; 
25 µg/ml for 45 min), which blocks cell division. We found that CLIC4 knockdown 
results in significantly more severe inhibition of network formation when compared with 
mitomycin C-treated control cells (Fig 2.6a). The inhibitory effect of mitomycin C on cell 
proliferation was confirmed using the WST-8 proliferation assay done with endothelial 
cells grown as a monolayer for 120 h, the duration of the network formation assay (Fig 
2.6b). In fact, mitomycin C-treated control HUVEC showed significantly greater 
inhibition of proliferation than HUVEC shRNA3. 
 Quantification of network surface area and number of branch points (Fig 2.6c, d) 
confirmed that CLIC4 knockdown cells formed a less extensive capillary-like network 
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than mitomycin C-treated control cells. HUVEC network surface area occupation 
analysis indicates that HUVEC shRNA3 and shRNA5 covered only 74.1 and 63.9% of 
the surface area occupied by mitomycin C-treated control, respectively. Branch point 
number analysis at 5× objective also indicates that CLIC4 knockdown lines significantly 
inhibit network branching when compared with mitomycin C-treated control. We 
conclude that reducing CLIC4 expression has effects on in vitro endothelial network 
formation independent from the effects of reduced CLIC4 expression on proliferation. 
 
2.6 Altered CLIC4 expression affects capillary-like sprouting and lumen
 formation 
 Since the network structures in the previous assay are formed from cords without 
lumens, we assessed the effect of CLIC4 expression on in vitro capillary-like tube 
formation in a fibrin bead assay. HUVEC were adhered to dextran-coated Cytodex-3 
beads and embedded in a fibrin clot. D551 fibroblasts were then seeded and cultured in 
EGM-2 medium for 10 days as a monolayer on top of the fibrin clot to provide secreted 
factors [74]. Photographic documentation occurred on or between days 3 and 11, with 
sprout formation assessment beginning on day 3; sprout extension, branching, and lumen 
formation assessed from days 4 to 11; and anastomosis assessed from days 7 to 11. The 
sprouts resulting from this assay were multicellular, lumen-containing processes, 
consistent with previously published results [75]. 
 Chloride intracellular channel 4 knockdown HUVEC lines exhibited stunted 
sprouting and formed fewer sprouts (Fig 2.7a, b). Sprouts that formed from CLIC4 
knockdown HUVECs showed undersized sprouting, indicating a defect in sprout 
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elongation into the surrounding environment. Although HUVEC shRNA3 cells formed 
only shortened sprouts, these sprouts still contained lumen. In contrast, HUVEC shRNA5 
cells, which have less CLIC4 expression than HUVEC shRNA3, showed a reduction in 
lumen-containing structures. This was consistent with results from a separate but similar 
assay in which HUVEC were embedded in a thick collagen layer and allowed to undergo 
morphogenesis (Supp Fig 2.2) [76].  
Quantification of HUVEC shRNA5 results revealed that this lumen-forming 
defect was significant when compared with the number of lumen-containing sprouts 
control cells formed (Fig 2.7c). Disjointed lumen formation was also observed within 
CLIC4 knockdown cell line shRNA5 (Fig 2.7a, b). CLIC4 overexpression resulted in 
increased and more rapid sprouting when compared with pccl control cells (Fig 2.7d). 
Quantification of these results indicated that CLIC4 overexpression led to an increase in 
lumen-containing sprouts (Fig 2.7e). Together, these data demonstrate the necessity for 
appropriate CLIC4 expression to allow for in vitro capillary sprouting. Disrupting CLIC4 
function was found to impair HUVEC morphogenesis and lumen formation. 
 
2.7 Discussion 
 Chloride channels are known to function in several cellular processes such as 
maintaining membrane potentials, controlling cell volume, and regulating pH. To date, at 
least five independent chloride channel families have been documented in mammals [51]. 
To emphasize the importance of intracellular chloride regulation further, defects of 
intracellular chloride channels are associated with numerous diseases including those that 
affect the human neuromuscular, renal, skeletal, and respiratory systems [77]. As the 
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most recently discovered intracellular chloride channel family, our knowledge of CLIC 
functions is still evolving, and this study sought to determine if intracellular chloride 
channels also play a role in angiogenic processes and pathologies. 
 Currently, there are six identified mammalian CLICs defined by a C-terminal 
sequence of roughly 230 amino acids that display GST-like structure and function [54]. 
CLICs are highly homologous to each other and are conserved between vertebrate and 
invertebrate species [37]. Unlike other mammalian ion channels, CLICs are present in 
cells as both soluble cytoplasmic proteins and integral membrane proteins [54]. CLIC 
proteins have been shown to localize to intracellular membranes such as those of the 
Golgi, endoplasmic reticulum, mitochondria, and other membrane types [37, 50, 51]. 
CLIC4 localization can vary in different cell types and this seems to be specific to its 
function [51]. For example, in pro-apoptotic keratinocytes, CLIC4 translocates from the 
mitochondria to the nucleus, with the level of translocation being a factor in stress 
response regulation [45, 78]. Overexpression of CLIC4 in cells was also shown to 
promote membrane localization where CLIC4 may exhibit anion channel activity [79]. 
 In general, the activities of CLIC proteins are not well-documented and their 
precise functions in cellular processes are poorly understood. Even less is known about 
CLIC4 function in endothelial cells. To date, CLIC1 and CLIC4 are the only members of 
the CLIC family confirmed to be expressed in endothelial cells [49, 52, 54]. However, 
recent research identified a C. elegans homologue of CLIC4, EXC-4, as having 
tubulogenic functions, indicating a potential role for CLIC4 in endothelial angiogenesis 
[50]. Another study found CLIC4 to be among 120 proteins affected during VEGF-A 
driven endothelial tubulogenesis [49]. To support the notion of a CLIC4 role in 
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tubulogenesis, localization of CLIC4 on tubulogenic vesicles should be tracked at 
endogenous, knockdown, and overexpressing levels during angiogenesis either in vitro or 
ex vivo in a developing mouse retina.  
 We hypothesized that reduced CLIC4 expression in primary endothelial cells 
would negatively affect angiogenic processes, while increasing CLIC4 expression would 
lead to promoted endothelial angiogenesis. To test this hypothesis, RNAi were used to 
generate stable cultured primary HUVEC lines exhibiting CLIC4 knockdown expression. 
CLIC4-overexpressing HUVEC lines were also created using a lentiviral construct 
expressing full-length CLIC4. To analyze the effects of CLIC4 expression on various 
steps of in vitro angiogenesis, we utilized in vitro assays assessing endothelial cell 
survival, proliferation, migration, network formation, tube formation, and capillary 
sprouting. We present here a comprehensive analysis of the potential angiogenic 
functions of CLIC4 in vitro. 
 We found that CLIC4 is involved in several steps of in vitro angiogenesis after 
observing aberrant network formation, capillary sprouting, and lumen formation due to 
altered CLIC4 expression (Figs 2.5, 2.6 and 2.7). We also found that reduced CLIC4 
expression has a modest effect on endothelial cell survival (Fig 2.4) and a significant 
effect on cell proliferation (Fig 2.3). With these results, we conclude that CLIC4 
expression is required for proper endothelial cell proliferation and morphogenesis in vitro. 
Thus, we have defined a novel angiogenic signaling regulator and present CLIC4 as a 
potential target for anti-angiogenic therapies. 
 Using transient transfection of human telomerase-immortalized microvascular 
endothelial (TIME) cells with CLIC4 antisense constructs, a previous study [49] 
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documented decreased in vitro angiogenesis with an indication of reduced tube-like 
structures. In contrast to this report, our study documented several steps in angiogenesis 
dependent on proper CLIC4 expression, including cellular proliferation, endothelial 
network formation, and lumen formation, providing a deeper understanding of the role of 
CLIC4 in angiogenesis. This is the first study on CLIC4 function in primary endothelial 
cells (HUVEC), demonstrating a role for CLIC4 in endothelial proliferation and 
branching morphogenesis. 
 The mechanism by which CLIC4 functions to regulate in vitro angiogenesis is 
still unclear. A current model for endothelial tubulogenesis is based on vesicular fusion 
and cord hollowing [9, 20]. This process is known to involve cell apicobasal polarity [9, 
20], but the factors and molecular mechanisms that regulate this process are still not well 
understood. CLIC4 has previously been localized to intracellular vesicles in proliferating 
endothelial cells [49]. In C. elegans, EXC-4 is reported to localize to the apical luminal 
membrane of the excretory cell [50]. It is possible that the chloride ion channel function 
of CLIC4 plays a role in regulating vacuole formation, enlargement, and fusion since 
chloride channels are known to regulate water transport between a cell and its 
environment. As an ion channel, another plausible mechanism for CLIC4 involvement in 
angiogenesis would involve regulating electric potentials generated by the acidification 
required for vesicular fusion [80]. The resolution of the precise mechanisms of CLIC4 
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Figure 2.1 | Establishing CLIC4 knockdown and overexpression in endothelial cells. 
(a) Immunoblotting for CLIC4 confirms knockdown of CLIC4 protein expression in 
shRNA3 and shRNA5 endothelial cell lines compared with plko sc control line. CLIC1 
immunoblotting confirms that knockdown is specific to CLIC4 and CLIC1 expression is 
not affected. (b) Immunoblotting for CLIC4 confirms CLIC4 overexpression in the 
CLIC4 endothelial cell line compared with pccl control. Alpha-tubulin serves as a 
loading control. (c) HUVEC shRNA3 knockdown cells exhibit no major change in 
endothelial cell morphology while HUVEC shRNA5 appear to be more rounded when 
compared with plko sc. HUVEC refer to endothelial cells that have not been infected 
with any constructs. (d) No major change was observed in endothelial cell morphology 
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Figure 2.2 | CLIC4 expression has no effect on endothelial cell migration. (a) CLIC4 
knockdown cell lines shRNA3 and shRNA5 exhibited no noticeable change in directed 
endothelial cell migration 6 h after scraping in a migration assay when compared with 
control plko sc. (b) Likewise, CLIC4-overexpressing cells exhibited no noticeable change 
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Figure 2.3 | CLIC4 expression promotes endothelial cell proliferation. (a) Inhibition 
of CLIC4 expression by shRNA resulted in decreased endothelial cell proliferation when 
compared with plko sc control. (b) CLIC4 overexpression resulted in a significant 
increase in endothelial cell proliferation when compared with control pccl. (*p < 0.05; 
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Figure 2.4 | Altering CLIC4 expression affects endothelial cell survival. (a) CLIC4 
knockdown lines significantly increased cell survival at 48 h, but not 24 h post-seeding. 
(b) CLIC4 overexpression resulted in significantly decreased endothelial cell survival at 
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Figure 2.5 | CLIC4 expression promotes in vitro endothelial network formation. (a) 
Microscopy of CLIC4 knockdown or overexpressing cells in a collagen network 
formation assay shows decreased network formation with CLIC4 knockdowns, while 
CLIC4 overexpression results in increased network formation when compared with 
respective controls. (b) Quantification confirms that CLIC4 knockdown results in 
decreased network formation by showing that reduced CLIC4 expression leads to a 
significant reduction in surface area coverage by endothelial cells. CLIC4 overexpression 
leads to increased network formation with a significant increase in surface area occupied 
by endothelial cells. Control standards were set at 100% surface area occupation. (c) 
Quantification of branch points for each knockdown cell line further confirms CLIC4 
knockdown inhibition on endothelial network formation. Knockdown cell lines form 
significantly fewer branch points than control plko sc. Quantification was done by 
counting visible branch points per field of view at 10× objective. (d) CLIC4-
overexpressing cells form significantly more branch points than control pccl. 
Quantification was done by counting visible branch points per field of view at 5× 
objective. One branch point was considered any focal intersection of two or more cords. 
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Figure 2.6 | Reduced CLIC4 expression inhibits endothelial network formation 
independent of its proliferative defect. (a) Comparison of network formation by 
knockdown cell lines and control cells treated with mitomycin C indicates that there is 
inhibition of network formation independent from reduced CLIC4 inhibition of 
proliferation. (b) A proliferation assay confirms mitomycin C growth arrest of plko sc 
control cells. (c) Quantification of surface area occupied by endothelial cells confirms an 
additional defect associated with reduced CLIC4 expression independent of reduced 
CLIC4 proliferation inhibition. Mitomycin C-treated control standards were set at 100% 
surface area occupation. (d) Quantification of branch points further confirms an 
additional defect associated with reduced CLIC4 expression separate from reduced 
CLIC4 proliferation inhibition. (*p < 0.05 compared with plko sc; **p < 0.01 compared 
with plko sc; 
+
 p < 0.05 compared with plko sc + mmc; 
++
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Figure 2.7 | CLIC4 expression affects capillary-like sprouting in vitro. (a) Microscopy 
indicates that HUVEC shRNA3 have altered tube morphogenesis in that they tend to 
form shorter, more stunted tube structures as indicated by a red arrow. HUVEC shRNA5 
show a decrease in the number of branches per sprout. HUVEC shRNA5 also exhibited 
stunted sprouts indicated by a red arrow. Unlike HUVEC shRNA3 cells, HUVEC 
shRNA5 cells did not form lumens. Black arrows indicate robust, lumen-containing 
sprouts. (b) Microscopy from a separate trial confirms the phenotypes of HUVEC 
shRNA3 stunted tube structures and HUVEC shRNA5 stunted sprouts without lumens. (c) 
Quantification of the number of lumen-containing sprouts shows that HUVEC shRNA5 
exhibits a significant decrease in the number of lumen-containing sprouts formed when 
compared with plko sc control. (d) Microscopy of CLIC4-overexpressing endothelial 
cells show increased sprouting and lumen formation when compared with plko sc control. 
Lumen-containing sprouts are indicated by black arrows. (e) Quantification for CLIC4-
overexpressing endothelial cells indicates a significant increase in the number of lumen-










2.9 Additional discussion 
 Two issues not addressed in our manuscript [56] are how CLIC4’s putative 
chloride channel activity and other possible functions of CLIC4 could affect angiogenesis. 
To date, CLIC4 has only shown poorly selective anion channel activity in artificial 
bilayers [58] and has not shown chloride conductance in cultured endothelial cells [46]. 
Consistent with these observations, Dazhi Xiong, from our collaborator Robert Kass’s 
laboratory, found no channel conductance in HEK 293 cells transfected with CLIC4-GFP 
overexpression vector (Supp Fig 2.3).  
Meanwhile, the GST-domain of CLIC4 is implicated in regulating translocation to 
the plasma membrane upon sphingosine-1-phosphate (S1P) or lysophosphatidic acid 
(LPA) induction [46], suggesting a previously unstudied role for the GST-domain of 
CLIC4. CLIC4 has also been implicated in immune responses to bacterial 
lipopolysaccharide induction, suggesting a role for CLIC4 in inflammation and 
macrophage function [81]. As S1P, LPA, and macrophages are well-documented 
mediators of angiogenesis [82-84], the role of CLIC4 in angiogenesis could certainly 
depend on one of these pathways instead of, or in addition to, its putative chloride 
channel activity. There are currently no reports addressing the potential roles of CLIC4 
when it is resident in the cytoplasm. The varying roles of CLIC4 in differing cell types 
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Supplementary Figure 2.1 | Clic1 and Clic4 are most highly expressed in cultured 
endothelial cells. HUVEC were screened for the expression of CLIC1-6 using specific 
primers through 30 PCR cycles in a semi-quantitative PCR screen. CLIC1 and CLIC4 
show highest expression while CLIC2 and CLIC5 are expressed at extremely low levels. 
Gene fragments cloned into a TA-cloning vector using the same screening primers were 
used as positive controls.  














Supplementary Figure 2.2 | CLIC4 expression affects endothelial morphogenesis in 
a three-dimensional extracellular matrix. HUVEC with CLIC4 knockdown exhibit 
reduced ability to form endothelial tube-like structures. Structures formed are tortuous 
and contain disjointed or absent lumens, indicated by red arrows in comparison to black 
arrows of control cells. HUVEC overexpressing CLIC4 are qualitatively comparable to 
control cells in terms of lumen formation (black arrows) and vessel morphology.  



















Supplementary Figure 2.3 | CLIC4 expression does not affect ion conductance at the 
plasma membrane in HEK 293 cells. Patch clamping was used to assess ion channel 
conductance at the plasma membrane of single HEK 293 cells transfected to express 
either GFP (control, left panel) or CLIC4-GFP (CLI4 overexpressing, right panel). 
Representative results from single cells are shown here. Currents shown here represent 
potassium currents known to be endogenous to HEK cells. No difference in currents were 
found between GFP-expressing control cells and CLIC4-overexpressing cells, suggesting 
that CLIC4 does not have any ion channel activity in HEK 293 cells at the plasma 
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Chapter Three: Generation and characterization of Clic4 knockout mice 
 
 To assess the physiological relevance of our in vitro findings, we designed and 
generated Clic4 knockout mice for in vivo analyses. This chapter details the generation 
and resultant examination of our Clic4 knockout mice. I performed all data gathering and 
analysis for the material in this chapter. Thomas Ludwig provided assistance in the initial 
design of the knockout mouse targeting construct and Southern blot genotyping strategy. 
Victor Lin performed electroporation of the targeting vector into ES cells and 
microinjection into blastocysts. Thaned Kangsamaskin and Ian Tattersall provided 
technical assistance with tumor implantation studies. Valeriya Borisenko performed 
sectioning on embedded tumors. Irina Jilishitz assisted in performing histology on tumor 
sections. Both Thomas Ludwig and Jan Kitajewski participated in analyzing results.  
 
3.1  Abstract 
 CLIC4 belongs to the CLIC family of proteins, which exist as both cytoplasm-
soluble and membrane-bound proteins in a wide variety of tissues. To examine the 
biological role of CLIC4 during vascular development, we engineered conditional Clic4 
knockout mice. Germline deletion of Clic4 was achieved by Cre-mediated recombination 
of the conditional allele. Mice heterozygous for Clic4 are viable, fertile, and appear 
normal. Clic4 homozygous knockout mice are fertile and viable, however they are 
underrepresented and have a subtle angiogenic defect in the developing retina 
characterized by less dense retinal vasculature. Preliminary results also reveal a 
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 The chloride intracellular channel (CLIC) family of proteins comprises CLIC1-6 
in mammals. CLICs are highly conserved in vertebrates and invertebrates [42], and their 
presence as both soluble and membrane-bound channels makes them unique as channel 
proteins [54]. Thus far, chloride channel activity has been shown for CLIC1, 2, 4, and 5 
[32, 33, 43, 66].  
 The subcellular localization of CLIC4 seems to be context-dependent, suggesting 
that CLIC4 may play roles in a variety of biological processes. CLIC4 has been localized 
to the cytoplasm, nucleus, mitochondria, at cell junctions, centrosomes, on intracellular 
vesicles, the plasma membrane, the nuclear membrane, and the mitochondrial membrane 
in various cell types [45, 49, 85, 86]. CLIC4 is reported to bind brain dynamin I directly 
and interact with several cytoskeletal elements such as actin, ezrin, and tubulin [70, 87]. 
CLIC4 is also shown to be VEGF- [49], F-actin- [43], S1P- [46], and p53-regulated [45, 
88], suggesting roles for CLIC4 in such diverse processes as angiogenesis, maintaining 
cell polarity, migration, and cell cycle regulation. In addition, CLIC4 is found in all 
tissues that have been analyzed, indicating ubiquitous expression [70, 78]. Furthermore, 
the putative channel activity of CLIC4 points to a function in maintaining membrane 
polarity or regulating cell/vesicle volume [80].  
 The structure of CLIC4 suggests that it is a single-pass transmembrane protein 
with the transmembrane domain near the N-terminus [33, 58]. A conformational change 
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from its globular cytoplasmic state to its transmembrane state is thought to be induced 
with redox reactions [59]. The channel activity of CLIC4 is still being assessed, though it 
is thought to form poorly selective anion channels with activity dependent upon pH [58]. 
As a soluble monomer, CLIC4 is structurally similar to CLIC1 [59], but CLIC4 has been 
found in its soluble state as a homotrimer, which imparts an organization distinct from 
CLIC1 [38].  
 CLIC4 is a 253 amino acid putative ion channel that is highly conserved across a 
range of species. Only two amino acid substitutions separate mouse CLIC4 from human 
CLIC4 [89]. In humans, Clic4 is located at 1p36.11 while it is at chromosome 4 D3; 4 in 
mice. Mouse Clic4 contains five introns and six exons with the coding sequence 
beginning 225 base pairs into exon 1.  
 The functional roles of CLIC4 remain unclear. To investigate the role of CLIC4 in 
vivo, we disrupted Clic4 in mice through the generation of conditional Clic4 knockout 
mice using homologous recombination in embryonic stem cells. Preliminary analyses 
indicate that Clic4 is not required for developmental angiogenesis or normal development, 
however loss of Clic4 results in decreased angiogenic activity and enhanced tumor 
development. 
 
3.3 Clic4 targeting scheme 
 As the putative transmembrane domain (PTM) of Clic4 is thought to be 
invaluable to its proper localization and function [37, 50], we targeted exon 2 for 
conditional deletion. Exon 2 encodes the pore-lining α-helix and second β-sheet of the 
PTM and is 110 base pairs [37, 89]. Upon Cre-mediated recombination, the elimination 
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of exon 2 would result in deletion of a majority of the PTM and a frameshift mutation. If 
a resulting splice variant were generated and stable, it would encode a roughly 10 kDa 
protein comprising 24 amino acids, encoded by exon 1 and 28 amino acids encoded by 
the disrupted exon 3 before the introduction of a stop codon. This protein would have no 
similarity to endogenously produced CLIC4.  
The targeting vector utilizes loxP sites, one each placed in introns upstream and 
downstream of exon 2 and in the same orientation (Fig 3.1a). A flrted (flanked by FRT) 
neomycin cassette was placed within intron 1 for positive selection of ES cell clones. The 
herpes simplex virus thymidine kinase (HSV-tk) gene cassette was used for negative 
selection in the targeting vector. This conditional targeting vector was termed 
pClic4floxed and constructed from a BAC RP23 genomic DNA clone.  
 pClic4floxed was electroporated into CSL3 ES cells derived from 
129S6/SvEvTac-Car3 (designated 129) background mice, and 192 neomycin-resistant 
clones were isolated. Southern blotting and PCR were used to identify clones that had 
undergone homologous recombination and carried the correctly targeted Clic4, termed 
the Clic4
fl
 allele. Southern blot analysis of PstI-digested genomic DNA with a 5’ 
32
P-
labeled probe external to the targeting vector was used to confirm proper integration of 
the upstream loxP site (Fig 3.1b) while PCR confirmed proper integration of the 
downstream loxP site (Fig 3.1c). Of the 192 isolated clones, 11 ES cell clones were found 
to be properly targeted with both loxP elements. Two of these ES cell clones were 
microinjected into C57BL/6 (designated B6) background host blastocysts for generation 
of chimeric mice. Germline transmission was established first by observing agouti coat 
color and then through genotyping. Subsequent genotyping for Clic4
fl
 was performed by 
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PCR using the same genotyping scheme to confirm proper integration of the downstream 
loxP site.  
 Once Clic4
fl
 chimeric mice were generated, mouse embryonic fibroblasts (MEFs) 
were isolated from mice heterozygous for the Clic4
fl
 allele and transfected with 
adenovirus expressing either GFP or Cre recombinase to ensure loxP recombination 
events were occurring. Screening for recombination events was done by Southern blot 
analysis using Pst1-digested genomic DNA isolated from the MEFs (Fig 3.1d). After 
confirming Cre recombination, Clic4
fl
 heterozygotes were intercrossed to produce 
Clic4
f/fll
 homozygous mice in a mixed B6;129 hybrid background.  
 
3.4 Clic4 knockout mice are underrepresented, but viable and fertile 
 For analysis of the Clic4 null allele, we crossed F1 generation B6;129 Clic4
fl/fl
 
homozygous male mice with female mice expressing EIIa-Cre transgenic mice, allowing 
for global removal of Clic4. The Ella adenoviral promoter drives Cre-recombinase 
expression in oocytes and preimplantation embryos [90]. All subsequent genotyping for 
Clic4 knockout mice occurred by PCR analysis as schematized in Figure 3.1a. Clic4
+/-
 
were crossed with pure B6 wild-type mice for 8 generations to generate Clic4
+/-
 mice in a 
pure B6 background. The data reported in this chapter were obtained from studies on 
these Clic4 knockout mice considered to be in a pure B6 genetic background.  
 Clic4
+/-
 mice were viable, healthy, and fertile; however crosses between two 
Clic4
+/-
 mice produced Clic4
-/-
 in skewed Mendelian ratios (Table 3.1a). Of the 25% mice 
from a pool of 78 resultant offspring expected to be Clic4
-/-





 mice are born 28.2% less than Mendelian distribution predicts as 
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analyzed by a χ
2
 test (p < 0.03). Postnatal morbidity is unlikely to account for this 
discrepancy as all pups born were genotyped. Furthermore, genotyping embryos at 9.5 
days post coitus (dpc) indicates that Mendelian distribution is restored (p > 0.05) (Table 
3.1b). PCR analysis and Western blotting of lung tissue isolated from Clic4 homozygous 
knockout mice confirmed corresponding loss of CLIC4 (Fig 3.2).  
Whole mount staining of 9.5 dpc embryos with endothelial marker endomucin 
showed no overt differences between vasculature of Clic4
-/-
 mice and wild-type 
littermates suggesting that vasculogenesis and angiogenesis are not affected by deletion 
of Clic4 (Fig 3.3). Surviving Clic4
-/-
 mice are viable, fertile, and did not exhibit gross 
physical phenotypes apart from a mild runting, consistent with reports of adult Clic4
-/-
 
mice being smaller in size by weight [67]. Nonetheless, this underrepresentation of Clic4
-
/-
 mice suggests that CLIC4 is required for embryonic viability in a small percentage of 
embryos. Thus, CLIC4 plays a role in development, but only minimally or rarely.  
 
3.5 Clic4 knockout mice display subtle defects in postnatal angiogenesis and may 
have reduced macrophage content in the developing retina 
 Although surviving Clic4
-/-
 mice appeared to develop normally, we wanted to 
evaluate the effect of Clic4 loss on postnatal angiogenesis, given its established role in in 
vitro angiogenesis as described in Chapter 2. To study postnatal angiogenesis in our 
Clic4
-/-
 mice, we dissected retinas at specific stages of vascular development and 
performed FITC-conjugated isolectin staining on retina whole mounts to view the 
vasculature. The mouse retina is avascular at birth, and angiogenesis in the mouse retina 
is well-characterized in defined stages [91, 92]. Briefly, from birth to postnatal day 7 (P7), 
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angiogenesis from the central retinal artery forms a capillary network that extends 
through the retina to the periphery, termed the primary plexus or superficial layer. From 
P7 to P21, angiogenesis occurs first perpendicular to the primary plexus and then parallel 
to create the intermediate and deep vascular plexuses. While vasculature, marked by 
endothelium-specific marker IB4, appeared well-organized in P5 and P9 retinas isolated 
from Clic4
-/-
 mice, vascular density appeared reduced at all levels analyzed (Fig 3.4a), 
consistent with published data [67]. Vasculature in the deep vascular plexus of Clic4
-/-
 
mice also presents robust vascular structures that are not notable in wild type mice, 
suggesting an increased amount of vessel regression or pruning.  
Since macrophages are known to mediate anastomosis during angiogenesis 
through their responses to and secretion of angiogenic factors [82, 93-95], we also 
assessed macrophage content using macrophage-specific marker F4/80. Preliminary 
results suggest reduced macrophage content in retinas from Clic4
-/-
 mice as indicated by 
qualitatively lighter F4/80 staining, suggesting one possible mechanism by which Clic4 
knockout results in less dense retinal vasculature (Fig 3.4b). Lack of properly localized 
macrophages may be responsible for the increased pruning or regression seen in Clic4
-/-
 
mice retinas at the deep vascular plexus.  
 
3.6 Clic4 knockout may enhance tumor growth and metastasis 
 While we found normal physiological angiogenesis to be only subtly affected, 
other reports suggest that this phenotype is enhanced when pathological angiogenesis is 
induced [67]. Thus, we sought to determine if Clic4 knockout affects tumor-induced 
angiogenesis or tumorigenesis. To examine the effects of Clic4 knockout on 
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tumorigenesis, we used the murine Lewis lung carcinoma model, which has a well-
characterized metastatic pathway to the lungs [96]. The Lewis lung carcinoma line is 
syngeneic to the B6 genetic background, and these Lewis lung carcinoma cells express 
luciferase, enabling non-invasive visualization of tumor progression. Briefly, Lewis lung 
carcinoma cells were injected subcutaneously into the upper right flank of Clic4
-/-
 mice or 
wild type littermates. 21 days after implantation of Lewis lung carcinoma cells, tumors 
and lungs were harvested and analyzed. As the Lewis lung carcinoma cells are Clic4
+/+
, 
this presents an environment in which only the invading host cells are Clic4-/-, providing 
a means by which we are able to study the effects of Clic4 knockout only on invading 
vasculature.  
In preliminary experiments, we found that tumors isolated from Clic4
-/-
 mice 
tended to be larger by weight than tumors isolated from heterozygous littermates (p < 
0.05) (Fig 3.5a). Although not statistically significant, average tumor size by weight from 
Clic4
-/-
 mice tended to be greater than tumors from wild type littermates. There was no 





mice based on average size by weight. We also noted larger and more numerous 
metastases in lungs isolated from Clic4
-/-
 mice (Fig 3.5b). Metastases were visualized 
using the IVIS molecular imaging system to detect fluorescent signals in luciferin-soaked 
lungs.  
 Immunofluorescent histology with macrophage marker F4/80 performed on tumor 
sections suggests a reduction in macrophage content in tumors isolated from Clic4
-/-
 mice 
(Fig 3.5c); however F4/80 does not differentiate between macrophage subtypes. This 
finding could indicate a shift in M1:M2 macrophage phenotype ratios and further analysis 
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is needed to determine macrophage profile. Qualitatively, endothelial cell (CD31) and 





 mice, but overall vessel architecture appears altered (Fig 3.5d). Altered 
macrophage content and vessel architecture suggest two mechanisms by which Clic4 
knockout may be enhancing tumorigenesis.  
 
3.7 Discussion 
 Based on previous reports of CLIC4 being involved in in vitro angiogenesis [49, 
56], we sought to study the role of CLIC4 in a physiological setting by generating a Clic4 
knockout mouse line. The ubiquitous expression and evolutionary conservation of CLIC4 
across vertebrates and invertebrates suggests an important role for the normal function of 
CLIC4 [42, 70]. Because of this implication, we had anticipated embryonic lethality upon 
Clic4 knockout and designed a conditional Clic4 targeting strategy (Fig 3.1). Surprisingly, 
we found Clic4
-/-
 mice to be viable and fertile, albeit underrepresented at birth (Table 3.1). 
This difference in penetrance may be due to an underlying defect in the hypoxic response 
during prenatal development. Alternatively, Western blotting confirmed that Clic4
-/-
 mice 
did not express CLIC4 (Fig 3.2).  
 Analysis of Clic4
-/-
 embryos at 9.5 dpc, a critical time for embryonic angiogenesis, 
suggests that postnatal underrepresentation is not due to an angiogenic defect, although 
angiogenic defects may only occur in a small subset of Clic4
-/-
 embryos (Fig 3.3). 
Development progresses normally up to 9.5 dpc as embryo genotypes coincide with 
Mendelian ratios at this time point (Table 3.1). Nevertheless, surviving Clic4
-/-
 mice 
present subtle defects in postnatal angiogenesis in the retina, characterized by reduced 
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vascular density and the presence of less robust vascular structures (Fig 3.4a). These 
findings are consistent with in vitro analyses that concluded knocking down CLIC4 
reduces endothelial network formation and capillary-like sprouting [56]. Also consistent 
with previous findings, the reduced vascular density in the retina could be an effect of 
reduced endothelial cell growth since knocking down CLIC4 has been shown to reduce 
endothelial proliferation [56]. Increased vessel regression could be indicative of reduced 
vessel patency, which would be consistent with the hypothesis that CLIC4 plays a role in 
mediating tubulogenesis as capillaries without patent lumens would experience less sheer 
stress and be pruned [97, 98]. 
Preliminary results suggest that developing retinas from Clic4
-/-
 mice have 
reduced macrophage content (Fig 3.4b). This defect could be due to either a macrophage 
recruitment defect due to CLIC4 deficiency or a migratory defect in macrophages 
incurred by Clic4 deletion since the mice were global Clic4 knockouts. Regardless, the 
macrophage deficiency could account for the lower vascular density in Clic4
-/-
 mouse 
retinas as macrophages have been shown to mediate anastomosis during angiogenesis 
[82]. More in-depth analysis will be required to define the effects of Clic4 knockout on 
angiogenesis in either the endothelium or macrophages. Our conditional targeting design 
makes the generation of endothelial or macrophage tissue-specific Clic4 knockout 
possible for such studies. A macrophage-specific Clic4 knockout line would further 
address the question of whether or not the macrophage defect is cell autonomous.  
Based on our findings of reduced retinal vasculature and macrophage content in 
Clic4
-/-
 retinas, we initially hypothesized tumorigenesis in Clic4
-/-
 mice to be inhibited by 
reduced tumor-induced angiogenesis and decreased inflammation due to lower 
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macrophage content [8, 99, 100]. Interestingly, we instead found tumorigenesis to be 
enhanced in preliminary experiments, evidenced by larger tumors and more lung 
metastases from Clic4
-/-
 mice compared to their wild type littermates (Fig 3.5a & b). 
Upon histological analysis of tumor sections with endothelial, smooth muscle, and 
macrophage specific markers (CD31, αSMA, and F4/80, respectively), we found 
macrophage content to be reduced in tumors isolated from Clic4
-/-
 mice (Fig 3.5c). We 
also found endothelial and smooth muscle content to be relatively normal, however 
overall vessel architecture may be modified (Fig 3.5d).  
 One possibility to explain the unexpected findings from the tumor studies could 
be that an altered macrophage profile occurs due to loss of Clic4. Loss of Clic4 has been 
shown to be protective from lipopolysaccharide (LPS)-induced death characterized by a 
reduced inflammatory response [81]. Consistent with these findings, the same study 
found that CLIC4 overexpression enhanced the inflammatory response of macrophages 
after LPS exposure. These data indicate that CLIC4 plays a role in the innate immune 
response to microbial exposure functioning through macrophages. These reports together 
with my findings of reduced macrophage content in both Clic4
-/-
 developing retinas and 
tumors harvested from Clic4
-/-
 mice suggest that Clic4
-/-
 mice may have reduced abilities 
to clear cancer cells upon tumor implantation and during the early stages of 
tumorigenesis.  
 While macrophage content may be reduced in Clic4
-/-
 isolated tumors, the 
macrophage profile could be shifted from an M1 inflammatory macrophage phenotype to 
a more M2 pro-tumor macrophage phenotype. Tumor-associated macrophages (TAM) 
are now accepted to be of the M2 phenotype [101, 102]. The M1/M2 phenotypes of 
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macrophages have been well-reviewed [103, 104], but briefly, the M1 macrophage 
phenotype is generally associated with inflammation, tumor resistance, and tissue 
destruction while the M2 macrophage phenotype imparts a more pro-angiogenic, tissue 
remodeling, tumor promoting character. Cytokines and microbes are responsible for 
activating the two polarized macrophage phenotypes. It has been suggested that inhibiting 
M2 activity and inducing M1 activity could restore the anti-tumor functions of TAM 
[105].  
 Overall, this study suggests that the functional roles of Clic4 in murine 
developmental and postnatal angiogenesis can be compensated upon loss by Clic4-
independent pathways, or conversely, Clic4 does not participate in physiological 
angiogenesis. Such partial phenotypes as postnatal underrepresentation, subtle 
angiogenesis defects, and reduced macrophage content could also be due to functional 
compensation by other CLICs, specifically CLIC1, which is also widely expressed and 
evolutionarily well-conserved. This study also constitutes the first assessment of Clic4 
deletion effects on tumorigenesis and the discovery of a novel Clic4 deletion effect on 
macrophage content. Identification of critical Clic4 roles may depend on deletion of 
additional Clic family members, the deletion of Clic4 in a tissue-specific manner, and 
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Figure 3.1 | Diagram of Clic4 targeting strategy and ES cell targeting confirmation. 
(a) Schematic of the wild type Clic4 allele, targeting vector pClic4floxed, targeted Clic4
fl
 
allele, and the recombined Clic4
-
 allele. Clic4 exons, loxP sites, neomycin resistance 
cassette, and FRT sites are represented by black boxes, gray triangles, a white box (NEO), 
and light gray ovals, respectively. P1 refers to the probe used for Southern blot analysis, 
and Pst1 diagnostic restriction sites are depicted. Positive bands from Southern blot 
analysis are represented by dotted lines. The start site is depicted by a black arrow off 
exon 1, and primer sets used for PCR screening are depicted as dark gray and light gray 
arrows. (b) Presence of a lower band at 7.1 kb from Southern blotting of Pst1 digested 
genomic DNA isolated from representative, putatively targeted ES cell line ES1 indicates 
proper integration of the flrted neomycin cassette carrying the upstream loxP site. (c) 
Presence of a higher band at 239 bp from PCR of genomic DNA isolated from putatively 
targeted ES cell line ES1 confirms proper integration of the downstream loxP site. (d) 
Genomic DNA isolated from MEFs of mice heterozygous for Clic4
fl
 and transfected with 
GFP or Cre recombinase was digested with Pst1 and subject to Southern blotting. 
Absence of a band at 7.1 kb in the presence of Cre recombinase and subsequent presence 




















Figure 3.2 | Confirmation of Clic4 knockout. (a) Presence of a 420 bp band confirms 
deletion of Clic4 exon 2 in a genotyping PCR of wild type (WT), Clic4 homozygous 
knockout (
-/-
), and Clic4 heterozygous (
+/-
) mice genomic DNA. A 1.2 kb band is 
indicative of wild type Clic4 allele. (b) Absence of a band at 29 kD in a Western blot for 
CLIC4 of protein isolated from Clic4 homozygous knockout mice lung cells confirms 















































Figure 3.3 | Clic4 homozygous knockout mice are phenotypically normal at 9.5 dpc. 
Clic4
-/-
 mice exhibit mild runting at e9.5 dpc, but are otherwise phenotypically normal. 
Presence of vasculature highlighted by staining with endothelial marker endomucin 




























Figure 3.4 | Clic4 knockout mice show reduced retinal vasculature and macrophage 
content. (a) Retinal whole mount staining with endothelial marker IB4 (green) shows 
reduced vasculature density in the primary vascular plexus at P5 (above) and the 
developing deep vascular plexus at P9 (below). White arrows indicate less robust 
vasculature. (b) Retinal whole mount staining with macrophage-specific F4/80 (red) 
indicates reduced macrophage content in Clic4
-/-














































Figure 3.5 | Tumorigenesis is enhanced by Clic4 knockout. (a) Tumors harvested from 
Clic4
-/-
 mice are larger by weight than tumors harvested from Clic4 heterozygous 
littermates (p < 0.05) and tend to be larger than tumors from wild type littermates. No 
statistically significant difference in weight was found between tumors from Clic4 
heterozygous mice and wild type littermates. (b) The average number of metastases 
found on lungs dissected from Clic4 knockout mice was greater than lungs from either 
Clic4 heterozygous or wild type littermates. In addition, lungs dissected from Clic4 
knockout mice presented more large metastases as indicated by dark gray shading. Larger 
and smaller metastases were differentiated by fluorescent signal intensity. (c) 
Macrophage staining using F4/80 suggests reduced macrophage content in tumors from 
Clic4
-/-
 mice. (d) Endothelial (green) and smooth muscle (red) content appear comparable 
between tumors from Clic4 knockout and wild type mice. Vessel architecture may be 
altered as suggested by a lack of differentiation between the endothelial and smooth 
muscle layers. Endothelia are marked by CD31 while αSMA marks smooth muscle cells. 
























 embryos at 9.5 dpc 
n = 78, p = 0.03  n = 48, p = 0.72  
genotype expected actual  genotype expected actual  
Clic4
-/-
 19.5 14  Clic4
-/-
 12 14  
Clic4
+/-
 39 35  Clic4
+/-
 24 24  
Clic4
+/+
 19.5 29  Clic4
+/+
 12 10  
 
 
Table 3.1 | Clic4
-/-
 mice are underrepresented at birth. (a) Genotyping of 78 progeny 
from Clic4
+/-
 intercrosses reveals that Clic4
-/-







 ratios deviate significantly from normal Mendelian ratio (p < 
0.05). (b) Genotyping of 48 embryos collected at 9.5 dpc from Clic4 
+/-
 intercrosses 
concurs with normal Mendelian ratio (p > 0.05). Blue coloring indicates expected 
numbers for that genotype according to Mendelian predictions while red coloring 




Chapter Four: Chloride intracellular channel 1 functions in endothelial cell growth 
and migration 
 
 Once we determined that CLIC4 was an angiogenic effector, we sought to 
characterize CLIC1 in much the same manner. Our goals were to determine which steps 
of angiogenesis are affected when inhibiting CLIC1 expression. Using in vitro analysis, 
we found that knocking down CLIC1 most drastically affects endothelial growth and 
network branch formation. We noted some overlapping phenotypes between CLIC1 
knockdown and CLIC4 knockdown in endothelial cells, namely the effects on cell growth, 
network formation, and sprouting. Altering CLIC1 expression levels did not affect lumen 
formation like altering CLIC4 expression did, whereas only CLIC1 knockdown resulted 
in a migratory defect. This chapter contains the manuscript I authored on this subject as 
published in Journal of Angiogenesis Research (Nov 2010) as well as additional results 
and discussion. I performed all data gathering and analysis for the material in this chapter. 
Jan Kitajewski participated in analyzing results. Jan Kitajewski participated in revising 
the manuscript, with assistance from Minji Kim and Sonia Hernandez during the editing 
process. Samuel N Breit provided the Clic1
-/-
 mice that are characterized in section 4.11.  
 
4.1 Abstract 
 Little is known about the role of CLIC1 in endothelium. These studies investigate 
CLIC1 as a regulator of angiogenesis by in vitro techniques that mimic individual steps 
of the angiogenic process. Using shRNA against Clic1, we determined the role of CLIC1 
in primary human endothelial cell behavior. Here, we report that reducing CLIC1 
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expression causes a reduction in endothelial migration, cell growth, branching 
morphogenesis, capillary-like network formation, and capillary-like sprouting. FACS 
analysis showed that CLIC1 plays a role in regulating the cell surface expression of 
various integrins that function in angiogenesis including β1 and α3 subunits, as well as 
αVβ3 and αVβ5. Together, these results indicate that CLIC1 is required for multiple steps 
of in vitro angiogenesis and plays a role in regulating integrin cell surface expression. 
 
4.2 Introduction 
 The chloride intracellular channel (CLIC) gene superfamily consists of seven 
distinct paralogues (p64 and CLIC1-6) and constitutes a unique class of mammalian 
channel proteins that exist as both cytoplasm-soluble proteins and membrane-bound 
channels [106]. CLICs are structurally related to the glutathione S-transferase (GST) 
superfamily and are defined by an approximately 240 conserved amino acid sequence at 
the C-terminus [107]. Most of the distinct CLIC proteins are shown to form channels in 
artificial bilayers [39, 59, 66, 108, 109], but their selectivity for chloride as channels is 
still under contention [43, 58]. CLICs and their homologues are highly conserved among 
both vertebrates and invertebrates [36, 37]. 
 Since their discovery, members of the CLIC family have been implicated in such 
diverse biological processes as apoptosis [45], differentiation [45, 110], cell cycle 
regulation [106], and cell migration [43] in a variety of different cell types. In separate 
studies, CLIC4 was found to promote endothelial proliferation and morphogenesis [56] 
and to function in mouse retinal angiogenesis [67]. The current model for the angiogenic 
function of CLIC4 involves CLIC4 channel activity in the acidification of vesicles [67], a 
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process that may be linked to lumen formation or tubulogenesis [20]. The Hobert group 
also demonstrated the requirement of C. elegans CLIC4 orthologue EXC-4 expression in 
preventing cystic disruption of an expanding C. elegans excretory canal and defined a 
role for EXC-4 in maintaining proper excretory canal lumen size[49]. A chimeric 
construct expressing human CLIC1 with the putative transmembrane domain (PTM) of 
exc4 is able to rescue the cystic disruption phenotype of the excretory canal in exc4 null 
mutants, suggesting that CLIC4 and CLIC1 may have overlapping functions [37]. 
 To date, six CLIC genes (CLIC 1-6) are identified in mice and humans, and 
CLIC1 and CLIC4 are reported to be strongly expressed in endothelial cells [49, 52, 54]. 
As CLIC4 is linked to the process of angiogenesis and lumen formation within 
endothelial cells [50, 67], interest in the possibility that other CLICs are involved in 
angiogenesis has grown. Structural studies indicate that oxidized CLIC1 forms dimers in 
artificial bilayers and vesicles with the PTM located near the N-terminus [39, 111]. It is 
also suggested that CLIC1 activity is dependent on pH [40]. Studies localize CLIC1 to 
the nuclear membrane and it is suggested that CLIC1 can regulate the cell cycle of CHO-
K1 cells [106]. CLIC1 is almost ubiquitously expressed in human and mouse adult and 
fetal tissue [106] and is shown to be F-actin regulated, suggesting that it could function in 
solute transport, during any number of stages in the cell cycle, or during cell migration 
[43]. In several columnar epithelia tissue samples, including but not limited to the renal 
proximal tubes, small intestine, colon, and airways, CLIC1 is found to be expressed in the 
apical domains suggesting a role in apical membrane recycling [54]. The same study also 
finds that CLIC1 subcellular distribution is polarized in an apical fashion in human colon 
cancer cells while another study finds it localized to intracellular vesicles in renal 
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proximal tubule cells [112]. Since the process of angiogenesis is known to involve 
endothelial cytoskeletal reorganization, apical-basal polarization, and endothelial 
proliferation [9, 113], these studies suggest CLIC1 may function in endothelial 
morphogenesis by influencing some or all of these cellular and subcellular processes. 
 Most recently, the Breit group generated a CLIC1 knockout mouse and reported 
platelet dysfunction as well as inhibited clotting in CLIC1 nullizygous mice [114]. There 
are no other gross phenotypes reported in the CLIC1 nullizygous mice. Given the 
previously defined roles of CLIC4 in angiogenesis, the suggestion of functional 
redundancies between CLIC4 and CLIC1, and the implications of CLIC1 involvement in 
cytoskeletal organization and apical membrane recycling, we now seek to define the role 
of CLIC1 in endothelial cell behavior and angiogenesis. 
 Here, we demonstrate the importance of CLIC1 expression in multiple steps of in 
vitro angiogenesis as well as elucidate a role for CLIC1 in regulating integrin cell surface 
expression. We show that with reduced CLIC1 expression there is reduced endothelial 
migration, cell growth, branching morphogenesis, capillary-like network formation, and 
capillary-like sprouting. CLIC1 also plays a role in regulating the cell surface expression 
of various integrins important in angiogenesis, including αVβ3 and αVβ5 and subunits β1 
and α3. 
 
4.3 Generation of endothelial cell lines with stable CLIC1 knockdown 
 Human umbilical venous endothelial cell (HUVEC) lines with stable CLIC1 
knockdown expression were used to determine the function of CLIC1 in various steps of 
angiogenesis, modeled with in vitro assays. Endothelial cell lines were generated using 
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lentiviral-based vectors carrying Clic1-targeting shRNA. Immunoblotting for CLIC1 
confirmed knockdown at the protein level with a reduced band around 31 kDa (Fig 4.1a) 
[115]. Immunoblotting for CLIC4 indicated that the Clic1 shRNA did not target Clic4 
and that CLIC4 expression levels were not affected by CLIC1 knockdown. CLIC1 
knockdown HUVEC phenotypes were compared to control endothelial cells stably 
expressing the lentivirus-based vector backbone carrying a scrambled shRNA insert that  
is not known to target any human genes (hereafter referred to as "control"). 
 The cellular morphology of CLIC1 knockdown HUVEC was qualitatively 
assessed and we observed no major changes in morphology with respect to control (Fig 
4.1b). For this analysis, the CLIC1 knockdown and control cell lines were seeded in 
equal numbers as a subconfluent monolayer on collagen-coated plates and photographed 
48 h later. While no gross morphological changes were present, we noted that CLIC1 
knockdown cells appeared less dense than control cells, indicating that CLIC1 
knockdown may affect endothelial cell growth. 
 
 
4.4 CLIC1 knockdown inhibits endothelial cell growth 
 To determine if CLIC1 is involved in regulating endothelial cell viability or 
growth, we utilized WST-8 colorimetric cell counting assays to score cells under 
different conditions. Cell viability assays were performed on CLIC1 knockdown or 
control cells by seeding equal numbers of HUVEC on collagen-coated plates and scoring 
cells after being cultured for 48 h in serum-free medium (SFM) alone or SFM 
supplemented with the survival signal EGF. Cell counts in medium without survival 
factor EGF were then scored relative to cell counts of the same cell line in medium with 
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EGF to produce a percentage of cells that remain viable in medium without EGF. In the 
absence of EGF, we found that CLIC1 knockdown cells displayed a modest but 
significant increase in HUVEC viability (p < 0.05), indicating that CLIC1 knockdown 
may play a limited role in regulating cell viability (Fig 4.2a). 
 To determine the effects of knocking down CLIC1 on endothelial cell growth, 
CLIC1 knockdown or control HUVEC were seeded in equal numbers on collagen coated 
plates and cultured in SFM supplemented with survival signal EGF and VEGF to induce 
endothelial cell growth. Cells were allowed to grow for 96 h, and cells were then scored 
using WST-8 colorimetric detection. In contrast to the effect on cell viability, we found 
that reduction of CLIC1 expression led to a pronounced and significant reduction of 
HUVEC cell growth (p < 0.001), indicating that CLIC1 is involved in regulating 
endothelial cell growth (Fig 4.2b). 
 
4.5 CLIC1 knockdown inhibits endothelial migration 
 Given the previously described associations of CLIC1 with cytoskeletal elements 
[43], we utilized a directed cell migration scratch assay to determine if CLIC1 
knockdown affects directed endothelial cell motility. This assay involved creating an 
"open wound" across a confluent monolayer of HUVEC growing on collagen and 
documenting cell migration into the wounded area at various time points over a 12 h 
period. We found that CLIC1 knockdown resulted in reduced endothelial migration into 
the wounded area when assessed on a qualitative level (Fig 4.3a). Given that the CLIC1 
knockdown migratory defects are qualitatively noticeable as early as 3 h post-wounding 
and the migration assay terminated only 12 h post-wounding, it was unlikely that any 
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CLIC1 knockdown effects on endothelial survival or proliferation affected migration 
assay outcomes. 
 To quantify the extent to which reduced CLIC1 expression was inhibiting directed 
endothelial cell migration, TScratch software was used for quantifying open surface area 
[116]. Quantification of data collected from six separate experiments confirmed that 
CLIC1 knockdown cells occupy significantly less surface area at 6 (p < 0.02), 9 (p < 
0.001), and 12 h (p < 0.001) post-wounding (Fig 4.3b), indicating that CLIC1 knockdown 
significantly reduced directed endothelial cell migration as early as 6 h post-wounding. 
Thus, inhibiting CLIC1 expression reduces directed endothelial cell migration. 
 
4.6 CLIC1 influences expression of select integrins on endothelial cells 
 To explore the regulatory role of CLIC1 in endothelial migration further, we 
analyzed the effects of CLIC1 knockdown on various integrins by flow cytometry. For 
this assessment, CLIC1 knockdown and control HUVEC were cultured as subconfluent 
monolayers on either type I collagen-coated or fibronectin-coated plates and incubated 
with primary antibodies for various integrins. A secondary APC-conjugated antibody was 
then used to enable flow cytometry. Integrins examined include α2, β1, α3, αVβ3, and 
αVβ5. Endothelial marker CD31 served as a positive control while the absence of 
primary antibody served as a negative control. In addition to being important for cell 
attachment and migration on specific extracellular matrices, each of the integrins 
examined have been reported to affect the angiogenic process [117-121]. 
 Expression analysis revealed the same general expression patterns for HUVEC 
grown either on collagen-coated plates (Fig 4.4, left panels) or HUVEC grown on 
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fibronectin-coated plates (Fig 4.4, right panels). The expression assays were done three 
times and results from a typical flow experiment are depicted in Figure 4.4. A slight 
downward shift in CD31 was found to be typical of CLIC knockdown cells. Analysis 
from both plate types indicated that HUVEC with CLIC1 knockdown had increased cell 
surface expression of integrin subunits β1 and α3 while α2 remained mostly unaffected 
(Fig 4.4). Integrin αVβ3 surface expression was also increased in CLIC1 knockdown 
endothelial cells while αVβ5 expression was decreased on both extracellular matrix plate 
types. These results suggest that CLIC1 may be moderating endothelial migration 
through regulation of integrin expression at the cell surface. 
 
4.7 CLIC1 plays a role in capillary-like network formation 
 We next determined the effect of CLIC1 knockdown on endothelial cell 
morphogenesis by assessing the ability of HUVEC to organize into capillary-like 
networks. To do this, CLIC1 knockdown or control HUVEC were seeded in equal 
numbers between two layers of porcine collagen gel and cultured in SFM supplemented 
with VEGF and EGF for 96 h. Qualitative assessment of the results indicated a reduction 
in cord, network, and branch formations in CLIC1 knockdown relative to control (Fig 
4.5a). Network formation from cells with reduced CLIC1 expression was noticeably less 
dense when compared to control cells as indicated by more prevalent open surface area. 
In addition to these defects, we found dramatic cell aggregations at branch points when 
CLIC1 was knocked down, where one branch point was considered any intersection of 
two or more cords. This phenotype could have been due to the migratory defects 
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established earlier. As indicated in a previous study assessing CLIC4 function, these cell 
aggregations are not due to proliferative defects [56]. 
 Quantification of these results revealed that there is a significant reduction in 
surface area coverage by CLIC1 knockdown cells (p < 0.01) (Fig 4.5b). This was 
accompanied by a significant decrease in branch points formed by CLIC1 knockdown 
cells (p < 0.001) (Fig 4.5c). The decrease in surface area coverage in CLIC1 knockdown 
could have been due to the previously established proliferative defect in CLIC1 
knockdown HUVEC, however the reduction in branch point formation was novel, 
indicating that reduced CLIC1 expression inhibits endothelial network formation and 
branching. 
 
4.8 Reduced CLIC1 expression affects capillary-like sprouting and branching 
 Next, we assessed the effect of CLIC1 knockdown on capillary-like tube 
formation in a fibrin bead assay, which allowed for assessment of endothelial growth, 
sprouting, branching, and lumen formation. For this assay, CLIC1 knockdown and 
control HUVEC were attached to dextran-coated beads and embedded in a fibrin clot 
with fibroblasts seeded as a monolayer on top of the clot. The clot was cultured in EGM-
2 medium, and HUVEC morphogenesis was monitored and photographically documented 
for 11 days. As previously reported, resultant sprouts from this assay are multicellular, 
lumen-containing processes [74, 75]. In this assay, sprouting is noticeable as early as 
three days post-embedding. Sprouts are reported to extend, anastomose, and undergo 
tubulogenesis from day 4 until the termination of the assay at day 11. 
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 Our results indicated that knocking down CLIC1 expression results in stunted 
capillary sprouting and branching with little apparent effect on lumen formation (Fig 4.6a, 
b). Upon quantification of results from day 11, we found that the number of sprouts per 
bead and the average number of branches per sprout were significantly decreased in the 
CLIC1 knockdown group (p < 0.001) while the number of lumen-containing sprouts was 
not different (Fig 4.6c-e). The branching defect found in this assay was consistent with 
the branching defect found in the previous capillary-like network formation assay. 
Together, these data demonstrate that CLIC1 expression is required for capillary 
sprouting and branching morphogenesis, when assessed in vitro. 
 
4.9 Discussion 
 We have previously shown that CLIC4 knockdown results in lower endothelial 
cell growth and inhibited network formation, similar to the CLIC1 knockdown results 
shown here [56]. However, in contrast to the failure of CLIC4 knockdown cells to form 
networks, CLIC1 knockdown cells formed rudimentary networks but had a branching 
morphogenesis defect whereby cell aggregates formed at branch points. We suspect these 
cell aggregates are a manifestation of the migratory defect and a failure of knockdown 
cells to undergo appropriate branching morphogenesis. This would be consistent with the 
observation that CLIC1 knockdown reduces endothelial cell migration, whereas CLIC4 
knockdown has no effect on migration. Another difference our comparison highlights is 
the lack of a lumen formation defect in CLIC1 knockdown endothelial cells in contrast to 
the lumen formation defect previously found with CLIC4 knockdown [56]. To explore 
the possibility of functional redundancy between CLIC1 and CLIC4, we made several 
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attempts to generate HUVEC lines with both CLIC1 and CLIC4 knockdown. In contrast 
to HUVEC introduced with two different control vectors, all attempts to create double 
knockdown cell lines did not result in viable HUVEC. We found this observation 
consistent with the hypothesis that CLIC1 and CLIC4 may possess functional 
redundancies and that both are required for endothelial cell viability. 
 CLIC1 is found to be significantly up-regulated in highly metastatic gallbladder 
carcinoma cell lines [122]. More generally, chloride transport is reported to be integral in 
generating electrical signals that guide cell migration to wounds in corneal epithelium 
[123], and chloride channels are implicated directly in enabling glioma migration as well 
as regulating breast cancer invasiveness [124, 125]. One may thus hypothesize that 
CLIC1 is required for endothelial cell motility based upon its potential function as an ion 
channel. 
 Extensive work has been done to validate CLIC1 as an anion channel that can 
auto-insert into artificial bilayers and produce conductance [40, 108], however the 
channel selectivity is found to be poor with conductance being based on anion 
concentration [39-41, 106, 111]. As an anion channel, CLIC1 is redox-regulated and its 
sequence contains the putative transmembrane domain (PTM) purported to be essential 
for its proper integral membrane channel characteristics [32, 111]. CLIC1 ion channel 
activity is also shown to be pH-dependent with activity lowest around neutral pH [40]. 
Structural experiments show that low pH may stimulate the PTM for insertion [36, 126, 
127]. It will be important to assess whether these mechanistic features of CLIC1 are 
important for endothelial cell motility. 
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 One of the most interesting structural characteristics of CLIC1 is the fact that it 
can exist as both an integral membrane protein and a soluble cytoplasmic protein. In 
contrast to the well-documented anion channel activity of CLIC1, the roles of CLIC1 
independent of its channel activity are largely unknown. Studies demonstrate that a 
variety of CLIC proteins interact with the actin cytoskeleton either directly [43, 57, 70] or 
indirectly, mediated by scaffolding proteins [68, 115, 128]. With this in mind, we 
postulate that CLIC1 may be regulating endothelial cell migration by regulation of 
cytoskeletal elements. 
 Endothelial cell migration and adhesion also depend on appropriate integrin 
expression [129]. Studies show that adhesion to the extracellular matrix through integrin 
heterodimers is essential for proper endothelial cell motility, and endothelial migration is 
at its greatest with intermediate levels of adhesion [130, 131]. Of interest to our study are 
integrins αVβ3, which can bind with fibronectin; αVβ5, which binds only vitronectin; 
integrin subunits α2 and β1, which are known for binding collagens, laminins, and 
possibly fibronectin [132]; and the integrin α3 subunit, which binds fibronectin [133]. We 
found that reducing CLIC1 expression increased β1, α3, and αVβ3 expression while 
decreasing αVβ5 expression (Fig 4.3), suggesting a role for CLIC1 in mediating integrin 
presentation and a means by which CLIC1 may be affecting endothelial migration. By 
increasing the surface expression of β1, α3, and αVβ3, CLIC1 may be increasing 
endothelial cell adhesion to the extracellular matrix, inhibiting motility by preventing the 
cell from breaking its contact with the extracellular matrix. These shifts in integrin 
expression also provide a possible explanation for the cell growth and viability defects 
[134]. In addition, it is possible that CLIC1 alters integrin binding affinity for their 
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ligands through inside-out signaling resulting in increased integrin expression but less 
efficient ligand binding [135]. To determine a mechanism by which CLIC1 may be 
influencing integrin cell surface expression, we conducted Western blotting for β1 and β5 
integrin subunits and found that the protein levels of these integrins were unchanged by 
CLIC1 knockdown (data not shown). Based on these preliminary results, we hypothesize 
that changes to integrin cell surface expression are a result of altered cell trafficking as 
integrins cycle through the endosomal pathway and as a chloride channel, CLIC1 
contributes to endosomal acidification [136]. 
 In summary, we demonstrated here that CLIC1 is involved in several steps of 
angiogenesis in vitro and concluded that CLIC1 plays a role in mediating endothelial cell 
growth, branching morphogenesis, and migration, possibly via regulation of integrin 
expression. We found that CLIC1 and CLIC4 knockdown phenotypes are similar in that 
both result in reduced cell growth, modestly increased cell viability, and inhibited 
network formation, but are different in that only CLIC1 knockdown inhibits migration 
and only CLIC4 knockdown affects lumen formation. It will be important to understand 


















Figure 4.1 | Establishing human endothelial cell lines with CLIC1 knockdown. (a) 
Immunoblotting with polyclonal rabbit anti-CLIC1 antibody confirmed reduced CLIC1 
protein expression in CLIC1 knockdown (C1 kd) endothelial cell lines. Immunoblotting 
with rabbit polyclonal anti-CLIC4 antibody verified that CLIC4 expression was not 
altered by Clic1-targetting shRNA. α-tubulin served as a loading control. (b) Established 
HUVEC control and CLIC1 knockdown lines exhibited no gross morphological 
differences when cultured as a subconfluent monolayer on collagen-coated dishes. Scale 
bar, 30 µm. 
 
 













Figure 4.2 | CLIC1 knockdown has mild effects on viability and significantly inhibits 
endothelial cell growth. (a) CLIC1 knockdown mildly but significantly increased 
viability in endothelial cells 48 h post-seeding. Quantification of viability is shown as 
mean percentages relative to the respective starting number of cells with standard 
deviation. (*p < 0.05). (b) Reduced CLIC1 expression drastically and significantly 
inhibited endothelial cell growth. The line at 10000 cells on the y-axis indicates the 
number of cells at the start of the assay. Quantification of cell growth is shown as the 



















Figure 4.3 | Reduced CLIC1 expression inhibits endothelial migration. (a) CLIC1 
knockdown endothelial lines exhibited inhibited directed migration in a scratch assay, 
noticeable as early as 3 h post-wounding. Photographs shown here have been analyzed 
using the TScratch software for quantifying open surface area. Lighter shaded areas 
indicate area occupied by endothelial cells while darker shaded areas indicate surface 
area not occupied by endothelial cells. Scale bar, 50 µm. (b) Quantification using the 
TScratch software showed that there was significantly more open surface area in the 
CLIC1 knockdown group at and after 6 h post-wounding. Mean open surface area for 
each group is shown with standard deviation. (*p < 0.02; **p < 0.001). 







Figure 4.4 | CLIC1 expression plays a role in the expression of various integrins. 
Histograms from a typical flow experiment indicate that HUVEC with CLIC1 
knockdown (green) had increased β1, α3, and αVβ3 expression and decreased αVβ5 
expression while α2 expression remained generally unchanged. Trends persisted despite 
being cultured on collagen or fibronectin extracellular matrix components. A downward 















Figure 4.5 | Knocked down CLIC1 expression inhibits capillary-like network 
formation and branching morphogenesis. (a) Microscopy of control or CLIC1 
knockdown lines in a collagen network formation assay indicated decreased network 
formation and defective branching morphogenesis in cells with CLIC1 knockdown. In 
addition to having less dense network patterning (exemplified by blue arrowheads), cell 
aggregations were found where normal branch points should have been (exemplified by 
red arrows). Black arrowheads indicate regularly spaced network patterning, and black 
arrows indicate normal branch points. Scale bar, 50 µm. (b) Quantification of surface area 
occupied by endothelial cells showed a significant decrease in surface area occupation by 
cells with CLIC1 knockdown. Mean surface area occupied by endothelial cells for each 
cell line is shown with standard deviation. (*p < 0.01). (c) Quantification of branch point 
numbers revealed a significant decrease in the number of branch point formations in cells 
with CLIC1 knockdown. One branch point was considered any focal intersection of two 
or more cords. The mean number of branch points for each cell line is shown with 
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Figure 4.6 | Reduced CLIC1 expression affects capillary-like sprouting and 
branching. (a) Microscopy on day 7 of the fibrin bead assay showed that endothelial 
cells with CLIC1 knockdown had altered sprouting morphology. CLIC1 knockdown 
sprouts tended to be shorter, less branched, and less robust. Black arrows indicate long, 
robust, lumen-containing sprouts while red arrows indicate stunted tube structures. Scale 
bar, 10 µm. (b) Microscopy on day 11 of the fibrin bead assay showed that endothelial 
cells with reduced CLIC1 expression formed tube-like structures; however these 
structures were stunted and possessed a branching defect when compared to structures 
formed by control cells. Black arrows indicate anastomosis or long tube-like structures. 
Red arrows indicate lack of branching or stunted tube-like structures. Scale bar, 30 µm. 
(c) The average number of sprouts formed per bead was tabulated and quantified, shown 
here with standard deviation. Reduced CLIC1 expression was found to be accompanied 
by a significant reduction in the average number of sprouts per bead. (d) Quantification 
of the average number of branches per sprout indicated that CLIC1 knockdown 
endothelial cells formed significantly fewer branches per sprout. The average number of 
branches per sprout is shown with standard deviation. (e) Quantification of the number of 
lumen-containing sprouts revealed no significant difference between control cells and 
cells with CLIC1 knockdown. The average percentage of lumen-containing sprouts 
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4.11 Additional discussion 
 Our main interest in CLIC1 laid in the fact that it was one of two highly expressed 
CLIC proteins expressed in endothelial cells, along with CLIC4 (Section 2.9). We 
hypothesized that CLIC1 could functionally compensate for CLIC4 during angiogenesis 
as suggested by the mostly normal vascular development seen in Clic4
-/-
 mice (Chapter 3), 
despite the drastic phenotypes resultant from CLIC4 knockdown in endothelial cells 
(Chapter 2). To determine if CLIC4 and CLIC1 had overlapping functions in the 
endothelial response to angiogenesis, we sought to rescue the CLIC1 knockdown network 
formation phenotype with CLIC4 overexpression using our overexpression vector 
described in Chapter 3. Western blotting confirmed CLIC1 knockdown and CLIC4 
overexpression (Supp Fig 4.1). Preliminary results suggest that CLIC4 and CLIC1 do 
overlap in function to some extent as there was a partial rescue by CLIC4 overexpression 
of the network formation defect imparted by CLIC1 knockdown (Supp Fig 4.2).  
 In addition, we sought to determine the physiological relevance of our CLIC1 in 
vitro data by analyzing the Clic1
-/-
 mouse for angiogenic defect. We also sought to 
establish any phenotypic similarities between the Clic1
-/-
 mice and our Clic4
-/-
 mice lines. 
The Clic1
-/-
 mice were generated and initially characterized by members of Sam Breit’s 
group at St. Vincent’s Centre for Applied Medical Research in New South Wales, 
Australia, and the findings are reported in Genesis [114]. Briefly, Clic1
-/-
 mice are viable 
and fertile with no obvious developmental abnormalities. Further analysis revealed a 
platelet dysfunction phenotype characterized by prolonged bleeding and decreased 
platelet activation upon stimulation. After acquiring these mice, we determined that 
Clic1
-/-




retinal vasculature is also indistinguishable from vasculature of wild type littermates 
unlike Clic4
-/-
 mice, which had a subtle vascular defect in the developing retina. This 
indicates normal postnatal angiogenic development in Clic1
-/-
 mice (Supp Fig 4.3).  
 These additional data are consistent with the hypothesis that CLIC4 and CLIC1 
possess overlapping functions. Partial rescue of the CLIC1 knockdown network 
formation defect by CLIC4 is indicative of overlapping functions or crosstalk between 
the two proteins. Furthermore, the absence of a drastic angiogenic phenotype in either 
Clic4 or Clic1 mutant mice despite strong endothelial phenotypes in vitro suggests 
compensation by other pathways. To assess the possibility of functional redundancy 
further, deletion of both Clic4 and Clic1 in mice may be necessary.  
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Supplementary Figure 4.1 | Confirmation of CLIC4 overexpression and CLIC1 
knockdown. Western blotting for CLIC4 or CLIC1 confirms overexpression or 
knockdown of HUVEC lines, respectively. Csh2 denotes CLIC1 knockdown, CLIC4 
denotes CLIC4 overexpression, and plko sc and gfp are control vectors. α-tubulin served 
as a loading control.  
 












Supplementary Figure 4.2 | Partial rescue of the CLIC1 knockdown network 
formation defect by CLIC4. Overexpression of CLIC4 in CLIC1 knockdown cell lines 
partially rescues the network formation defect seen by CLIC1 knockdown alone 
(csh2/gfp). Networks maintain cell aggregates at branch points compared with control 
(plko sc/gfp and CLIC4/plko sc), but aggregations appear to be reduced in the rescue line 
(csh2/CLIC4).  
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Supplementary Figure 4.3 | Loss of Clic1 does not affect postnatal retinal 
angiogenesis. Staining with endothelium-specific marker IB4 (green) shows primary 
plexus retinal vasculature in P5 mice that are either homozygous null or wild type for 
Clic1 to be indistinguishable.  
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Supplementary Table 4.1 | Clic1
-/-
 mice confer with expected Mendelian ratios. 
Genotyping of 27 mice from Clic1
+/-
 intercrosses reveal no deviations from expected 
Mendelian ratios, according to a χ
2










Chapter Five: Clic4 and Clic1 are required for embryonic development 
 
 To determine whether CLIC4 and CLIC1 act in concert during developmental 









double knockout mice. I performed all data gathering and analysis for the material in this 
chapter. Carrie Shawber provided advice on experimental design and analysis. Valeriya 
Borisenko performed embryo sectioning and Irina Jilishitz provided technical assistance 
with histology. Jan Kitajewski and Carrie Shawber assisted in analyzing results.  
 
5.1 Abstract 
 Both CLIC4 and CLIC1 have been implicated in mediating angiogenesis in vitro, 
but initial characterizations of Clic4 and Clic1 knockout mice have revealed only a mild 
angiogenic defect in Clic4
-/-
 mice and no angiogenic defect in Clic1
-/-





 mice are known to exhibit angiogenic defects in utero. This study 
finds transgenic mice deficient for both Clic4 and Clic1 to be embryonic lethal with in 
utero time of death at 9.5 dpc. Lethality is accompanied by a defect in angiogenesis 
characterized by diminished or absent vasculature in the head and along the intersomitic 
vessels. Clic4;Clic1 double knockouts are also found to be growth retarded, characterized 
by smaller size. These results indicate that both CLIC4 and CLIC1 function concurrently 
during embryonic angiogenesis and both proteins are required for proper embryonic 
development.  
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5.2 Introduction 
 Of the 6 known mammalian CLICs, only CLIC4 and CLIC1 are shown to be 
highly expressed in endothelial cells [49, 52, 54]. CLIC4 and CLIC1 share similar protein 
structures and 60-66% amino acid homology in humans and mice [36, 59, 89]. Both 
proteins have been shown to elicit chloride channel conductance when reconstituted in 
artificial membranes. CLIC4 and CLIC1 are also shown to be widely expressed and 
evolutionarily well-conserved, suggesting an important role for both proteins in 
development. Indeed, both CLIC4 and CLIC1 have been found individually to have roles 
in diverse biological processes including angiogenesis and endothelial cell proliferation 
[55, 56], and both are F-actin regulated [43]. In both the human and mouse genomes, 
Clic4 and Clic1 localize to two different chromosomes.  
 CLIC4 was first implicated in angiogenesis as a regulator of tubulogenesis when 
CLIC4 C. elegans orthologue EXC-4 was found to be essential for proper formation and 
maintenance of the C. elegans excretory canal, which is thought to form lumens much the 
same way as mammalian capillaries [10, 37, 50]. CLIC4 was later found to be vascular 
endothelial growth factor-A (VEGF-A)-regulated [49]. As VEGF-A is a well-
characterized effector of angiogenesis [137-140], this further implicated CLIC4 in the 
angiogenic pathway. In addition, the cystic disruption of the C. elegans excretory canal 
that typifies the mutant exc-4 tubulogenic defect can be rescued with human Clic1 fused 
to the transmembrane domain of exc-4, suggesting functional overlap between CLIC4 
and CLIC1 in tubulogenesis. Evidence implicating CLIC1 in angiogenesis stems from its 
localization to the apical domain of several columnar epithelia [54], linking it to 
apicobasal specification, a process required for proper tube formation.  
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 Despite CLIC4 or CLIC1 knockdowns having drastic effects on the endothelial 
response in various in vitro angiogenesis assays (Chapter 3), neither Clic4 nor Clic1 
knockout mice exhibit lethal defects. Reports of Clic1
-/-
 mice indicate that it is wholly 
indistinguishable from wild type mice aside from a platelet activation defect, even under 
ischemic conditions [114, 141] while Clic4
-/-
 mice exhibit reduced native collateral 
density [67, 141]. Interestingly, under ischemic conditions, both CLIC4 and CLIC1 
expression are increased, further suggesting functional redundancy between the two 
proteins. Consistent with these data, Clic1
-/-
 mice do not exhibit any angiogenic defects in 
the developing retina (Section 4.11) while Clic4
-/-
 mice exhibit only mild angiogenic 
defects in the developing retina (Section 3.5). Taken together with in vitro results from 
CLIC4 or CLIC1 knockdown lines, these data suggest that an alternate pathway is 
functionally compensating for loss of either Clic4 or Clic1. 
 In primary cultured endothelial cells, CLIC4 and CLIC1 have some overlapping 
properties such as their roles in proliferation, branch formation, anastomosis, and 
capillary sprouting; however they also differ in that only CLIC1 affects endothelial 
directed migration while only CLIC4 has been shown to affect endothelial lumen 
formation. From their disparate roles in endothelial cells, we inferred that targeting both 
Clic4 and Clic1 simultaneously would result in a more severe phenotype than targeting 
either gene alone. Therefore, we generated transgenic mice in which both Clic4 and Clic1 




 genotype to be embryonic lethal at 9.5 days 





 embryos isolated at 9.5 dpc also show reduced endothelial 
content. The Clic4;Clic1 double knockout shows a more severe angiogenic defect than 
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found in either Clic4 or Clic1 single knockouts. Mice deficient for either Clic4 or Clic1 








) are viable, but 




) appear runted. Our 
results indicate that both Clic4 and Clic1 are required for normal angiogenesis during 
early embryonic development.  
   
5.3 Generation of Clic4 and Clic1 double mutants 
 Both CLIC4 and CLIC1 have been shown individually to affect angiogenesis in 
vitro, and endothelial cells express both proteins in high amounts [55, 56]. To determine 
the extent to which CLIC4 and CLIC1 affect angiogenesis during development, it was 
deemed necessary to target both genes to account for possible functional redundancies. 
We obtained Clic1
-/-
 mice from Dr. Samuel N Breit, and we generated Clic4
-/-
 mice, 
described in chapter 4. As previously reported and summarized in section 4.11, Clic1
-/-
 
mice are viable, fertile, and possess no gross angiogenic phenotypes in the retina [114]. 
As detailed in chapter 3, our Clic4
-/-
 mice are underrepresented, have subtle defects in 
developing retinal vasculature, and may have reduced macrophage content in the 
developing retina.  
Clic4
-/-
 knockout mice were mated with Clic1
-/-
















 mice, however no mice of this double 
knockout genotype were found in the F1 generation, deviating from predicted Mendelian 
ratios (p < 0.01) (Table 5.1), suggesting embryonic lethality. Mice representing all other 
expected genotypes including those missing three Clic alleles survived birth. Mice were 
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 double knockout mice are embryonic lethal at 9.5 dpc 












 intercrosses. The resulting F1 generation 




 mice. This deviation from Mendelian ratio again indicates 




 genotype (p < 0.01) (Table 5.2a). To 
determine time of death, we performed embryo dissections at various gestational time 
points.  









collected at 10.5 dpc had expired presenting growth retardation and cardiac edema (Fig 
5.1), indicative of vascular blockade [142, 143]. Pooled blood is also evident in double 
knockout embryos isolated at 10.5 dpc, suggestive of vessel hemorrhaging. Interestingly, 
embryos analyzed by whole mount endomucin staining at 10.5 dpc comprised embryos 
representative of all other genotypes including those missing three Clic alleles. At 10.5 














 embryos exhibited growth retardation, but vasculature 




 embryos may also have 





 littermates.  





 embryos dissected at 9.5 dpc were alive as evidenced by blood 
flow and beating hearts. Furthermore, Mendelian ratio was restored at 9.5 dpc (Table 











 double knockout mice display aberrant vascular development 























 embryos at 9.5 (Fig 5.3). Dissected 9.5 dpc embryos were analyzed by 
hematoxylin and eosin (HE) staining and whole mount staining with endothelial marker 
endomucin [144-146].  




 9.5 dpc embryos to be 
consistently lighter, indicating reduced endothelial content (Fig 5.4a). Severely reduced 





 mice. As major vessels are still present, we concluded that the double 
knockout phenotype is unlikely due to vasculogenic defects. We also concluded that the 
double knockout phenotype is unlikely due to arteriovenous specification defects because 
the dorsal aorta and cardinal vein are discernible and present in the double knockout 




 embryo is qualitatively 
more severe than the effects of either Clic4 or Clic1 knockout alone on vascular 
development at 9.5 dpc. Growth retardation indicated by smaller size is consistent with 
previously noted proliferation defects found in vitro (Section 2.4). Runting could also be 
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consistent with disrupted vascular development because tissues that are not well perfused 





 embryos collected at 9.0 dpc and earlier presented no gross 
morphological phenotypes aside from qualitatively lighter endothelial staining suggestive 





9.0 dpc embryos. These data suggest that vessel regression may be occurring between 9.0 
and 9.5 dpc to yield the 9.5 dpc angiogenic phenotype. Vessel regression may occur due 
to a lack of vessel patency [97, 98]. Qualitative analysis of embryos at 7.5 and 8.5 dpc 
suggest that vascular development occurs normally until 9.0 dpc.  
 










 embryos were 
collected at 9.5 dpc for fixed-frozen sectioning and histological analysis. Preliminary 




 sections indicating 
reduced endothelial content (Fig 5.5). Analysis with additional endothelial marker 
vascular endothelial growth factor receptor-2 (VEGFR-2) also suggests reduced 
endothelial content consistent with endomucin-stained whole mounts (Fig 5.6). 




 embryo sections appears lighter in both 




 embryo heart, VEGFR-2 staining of the 
endocardium is present, but the endothelium along the descending aorta appears thinner 
while the aorta itself seems dilated (Fig 5.6a). This suggests impaired aortic development 
in double knockout embryos. Analysis of VEGFR-2 and αSMA should be performed on 
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transverse embryo sections to assess aortic dilation further. While VEGFR-2 staining of 




, VEGFR-2 stained ISVs 
appear disjointed, suggesting disruption of ISV development (Fig 5.6b).  




 embryo sections, 
most notably in the heart and at the otic vesicle (Fig 5.7a). This suggests that Clic4 may 
regulate Notch1 signaling through Jag1 [148, 149]. αSMA staining revealed no major 
changes in smooth muscle cell content by qualitative assessment (Fig 5.7b). Based on 
αSMA staining, trabeculation appears normal and the myocardium appears comparable in 
both samples.  
 At 9.5 dpc, all cell types are actively proliferating in a normal mouse embryo. 
Preliminary analysis with proliferation marker phospho-histone H3 (Ser10) suggests 
reduced proliferation throughout the embryo along two different planes (Fig 5.8). While 
quantification of preliminary results does not reach statistical significance due to variance 




 embryos is 
evident (Fig 5.8b). This finding is consistent with in vitro data (Section 2.4) as well as the 








 9.5 dpc embryos also tend 
to exhibit moderately increased apoptosis, revealed by caspase 3 (CASP3) staining (Fig 




 embryos is not necessarily 
associated with endothelial cells.  
 
5.7 Discussion 
 The effects of knocking down CLIC4 or CLIC1 on endothelial cell 
morphogenesis in vitro suggested that both CLIC4 and CLIC1 may play an important 
112 
role in vasculogenesis or angiogenesis during development [55, 56]. Conversely, 
knockout of either Clic4 or Clic1 does not result in major functional or developmental 
defects (Chapter 3 and Section 4.11). Although subtle angiogenic defects may have gone 
unnoticed during initial characterization, both Clic4 and Clic1 null mice were viable, 
fertile, and presented normal appearing vasculature by whole mount analysis. The 
similarities in expression patterns, structure, and effects on endothelial morphogenesis in 
vitro suggest that CLIC4 and CLIC1 may at least partially compensate for each other 
during critical roles. Here, we provide the first study supporting the concept of functional 
redundancy between CLIC4 and CLIC1 during development.  





 double knockout mice (Table 5.1). Further analysis revealed that 
embryonic development is arrested in double knockouts at 9.5 dpc as evidenced by the 





had already expired and presented pooled blood near the heart as well as cardiac edema 




 genotype were 
present, and deletion of three Clic alleles did not appear to affect vascular development 














embryos presented qualitatively normal vasculature along with mild runting, which 
suggests vessel regression or deterioration between 9.0 dpc and 9.5 dpc to yield the 9.5 
dpc phenotype of lacking vasculature (Fig 5.4). These data would be consistent with a 
vessel occlusion or leakage phenotype [97, 98], however further analysis is required to 
determine the mechanism by which this phenotype is manifested.  
  113  




 embryo sections were consistent 
with whole mount phenotypes (Fig 5.5, 5.6, & 5.7). Stainings with an additional 





sections suggestive of reduced endothelial content and reduced Notch1 signaling, 
respectively. VEGFR-2 staining also suggested thinner endothelium along the descending 
aorta. Interestingly, Notch1 is an established regulator of angiogenesis [150], and Notch1 
ligand Jag1 is expressed in the descending aorta [151]. This presents a possible pathway 
in which CLIC4 is functioning to exhibit its effects on angiogenesis and aortic 
development.  
 Smooth muscle content does not appear to be altered, and the myocardium 
appears normal. Overall proliferation tends to be reduced in double knockout embryos, 
consistent with in vitro data and embryo runting (Fig 5.8). Meanwhile, apoptosis tends to 
be increased in double knockout embryos (Fig 5.9), possibly due to malnourished tissue 
as a result of defective vascular development.  
 Several knockout lines exhibit lethal vascular defects around 9.5 dpc such as 
knockouts of VEGF pathway members, Notch1, Jag1, Ang1/Tie2, and ERK5. These 
knockouts and others that are similar have been well reviewed [152]. Indeed an 
analogous example to our Clic4;Clic1 double knockout is provided by the Hey1;Hey2 
double knockout, whereby knockout of both Hey1 and Hey2 result in embryonic lethality 
after 9.5 dpc with major vascular deficiencies while either Hey1 or Hey2 single 
knockouts result in no major vascular phenotypes [153].  




 embryonic lethality 
are placental insufficiency or defects in chorioallantoic fusion [154, 155]. A defect in 
114 
either placental development or chorioallantoic fusion would result in decreased 
nourishment for the developing embryo, causing delayed or stunted development. To 
determine if placental and chorioallantoic development are affected by Clic4;Clic1 
knockout, the placenta should be assessed for proper trophoblastic differentiation and 
vascular development. The placental labyrinth where fetal and maternal blood supply are 
exchanged should be closely examined. In addition, 8.5 dpc embryos should be assessed 
for proper chorioallantoic fusion.  
 Although embryonic lethality of the Clic4;Clic1 double knockout precludes 
analysis of global Clic4 and Clic1 function in adult mice, we had initially generated the 
Clic4 knockout to be conditional. With a conditional Clic4 knockout in a Clic1 null 
background, we are able to conduct studies on how Clic4 may contribute to vessel 
maintenance and remodeling in adult mice through crosses with inducible, endothelium-
specific Cre drivers, such as flk-1-Cre-ER mice that are Tamoxifen-inducible. Such a 
system would also allow studies on how Clic4;Clic1 may contribute to pathological 
angiogenesis, such as angiogenesis during tumor development. Furthermore, crosses with 
an early endothelia-specific Cre driver such as VE-Cadherin-Cre mice would enable 
analysis of Clic4 function specifically in vascular development without interference from 
the effect of Clic4 knockout in other cell types or potential compensation by Clic1 [156].  
 Our identification of the requirement for Clic4 and Clic1 in embryonic 
development extends our knowledge of CLIC4 and CLIC1 biological functions and 
identifies a novel pathway in angiogenic development. While our study provides direct 
evidence that Clic4 and Clic1 are both required for proper embryonic development, the 
challenge now is to determine if Clic4 and Clic1 function in a complex, in the same 
  115  
pathway, or merely concurrently. A co-immunoprecipitation using either CLIC4 or 
CLIC1 to precipitate would determine if the two proteins function together in a complex. 
Downstream effectors of CLIC4 and CLIC1 should be determined by comparing 




 cells [157]. 
Clustering by using gene ontology and bioinformatic approaches would reveal relevant 
targets [158]. Common targets of CLIC4 and CLIC1 could then be assessed and used to 
participate in rescue experiments. To determine functional redundancy between CLIC4 
and CLIC1, rescue experiments could be performed in zebrafish, whereby Clic4 or Clic1 
mRNA is used to rescue any Clic1 or Clic4 morpholino phenotype, respectively [159].  
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 (middle and right panels) embryos dissected at 10.5 dpc were expired as 
indicated by a lack of blood flow or beating heart. Compared with Clic4 single null 
control embryos (left panel), double knockouts are also appear growth retarded, have 
accumulated fluid in the pericardial sac (outlined by red boxes), and present blood 
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Figure 5.2 | Embryos missing three Clic alleles are represented at 10.5 dpc. With the 
exception of deleting all four Clic4 and Clic1 alleles, all other genotypes are represented 
at 10.5 dpc. Whole mount staining of 10.5 dpc embryos with endomucin indicate that 
vasculature is developing properly at this stage even in genotypic backgrounds that are 





 (middle) embryos are comparable both in size and developed 
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 embryos. Embryos dissected at 9.5 dpc underwent endomucin whole 
mount staining to view the vasculature. Vasculature in embryos of both genotypes 
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 embryos occurs at 9.5 dpc with growth 
retardation and an angiogenic defect. Endomucin whole mount staining was used to 





 embryos indicate reduced endothelial content. (a) Clic4;Clic1 double 
knockout embryos isolated at 9.5 dpc are runted, indicating general growth retardation. 
Double knockout embryos also show lack of vasculature in the head as indicated by the 
red arrows and along the intersomitic vessels as indicated by the red arrowheads. (b) 
Double knockout embryos isolated at 9.0 dpc are also runted, but present intact 
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 developing embryos. 
DAPI (blue) was used to counterstain nuclei. Endothelium-specific marker CD31 (green) 
was used to analyze vasculature in the developing heart by histology. Lighter staining 
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 embryos. Serial 
sections of 9.5 dpc embryos were analyzed using endothelial marker VEGFR-2 (red) for 
immunofluorescence histology. Nuclei are marked in blue with DAPI counterstaining. 




 embryo sections, consistent 
with lighter endothelial staining seen in whole mounts. (a) VEGFR-2 staining in the heart 




 sections. Magnification of the boxed area 
highlights the descending aorta, which appears dilated in addition to being more weakly 
stained in double knockouts. The white line is the same size in both photographs and 
emphasizes the differing diameters of the two aortas. Double knockout embryos also 
seem to possess thinner endothelium lining the aorta. (b) VEGFR-2 staining of the 




 embryos, consistent with the 




 embryo, which appear disjointed compared with ISVs in control embryos that are 
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 embryos. Nuclei are 




 embryos, particularly in the heart and the otic vesicle. The otic vesicle is 
highlighted by a yellow arrow in the double knockout compared to the white arrow 
signifying the otic vesicle of control. (b) α-SMA labeling of smooth muscle cells in red 
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embryos. Phospho-histone H3 (Ser10) staining (red) was used to identify proliferating 
cells. Sections are counterstained with DAPI to mark nuclei. (a) Clic4;Clic1 double 
knockout embryos show overall reduced proliferation as suggested by reduced staining at 
two different section depths. (b) Quantification of several sections stained with 
proliferation marker phosphor-histone H3 is consistent with qualitative assessment based 
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embryos. CASP3 staining (red) was used to identify cells undergoing apoptosis in 9.5 
dpc embryo sections. Sections are also stained with VEGFR-2 (green) to indicate 





embryo sections show increased apoptosis by qualitative assessment. Cells positive for 





sections, indicating cells undergoing apoptosis are not necessarily endothelial. (b) 




 embryo sections tend to have an increased percentage of apoptotic cells, however 

















n = 125, p = 0.56E-05
 
 




 intercrosses deviates from predicted 
Mendelian ratios. A χ
2
 test for goodness of fit indicates that the genotypic ratio of 




 intercrosses deviated significantly from ratios 
predicted by Mendelian genetics. Expected numbers are noted in blue while actual 









 genotype, however none were and this is 
highlighted in green.  
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Table 5.2 
 
    b.   





    n = 48, p = 0.17 









 12 17 




 24 23 























 10.25 16  n = 34, p = 0.84  
    genotype expected actual 




 8.5 8 




 17 16 




 8.5 10 
 
 
Table 5.2 | Mendelian inheritance is restored at 9.5 dpc. (a) At birth, genotypes of 




 intercrosses deviate significantly from Mendelian 
ratio with no double nulls present. (b) Genotypic ratios of embryos at 9.5 dpc are 
consistent with predicted Mendelian ratios from the indicated matings. Double nulls are 
present at 9.5 dpc. Expected numbers based on Mendelian predictions are in blue while 
red represents actual numbers. Significance was established using χ
2
 statistical analysis. 
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Chapter Six: Conclusions and future directions 
 
 We have examined the role of CLIC4 and CLIC1 in developmental and 
pathological angiogenesis. During the conception of this study, we determined that 
CLIC4 and CLIC1 were the two most highly expressed CLIC protein members in human 
umbilical vein endothelial cells, although CLIC2 and CLIC5 were also present. Due to 
their evolutionary conservation across invertebrates and vertebrates as well as their high 
expression in endothelial cells, we anticipated noteworthy roles for both CLIC4 and 
CLIC1 in mediating angiogenesis. This study identifies CLIC4 and CLIC1 as players in 
angiogenesis and represents the first documentation of the requirement for both Clic4 and 
Clic1 during embryonic development.  
 Analysis of cultured primary endothelial cells with CLIC4 knockdown or 
overexpression revealed that CLIC4 promotes endothelial cell growth, network and 
branch formation, capillary sprouting, and lumen formation in vitro. Likewise, cultured 
primary endothelial cells with CLIC1 knockdown exhibited reduced endothelial cell 
growth, network and branch formation, and capillary sprouting in vitro. Unlike cultured 
endothelial cells with CLIC4 knockdown, CLIC1 knockdown cells exhibited no effect on 
lumen formation but did show reduced directed migration. These results are described in 
chapters 2 and 4.  
 In analyzing the roles of CLIC4 and CLIC1 in angiogenesis further, we generated 
a Clic4 knockout mouse line and acquired the Clic1 knockout mouse line [114]. First, we 
characterized the Clic4 knockout mice as described in chapter 3. We found a significant 
difference between predicted inheritance and the resultant genotypes of mice from Clic4 
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heterozygote intercrosses at birth, suggesting partial prenatal lethality for Clic4 nulls. 
Dissecting embryos at 9.5 dpc revealed that inheritance deviation is occurring after 9.5 
dpc as embryos of all genotypes appeared largely normal, even upon endothelial whole 
mount staining. As Mendelian ratios are restored at this time point, it is unlikely that 
embryos are suffering developmental arrest prior to 9.5 dpc [160, 161]. To determine the 
point at which embryos are experiencing death, embryos should be genetically evaluated 
at various time points after 9.5 dpc during gestation and phenotypically evaluated at the 
time when genotypes deviate from Mendelian ratios.  
 Based on reported information and our own studies, we postulate that partial 
prenatal lethality of Clic4 knockouts may be due to a subtle defect in the hypoxic 
response or hematopoiesis. Mice deficient for the hypoxia-response element in the Vegf 
promoter (Vegf
/
mice) exhibit partial in utero lethality during late gestation caused by 
hitherto unknown reasons [162]. Speculation implicates vascular defects as the cause of 
death, and a recent study has shown inferior hematopoietic stem cell survival in Vegf
/
 
mice [163]. In addition, VEFG-A, hypoxia-inducible factor 1α (HIF-1α), and 
angiopoietin-2 expression levels were found to be reduced in Clic4
-/-
 mice in ischemic 
conditions, indicating CLIC4 regulation of these elements [141].  
 Postnatally, we noted that Clic4 null mice had reduced vascular density in both 
the developing primary and deep retinal vascular plexuses. The increased presence of 
delicate sprouts in Clic4 knockout retinas suggests that the vascular defect is due to a 
delay in development or increased vascular regression due to lack of vessel patency [164, 
165]. Since whole mount analysis for macrophage content suggested that Clic4
-/-
 retinas 
have reduced macrophage content, and macrophages are known to be involved in 
138 
mediating anastomosis, the latter must be considered [82]. To determine if vessel 
regression is the culprit, whole mount staining for type IV collagen, which is a main 
component of vascular basement membranes, should be used to mark vessel sleeves in 
the event of vessel regression [166]. Sectioning retinas and staining for endothelial and 
mural cell markers will also reveal any differences in vessel patency and stability. In 
addition to analyzing the retina further, the vascular beds in the kidneys as well as the 
ovaries, endometrium, and mammary glands of the female reproductive system should be 
analyzed for similar phenotypes [167, 168]. Since angiogenesis during estrus or 
pregnancy is characterized as intense, studying vascular development here may be useful 
in studying the role of Clic4 in the induction of physiological angiogenesis during 
adulthood [169-171]. This would also provide insight into the mechanisms driving the 
surprising phenotype we noted regarding tumorigenesis in Clic4 knockout mice.  
 Using the Lewis lung carcinoma model for tumorigenesis, we found that Clic4
-/-
 
mice tended to present larger tumors than wild-type and Clic4
+/-
 and more lung 
metastases than their wild type counterparts in preliminary experiments. Histological 
analysis of tumor sections did not reveal any gross differences in endothelial or smooth 
muscle cell content, however this was not quantified. While endothelial and smooth 
muscle cell content is not significantly altered by loss of Clic4, the architecture of the 
tumor vessels may be altered (Section 3.6). Furthermore, histology for macrophages in 
tumors isolated from Clic4
-/-
 mice recapitulated the reduced macrophage content 
phenotype we noted in Clic4
-/-
 retinas. We suggest that the altered macrophage content in 
Clic4 knockout-isolated tumors may be indicative of a shift in macrophage phenotype 
toward tumor-associated macrophages.  
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 One alternative mechanism we did not address is the possibility that Clic4 may be 
altering the innate immune response to tumorigenesis. If loss of Clic4 indeed results in 
reduced macrophage content, having fewer activated macrophages at the site of initial 
transformation may inhibit the hosts immune response to combat transformed cells [172]. 
As loss of Clic4 has already been reported to result in a reduced inflammatory response 
to bacterial infection, there is merit to investigating the possibility of this latter 
mechanism. Moreover, CLIC4 is suggested to function in a positive feedback loop 
leading to enhanced TGF-β signaling [173, 174], lending further credence to this latter 
hypothesis of a reduced innate immune system. Without CLIC4, TGF-β signaling was 
shown to be abrogated. Because TGF-β signaling can enhance hematopoietic 
differentiation factor M-CSF production in mesenchymal cells [175], loss of Clic4 could 
result in an increase of undifferentiated hematopoietic stem cells [176, 177]. Since we 
designed our Clic4 knockout line to be conditional, one could assess the effects of Clic4 
knockout on the macrophage or hematopoietic lineage [178, 179]. In addition, the role of 
Clic4 in regulating TGF-β function could implicate it in a vast milieu of important 
biological activities such as cell cycle regulation [180-182] and extracellular matrix 
deposition, which would also affect angiogenesis [183].  
 Clic1 knockout mice did not exhibit gross angiogenic phenotypes despite the 
drastic effects of CLIC1 knockdown on in vitro angiogenesis as described in chapter 4. 
During the initial characterization of Clic1
-/-
 mice, a clotting defect was noted, typified by 
prolonged bleeding times as well as lower rates of platelet activation and aggregation 
despite having higher platelet counts [114]. Since platelets are known to mediate the 
angiogenic response during wound healing and under inflammatory circumstances [184], 
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it is possible that Clic1
-/-
 mice may have an angiogenic defect in a wound healing model. 
Platelets are also reported to sequester angiogenesis regulators [185], so the increase in 
platelet count in Clic1
-/-
 mice may also have an effect on induced or pathological 
angiogenesis. In addition, CLIC1 is suggested to play a role in macrophage activation as 
CLIC1 expression is upregulated upon phorbol-12-myristate-13 acetate (PMA) exposure 
in a monocyte cell line and Aβ activation of microglia [186, 187]. Inhibition of CLIC1 
has also been shown to reduce the inflammatory response in microglia [187]. Thus, like 
CLIC4, CLIC1 may also affect the initiation of the host innate immune response.  
 A central idea in our analyses is that CLIC4 and CLIC1 may be functionally 
redundant, as suggested by their similar structures, sequence, tissue expression, and their 
roles in endothelial cell morphogenesis in vitro, which we had determined [55, 56]. As 
such, our work focused mainly on the roles of CLIC4 and CLIC1 as well as their 
potential overlapping functions; however CLIC2 and CLIC5 were also found to be 
expressed in endothelial cells albeit at low levels, and we have not examined their 
potential roles in regulating angiogenesis.  





 mice, but we were unable to obtain pups of that genotype. Embryonic 




 genotype is lethal resulting in death at 9.5 dpc 




 embryos analyzed at 9.5 dpc exhibit drastically reduced vasculature in the head 




 embryos at 9.0 dpc exhibit mostly 
normal vascular patterning. These data imply that while vasculogenesis occurs normally, 
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angiogenic vessels are deficient and regress by 9.5 dpc causing death. As such, we 





In this model, we suggest that when vessels fail to form lumens, the lack of shear stress 
from flowing blood and the lack of mechanotransduction signals for the pruning of 
occluded vessels [97, 165, 188, 189]. Cords unable to undergo tubulogenesis due to a 
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defect in vesicular fusion should appear multivacuolated. We postulated that endothelial 
cells of occluded vessels then undergo apoptosis or migrate from the site of vessel 
formation along with other cell types that were initially recruited during pruning [98]. A 
vessel sleeve composed of newly synthesized basement membrane components remains 
as a shadow of the regressed vessel [190]. We postulated that Clic4;Clic1 double 
knockout may lead to such vessel occlusions resulting in the regression of small vessels 
and capillaries. Further analysis for vessel sleeves by staining for basement membrane 





phenotype. An increased number in apoptotic endothelial cells or migratory mural cells 
near the site of vessel sleeves would further indicate vessel regression.  
 Our whole mount histological analyses with various endothelial markers 
suggested reduced endothelial content in double knockout embryos. Histology also 




 9.5 dpc embryos with thinner lining 
endothelium. Double knockout embryos at both 9.0 and 9.5 dpc present growth 
retardation, consistent with histological analysis of 9.5 dpc embryos for proliferation. 
This is also consistent with in vitro data showing that CLIC4 and CLIC1 knockdown 
reduces endothelial cell growth. Two causes of death we did not examine are the 
possibilities that chorioallantoic fusion is not occurring properly or there is placental 
insufficiency [191-193]. Defects in either of these processes could lead to nutritional 
insufficiency, which could lead to regressing vessels and cause death [98, 194-196].  
 While the Clic1 knockout is a straight knockout, knockout of Clic4 is conditional. 
To study the contribution of Clic4 to developmental angiogenesis without the possibility 
of functional compensation from Clic1, Clic4 conditional knockouts can be generated in 
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a Clic1
-/-
 background. Crossing the conditional Clic4 allele to endothelia-specific and 
macrophage-specific Cre drivers in a Clic1 null background would be advantageous in 
evaluating the contributions of Clic4 to angiogenesis and macrophage function. Indeed, it 
would also help reveal specific processes during which Clic4 and Clic1 concurrently 
function. Generating a conditional Clic4 knockout in a Clic1 null background will also 




 mice by using inducible Cre drivers. 
Such a model would be beneficial in studying pathological angiogenesis as well as 
determining if Clic4 and Clic1 are required for the maintenance of existing vasculature.  
 All of our discoveries and the data presented here either directly or indirectly 
implicate both CLIC4 and CLIC1 in angiogenesis. With our current knowledge, we 





We suggest that CLIC4 and CLIC1 both promote endothelial proliferation, networking, 
branching, and sprouting either additively or synergistically, and all these processes lead 
to angiogenesis. CLIC4 plays additional roles in regulating tubulogenesis and recruiting 
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or activating macrophages to mediate anastomosis. Meanwhile, CLIC1 plays the 
additional roles promoting endothelial cell migration as well as activating platelets during 
the induction of angiogenesis. Furthermore, we present this model with postulations as to 





We suggest that CLIC4 mediates tubulogenesis through its functions in vesicular 
trafficking or acidification as indicated by dotted lines, and we also suggest that CLIC1 is 
mediating endothelial migration through its interactions with the cell cytoskeleton. 
CLIC1 may also play a role in macrophage activation during induction of angiogenesis.  
 Since the groundbreaking C. elegans experiments linking CLICs to tubulogenesis 
[50], much research has been done in an effort to link CLICs with vertebrate vessel 
formation. Results from our in vitro studies on CLIC4 are consistent with the original 
notion that CLIC4 regulates tubulogenesis. CLIC4 knockdown resulted in reduced lumen 
formation and a significant increase in lumen formation was seen with CLIC4 
overexpression. A future study could determine if CLIC4 localize to specific intracellular 
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vesicles and determine the mechanism by which it may be modulating tubulogenesis. To 
determine if vertebrate CLIC4 possesses any functions independent of its putative 
channel properties, functional studies on CLIC4 excluding its PTM or with a mutated 
PTM should also be done as structural and gene disruption studies have suggested an 
enzymatic role for CLIC4 [46].  
 Our studies also attempt to address the possible functional redundancy between 
CLIC4 and CLIC1 suggested by the initial studies done in C. elegans [50] in the creation 
of a Clic4;Clic1 double knockout mouse line. The absence of living postnatal Clic4;Clic1 
double knockout mice during our studies is consistent with the notion that CLIC4 and 
CLIC1 are functionally redundant to some extent since knockout of either Clic4 or Clic1 
alone results in little to no phenotype. Double knockout embryos collected around 
prenatal time of death also present an angiogenic phenotype not present in either single 
knockout, further supporting the role of both CLIC4 and CLIC1acting either concurrently 
or in concert during angiogenesis. Again, CLIC4 and CLIC1 intracellular localization 
during angiogenic processes should be determined as a next step. The co-localization of 
CLIC4 and CLIC1 during tube formation would further support the hypothesis of 
functional redundancy between the two proteins.  
 In summary, we have established that CLIC4 and CLIC1 are involved in 
regulating angiogenesis through their roles in promoting endothelial proliferation, 
branching, network formation and capillary sprouting; CLIC4 plays a role in promoting 
lumen formation; loss of CLIC4 may enhance tumorigenesis while altering macrophage 
function; CLIC1 plays a role in mediating endothelial migration; CLIC4 and CLIC1 
function concurrently during developmental angiogenesis; and both CLIC4 and CLIC1 
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are required for embryonic development. Judah Folkman essentially pioneered 
angiogenesis research and since then, targeting angiogenesis has become an accepted 
method of combating tumorigenesis and vascular disease. Much remains to be elucidated 
regarding the mechanisms that drive angiogenesis, however our work has identified a 
novel pathway leading to angiogenesis. By continuing to discover the programs that 
govern angiogenesis both physiologically and pathologically, we will be able to better 
understand this important biological process as well as uncover new potential targets for 
generating angiogenic therapies.  
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Chapter Seven: Materials and methods 
 
Ethics statement 
 No human subjects were used in this study. The collection of human umbilical 
venous endothelial cells (HUVEC) was approved by the Columbia University IRB 
(AAAE4646.). Transgenic mice were generated and maintained under IACUC protocol 
(AAAB0592). Tumor studies were conducted under IACUC protocol (AAAA9302). 
 
Statistics 
 Unless otherwise noted, independent two-tailed Student’s t-tests were performed 
on all quantified data to determine significant differences between two means. Pearson’s 
χ
2
 testing was used to determine goodness of fit between observed genotype distributions 
and theoretical Mendelian distributions during in vivo analyses. P values less than 0.05 
were considered statistically significant, and equal variances were assumed. All error bars 
shown represent standard deviation. 
 
Semi-quantitative PCR analysis 
 Total RNA was isolated from HUVEC using the RNeasy kit (Qiagen, Valencia, 
CA), and first strand cDNA synthesis was done using the Thermo Scientific Verso cDNA 
kit (Waltham, MA). PCR was then performed for human Clic1-6 for 30 cycles and an 
annealing occurred at 56°C for Clic5, 64°C for Clic1-4, and 66°C for Clic6 for 20 sec. 
Elongation time was 40 sec at 72°C. Primers used are as follows: Clic1 forward 5’-
CCAAAAGGCGGACCGAGACA-3’, reverse 5’-AGGGTGAGCTCGTTGCCATCCA-
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3’; Clic2 forward 5’-TGTCCCTTTTGCCAACGCCTTT-3’, reverse 5’-
CCTTGGAGGAGCCAGGGTTTGT-3’; Clic3 forward 5’-
TGCCAGCGGCTCTTCATGGT-3’, reverse 5’-CGCGGAGAACTTGTGGAAAACG-
3’; Clic4 forward 5’-GCCCCTCATCGAGCTCTTCGTCAA-3’, reverse 5’-
CAGGAGACCCCTCTCCAGTGCTTCA-3’; Clic5 forward 5’-
CAACACAGCGGGCATCGACA-3’, reverse 5’-CCACATGGAGCTTGGGCAACA-3’; 
Clic6 forward 5’-GAAGAGGAATCCCCCGACAGCA-3’, reverse 5’-
TGTTCCGGGAGCCAGGTTCT-3’.  
 
Cells and culture 
 HUVEC were isolated from human umbilical veins as previously described [197] 
and cultured on dishes coated with type I rat tail collagen (VWR, West Chester, PA) in 
EGM-2 BulletKit medium (Lonza, Basel, Switzerland). Detroit 551 fibroblasts and 293T 
fibroblasts were purchased from ATCC (Manassas, VA) and cultured in Eagle’s 
Minimum Essential Medium (EMEM) (ATCC, Manassas, VA) and Iscove’s Modified 
Dulbecco’s Medium (Invitrogen, Carlsbad, CA), respectively. Both media were 
supplemented with 10% FBS (Invitrogen, Carlsbad, CA), and 0.01% Pen-Strep 
(Invitrogen, Carlsbad, CA). Unless otherwise noted, cells were cultured under standard 
conditions in a humidified incubator at 37°C, 5% CO2.  
 
Gene silencing and overexpression 
 Human CLIC4 shRNA-containing constructs were purchased from Sigma–
Aldrich (St. Louis, MO) and screened for significant Clic4 knockdown in HUVEC by 
  149  
immunoblotting as described below. Oligonucleotides were provided in lentiviral vector 
pLKO.1-puro, which carries puromycin resistance allowing for selection of shRNA-
expressing cells. Two shRNA were selected with the target sequences of 5′-
GCATATAGTGATGTAGCCAAA-3′ and 5′-GCCGTAATGTTGAACAGAATT-3′ 
denoted as constructs shRNA3 and shRNA5, respectively. pLKO.1-puro, denoted as plko 
sc, expressing a scrambled shRNA insert that does not target any known genes, served as 
a control.  
 A human Clic1 shRNA-containing construct in lentiviral vector pLKO.1-puro 
(Sigma-Aldrich, St. Louis, MO) was used to provide Clic1 knockdown in HUVEC, 
which was confirmed by immunoblotting. The Clic1-targetting shRNA possessed the 
target sequence of 5'-CCTGTTGCCAAAGTTACACAT-3'. Again, lentiviral vector 
pLKO.1-puro expressing scrambled shRNA was used as the control (Sigma-Aldrich, St, 
Louis, MO).  
 Full-length human CLIC4 cDNA was prepared by RT-PCR using mRNA from 
HMVEC (human dermal microvascular endothelial cells) with the following primers: 5′-
ATGGATCCGCCACCATGGCGTTGTCGATGCCGCTGAATG-3′ forward and 5′-
ATGTCGACTTACTTGGTGAGTCTTTTGG-3′ reverse. The sequence of the cloned 
CLIC4 was determined and found to be identical with that of human CLIC4 (AF097330) 
except for a G to A nucleotide change in position 291, which did not affect the coding 
sequence. The full-length CLIC4 cDNA was cloned into lentiviral pCCL.pkg.wpre 
(referred to as pCCL-CLIC4) and screened for significant Clic4 overexpression by 
immunoblotting. pCCL.pkg.wpre-expressing GFP, denoted as pccl, served as a control 
for this overexpressing line.  
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Lentivirus-mediated stable expression of shRNA and full-length constructs in HUVEC 
 For lentiviral gene transfer, the lentiviral vector pLKO.1 was used for shRNA 
knockdown lines while pCCL was used for the overexpressing HUVEC line. About 
2.5 × 10
6
 293T packaging cells were seeded and transfected with 3 µg pVSVG, 5 µg 
pMDLg/pRRE, 2.5 µg pRSV-Rev, and either 10 µg pLKO.1-Clic4 shRNA (CLIC4 
knockdown), pLKO.1-Clic1 shRNA (CLIC1 knockdown), pLKO.1-scrambled shRNA 
(knockdown control), pCCL-CLIC4 (CLIC4 overexpression), or pCCL-GFP 
(overexpression control). Lentivirus-containing supernatants were collected 48 and 56 h 
after transfection, passed through a 0.45 µm filter, and added to 1 × 10
6
 low-passage 
HUVECs. About 48 h after infection, pLKO.1-expressing HUVECs were selected with 
puromycin (3 µg/ml) for 72 h and maintained with puromycin at 1.5 µg/ml.  
 
Immunoblotting 
 HUVEC protein lysates were prepared in TENT lysis buffer (50 mM Tris pH 8.0, 
2 mM EDTA, 150 mM NaCl, and 1% Triton X-100) containing Protease Inhibitor 
Cocktail Set IV (EMD Chemicals, Inc., Gibbstown, NJ) prepared according to the 
manufacturer's protocol. Lysates were boiled for 5 min after addition of SDS and β-
mercaptoethanol-containing sample buffer. Protein concentrations were determined using 
the Bradford protein assay (Bio-Rad Laboratories, Hercules, CA) according to the 
manufacturer's protocol, and sample volumes were adjusted to equivalent concentrations 
for equal protein loading into SDS-PAGE. Protein was then electroblotted onto 
nitrocellulose membrane and blocking occurred in 5% milk dissolved in PBST (1× PBS 
with 0.2× Tween20). Incubation of primary antibody (1:250 for CLIC1; 1:250 for 
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CLIC4; or 1:5000 for α-tubulin) was done in 2.5% milk dissolved in PBST, and 
incubation of secondary antibody (1:5000 for both HRP-conjugated goat anti-rabbit and 
goat anti-mouse) occurred in 2.5% milk in PBST. Protein bands were visualized using 
Enhanced Chemiluminescence (GE Healthcare Bio-Sciences Corp., Piscataway, NJ) 
according to the manufacturer's protocol. 
 Primary polyclonal rabbit anti-human CLIC1 (B121) antibody was a gift from 
Mark Berryman at Ohio University College of Osteopathic Medicine (Athens, OH) [115]. 
Primary polyclonal rabbit anti-human CLIC4 antibody was purchased from Abcam Inc. 
(Cambridge, MA) while primary monoclonal mouse anti-α-tubulin antibody was 
purchased from Sigma-Aldrich (St. Louis, MO). Secondary goat anti-rabbit and goat anti-
mouse horseradish peroxidase (HRP)-conjugated antibodies were purchased from Sigma-
Aldrich (St. Louis, MO).  
 
Cell viability and cell growth analysis 
 HUVEC were seeded at 3 × 10
4 
cells/well of a 24-well plate and cultured in either 
serum free medium (SFM) alone or SFM with 20 ng/mL epidermal growth factor (EGF) 
for 48 h for cell viability assays (Invitrogen, Carlsbad, CA). Cell numbers after 48 h were 
quantified using Cell Counting Kit-8 WST-8 (Dojindo Molecular Technologies, 
Gaithersburg, MD) according to the manufacturer's protocol. Similarly for cell growth 
assays, HUVEC were seeded at 1 × 10
4 
cells/well of a 24-well plate and cultured in SFM 
with 20 ng/mL EGF and 20 ng/mL recombinant human vascular endothelial growth 
factor-A (rhVEGF) for 96 h (Invitrogen, Carlsbad, CA). Again, cell numbers were scored 
using Cell Counting Kit-8 WST-8, and a calibration curve was generated following 
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Dojindo's protocol (Gaithersburg, MD). Assays were performed in triplicate and 
replicated at least five times. 
 
Migration “scratch” analysis 
 To determine changes in directed cell migration, cells were seeded to confluence 
on collagen-coated 12-well plates at 1 × 10
6
 cells/well in EGM-2 medium (Lonza, Basel, 
Switzerland). 24 h post-seeding, cell monolayers were bisected along the diameter of 
each well with a 200 µL pipette tip, creating an open "scratch" or "wound" that was clear 
of cells. The dislodged cells were removed by three washes with 1× PBS, EGM-2 
medium was replaced, and cells were incubated under standard conditions. Migration into 
the open area was documented at 0, 3, 6, 9, and 12 h post-scratching. Quantification was 
done using TScratch software and performed according to the creator's protocol [116]. 





HUVEC were incubated at 4°C on a rotator for 1 h with primary antibody (1:50 
for each of α2, β1, α3, αVβ3, αVβ5, CD31, and without primary for negative controls) in 
PCN (0.1% NaN3, 0.001 M MgCl2, 0.5% FBS in 1× PBS). Cells were incubated with 
secondary antibody (1:100 for APC-conjugated goat anti-mouse in PCN) on a rotator for 
45 min at 4°C and kept on ice overnight. The BD FACSCalibur was used to perform flow 
cytometry according to the manufacturer's protocol and data analysis was performed 
using CD CellQuest Pro software (San Jose, CA). Experiments were repeated at least 
three times. Primary monoclonal mouse anti-human antibodies for integrin subunit chains 
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α2, β1, and α3 were purchased from BD Biosciences (San Jose, CA) and primary 
monoclonal mouse anti-human antibodies for integrins αVβ3 and αVβ5 were purchased 
from Millipore (Billerica, MA). Primary monoclonal mouse anti-human CD31 antibody 
was purchased from Dako (Carpinteria, CA). Secondary goat anti-mouse 
allophycocyanin (APC)-conjugated AffiniPure IgG antibody was obtained from Jackson 
ImmunoResearch Laboratories, Inc. (West Grove, PA). 
 
Network formation and branching analysis 
 HUVEC were cultured at standard conditions as a monolayer between two layers 
of porcine collagen gel (Wako USA, Richmond, VA) as previously described for the 
network formation assay [73]. Briefly, HUVEC were seeded between two layers of 
porcine collagen gel at 1 × 10
5 
cells/well of a 24-well plate. Gels were cultured in SFM 
supplemented with 20 ng/mL EGF and 20 ng/mL rhVEGF for 96 h and photographically 
documented. Experiments were performed in triplicate and repeated at least five times. 
 Quantification for surface area was done by assessing collagen gel sandwiches 
96 h post-seeding by applying MTT (Dojindo Molecular Technologies, Gaithersburg, 
MD) for 3 h, photographing the networks, and using Image-Pro Plus (Media Cybernetics, 
Bethesda, MD) software to calculate the surface area sum occupied by colored objects, 
which in this case would be the MTT-treated HUVECs. Branch points were quantified by 
counting the number of branch points per field of vision at 10× objective for knockdown 
cell lines and 5× objective for overexpression lines. One branch point was considered any 
focal intersection of two or more cords. For experiments involving mitomycin C 
treatment, cells were exposed to mitomycin C (Sigma–Aldrich, St. Louis, MO) at 
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25 µg/ml for 45 min prior to seeding. After 45 min of exposure to mitomycin C, cells 
were used immediately for downstream applications. Mitomycin C was dissolved in 
dH2O and kept at 4°C as a 1 mg/ml stock solution. Accordingly, cells without mitomycin 
C treatment received treatment with dH2O.  
 
Capillary-like sprouting fibrin bead assay and quantification 
 The capillary sprouting assay was performed as previously described [75] with 
two modifications: thrombin concentration and Detroit 551 fibroblast seeding. Briefly, 
HUVEC and Detroit 551 fibroblasts (ATCC, Manassas, VA) were cultured in M199 with 
10% FBS and 0.01% Pen-Strep (Invitrogen, Carlsbad, CA). HUVEC were attached to 
dextran-coated Cytodex 3 microcarrier beads (GE Healthcare Bio-Sciences Corp., 
Piscataway, NJ) at 400 HUVEC/bead. HUVEC-coated beads were then embedded at 
~250 beads/well of a 24-well plate in a fibrin clot consisting of 2 mg/ml fibrinogen 
(Sigma–Aldrich, St. Louis, MO), 0.15 U/ml aprotinin (Sigma–Aldrich, St. Louis, MO), 
and 0.0625 U/ml thrombin (Sigma–Aldrich, St. Louis, MO). After 24 h, Detroit 551 
fibroblasts were seeded on top of the fibrin gel at 1.5 × 10
5
 cells/well. Clots were cultured 
at standard conditions in EGM-2 medium and the assay was allowed to run for 11 days. 
Experiments were performed in triplicate and replicated at least three times. 
 Quantification for sprout number/bead, branch point/sprout, and the ratio of 
lumen-containing sprouts to non-lumen containing cords was done by counting the 
number of sprouts, branch points, or lumen-containing sprouts for 300 beads for each cell 
line in one experiment using normal optical microscopy. One branch point was 
considered any focal point where at least two vessels intersect or where one vessel 
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divides. A lumen-containing sprout was tabulated as any sprout with a continuous lumen 
that occupied at least 50% of the sprout length.  
 
Three-dimensional endothelial morphogenesis assay 
 Three-dimensional analysis of endothelial morphogenesis in forming tube-like 
structures was performed as previously reported [76]. HUVEC were suspended at 1 x 10
6
 
cells/mL of porcine collagen gel as prepared according to the manufacturer’s instructions 
(Wako USA, Richmond, VA). 100 mL aliquots of the collagen/cell mixture were plated 
into one well of a 24-well plate and allowed to polymerize for 30 min at 37°C, 5% CO2, 
and cultured in SFM supplemented with 40 ng/mL EGF (Invitrogen, Carlsbad, CA), 40 
ng/mL bFGF (Invitrogen, Carlsbad, CA), and 40 ng/mL rhVEGF-A165 (Research 
Diagnostics, Inc, Concord, MA). Photographs using light microscopy documented 
progress at 48 h and 72 h. Experiments were performed in triplicate and repeated at least 
three times.  
 
Patch clamp assay for channel activity 
 HEK 293 cells were transfected with either pCCL-CLIC4 and a positive selection 
marker (CD8) or pCCL-GFP using Lipofectamine transfection according to the 
manufacturer’s protocol (Invitrogen, Carlsbad, CA). Cells are suspended as single whole-
cell suspensions in a bath solution of 132 mM NaCl, 4.8 mM KCl, 10 mM HEPES, 5 mM 
glucose, 1.2 mM MgCl2, and 2 mM CaCl2 at pH 7.4. A pipette solution of 110 mM K-
Asp, 5 mM ATP-K2, 11 mM EGTA, 10 mM HEPES, 5.5 mM (100 nM free) CaCl2, and 1 
mM MgCl2 at pH 7.3 was applied. The holding potential was kept at -100 mV, pulsing 
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from -100 mV to +100 mV at 20 mV increments for pulse durations of 1 sec. Ion channel 
blockers were not used in our analysis to detect all ion channel activity resultant from the 
transfections.  
 
Targeting vector construction 
 Multiple cloning steps were applied in the construction of the Clic4 targeting 
vector. Subcloning of Clic4 exon 2 from bacterial artificial chromosome (BAC) RP23-
57P18 into pDrive vector (QiagenValencia, CA) was performed using PCR with forward 
primer 5’-AGCCCGGGGGGGGCATCTTCATCAGACCA-3’ and reverse 5’-
ACTCTAGACCCTCAAAGCCCCCACAGAGATCCA-3’. An Xma1 site was attached 
to the 5’ end of the forward primer while an Xba1 site was attached to the 5’ end of the 
reverse primer for subsequent subcloning purposes. Likewise, 3.2 kb upstream and 3.2 kb 
downstream homology arms were subcloned into separate pDrive vectors using the 
following primers: upstream homology arm forward 5’-
ACGCGGCCGCCTGGATGGCAGTGGCTCATGGCAGA-3’ and reverse 5’-
ACCTCGAGCAGCTTGTGGCGCTGTTTGGA-3’; downstream homology arm forward 
5’-ACGTCGACTAGAGCCCCCTCCCAGCTAGCACA-3’ and reverse 5’-
ACGGTACCTGCCATAAGTCTGCCACCAC-3’. A NotI site and an XhoI site was 
engineered to the 5’ ends of the upstream homology arm forward and reverse primers, 
respectively. To the 5’ ends of the downstream homology arm forward and reverse 
primers, a SalI site and an Acc651 site was added, respectively.  
 The majority of the targeting allele was assembled by directional cloning into 
pBluescript II SK (Fermentas, Ontario, Canada) using the three pDrive constructs 
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containing Clic4 exon2, the upstream homology arm, and the downstream homology arm 
described above as well as pBS containing a loxP-flrted neomycin cassette referred to as 
FNFL (pBS-FNFL) and pBS-LoxP, which contained a single loxP site. NotI was used for 
ligation of the 5’ end of the upstream homology arm into pBS while the XhoI site of the 
3’ end was ligated to the SalI-digested 3’ end of FNFL from pBS-FNFL; the 5’ end of 
FNFL was ligated into pBS using XmaI to yield pBS containing the upstream homology 
arm ligated to the neomycin cassette (pBS-5F). In a separate pBS, XmaI was used for 
insertion of the 5’ end of Clic4 exon 2, which was digested with XbaI on its 3’ end and 
ligated to the NheI-digested 3’ end of the single loxP site from pBS-LoxP; the 5’ end of 
the lone loxP was ligated into pBS by SalI digestion (pBS-EL). In a third pBS, the 5F 
fragment of pBS-5F and the EL fragment of pBS-EL were ligated into pBS cut with NotI 
and SalI after lifting them from their vectors using NotI and XmaI, and XmaI and SalI, 
respectively (pBS-5FEL). Finally, pBS-5FEL was cut with SalI and Acc651 for ligation 
of the downstream homology arm, which had been digested from its vector using SalI 
and Acc651. The final product was pBS containing the upstream homology arm, 
followed by the FNFL cassette, Clic4 exon 2, the single loxP site, and the downstream 
homology arm (pBS-5FEL3). The entire 5FEL3 product was then lifted from pBS using 
NotI and Acc651 and ligated into pPNT1, which had also been digested with NotI and 
Acc651. pPNT1 contained the negative selection marker HSV-tk, which would have been 
downstream of the 5FEL3 insert (pPNT1-5FEL3). NotI was used to linearize the final 
pPNT1-5FEL3 targeting construct for downstream applications.  
 In all cases, PCR was performed using AccuPrime Taq DNA Polymerase High 
Fidelity (Invitrogen, Carlsbad, CA). Ligations were done using T4 ligase, bacterial 
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transformations occurred in DH10B competent cells, and minipreparation of DNA was 
done according to standard protocols (Life Technologies Corporation, Carlsbad, CA). All 
gel extractions of PCR products or restriction enzyme-digested products were done using 
the QIAquick Gel Extraction kit (Qiagen, Valencia, CA). Sequencing (Genewiz, South 
Plainfield, NJ) and restriction mapping were used at each cloning step to confirm 
successful cloning. pPNT1, pBS-FNFL, and pBS-LoxP were gifts from Thomas Ludwig 
(Columbia University Medical Center, New York, NY). The final product was subjected 
to restriction mapping and sequencing to confirm proper cloning of all essential elements 
using primers that include those used for cloning as well as the following: to sequence 
and screen for the FNFL cassette, forward 5’- CCATGACCACGGCAACTCCT-3’ and 
reverse 5’-CGAGATCAGCAGCCTCTGT-3’ (referred to hereafter as the FNFL primer 
set); to sequence and screen for the single loxP site, forward 5’-
ACCCGTGGCTGCATGTGGGTGAAT-3’ and reverse 5’-







 transgenic mice 
 The pPNT1-5FEL3 targeting construct was given to Victor Lin at Columbia 
University Medical Center’s Comprehensive Cancer Transgenic Facility (New York, 
NY) for generation of chimeric mice. Briefly, the targeting construct was linearized using 
NotI and electroporated into CSL3 ES cells derived from 129S6/SvEvTac-Car3 mice. 
After negative selection against HSV-tk and neomycin (G418) selection, 192 ES cell 
clones were screened for homologous recombination using Southern blot analysis to 
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confirm integration of the FNFL cassette. Correctly targeted ES cell clones were further 
screened for integration of the single loxP site by PCR using the LoxS primer set. From 
the eleven correctly targeted clones, two were chosen for microinjection into C56BL/6 
host blastocysts. Resultant chimeras were crossed with C57BL/6 mice and germline 
transmission was detected by agouti coat color. Germline transmission was confirmed by 
Southern blotting and PCR using LoxS primers. Chimeras were crossed with C57BL/6 
mice to establish the Clic4
fl
 mutation in a hybrid 129/B6 background.  
 To generate Clic4
-
 mice, female Clic4l
f/fl
 mice were crossed with male EllaCre 
homozygous mice [198], resulting in mice heterozygous for Clic4 knockout. Clic4
+/-
 
mice were then backcrossed with C57BL/6 mice for eight generations to produce Clic4 
heterozygotes in a pure B6 background. Clic4
+/-
 mice were subsequently intercrossed to 
produce Clic4 global knockout mice in B6 background. Clic4
-
 mice were genotyped by 
PCR using the forward primer from the FNFL primer set and the reverse primer from the 
LoxS primer set.  
 
Southern blotting analysis 
 To perform Southern blotting, genomic DNA (gDNA) was isolated from ES cell 
clones and digested with PstI. The digested DNA was then gel electrophoresed in a 
0.75% agarose gel containing ethidium bromide in 1X TAE buffer at 35 V. gDNA in the 
agarose gel was depurinated in 0.25 M HCl for 20 min at room temperature, washed in 
water, and denatured in 0.5 M Na OH and 1.5 M NaCl for 20 min at room temperature. 
The gDNA was then transferred to a nitrocellulose membrane by capillary action, which 
was then allowed to air dry for 10 min and baked at 80°C for 20 min. Prehybridization of 
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the membrane in rapid hybridization buffer with denatured salmon sperm for 30 min at 
65°C then occurred, followed by hybridization with the 32P-labeled probe for 2 hr at 
65°C. To generate the Southern probe, which is located upstream of the upstream 
homology arm, forward 5’-TCTACACTAAAGGTAAATGG-3’ and reverse 5’-
GGAATGTATCAGCGGGTTTTTG-3’ primers were used for PCR on wild type gDNA. 
The PCR product was gel purified, placed in pDrive, sequenced, and removed again by 
EcoRI digestion prior to 
32
P-labeling. The Prime-It II Primer Labeling Kit (Stratagene, La 
Jolla, CA) was used to radiolabel the probe. Following hybridization, the membrane was 
washed three times in three different solutions all at 65°C for 10 min: (1) 2X SSC, 0.5% 
SDS (2) 1X SSC, 0.5% SDS, and (3) 0.1X SSC, 0.1% SDS. The radiolabeled membrane 
was then exposed to film.  
 
Isolation of mouse embryonic fibroblasts 
 13.5 dpc embryos were minced and trypsinized after dissection and removal of 
the head and liver. Cells were plated on gelatin-coated plates. Resulting fibroblasts were 
cultured in DMEM (Invitrogen, Carlsbad, CA) supplemented with 10% FBS (Invitrogen, 
Carlsbad, CA) and 0.01% Pen-Strep (Invitrogen, Carlsbad, CA) at 37°C in 5% CO2. Yolk 
sacs were used for genotyping.  
 
Whole mount immunohistochemistry 
 Yolk sacs and extraembryonic membranes were removed from embryos during 
dissection, and embryos were fixed overnight at 4°C in 4% PFA. Embryos were then 
washed three times for 10 min each in PBS, once in 50% methanol (diluted in PBS) for 
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10 min, and three times in 100% methanol for 5 min each. Dehydrated embryos were 
then bleached for 5 hr in methanol:DMSO:H2O2 (4:1:1) at room temperature for 5 hr. 
Subsequent to rehydration by a 20-min wash in 50% methanol, three 15-min washes in 
PBT (0.2% BSA, 0.5% Triton X-100 in PBS), two 5-min washes in PBSMT (2% milk, 
0.5% Triton X-100 in PBS), three 15-min washes in PBSMT, and one 1-hr wash in 
PBSMT, embryos were incubated with rat anti-mouse endomucin (1:200, Santa Cruz 
Biotechnology, Inc., Santa Cruz, CA) in PBSMT overnight at 4°C with rocking. Embryos 
were then washed in 4°C PBSMT twice for 5 min, thrice for 15 min, and then seven 
times for 1 hr before incubation with HRP-conjugated goat anti-rat secondary antibody 
(1:2000, Sigma-Aldrich, St. Louis, MO) at 4°C overnight with rocking.  
 To visualize staining, embryos were first washed with PBSMT at 4°C twice for 5 
min, thrice for 15 min, and five times for 1 hr before two 5 min and three 15min washes 
with PBT at room temperature. Embryos were then incubated for 15 min in DAB solution 
(250 µg/mL DAB, 0.08% NiCl2 in PBT) before the addition of H2O2 at 1:1000. All 
embryos within a matched set were allowed to incubate in the H2O2 solution for the same 
amount of time, and the color reaction was stopped by rinsing embryos twice in PBT. 
After postfixing overnight at 4°C in 4%PFA, embryos were washed three times with PBT 
and cryopreserved with 80% glycerol in a series (10 min room temperature wash with 
25% glycerol, 10 min in 50% glycerol, and 10 min in 80% glycerol), embryos were 




Retina whole mount analysis 
 After removing whole eyes from sacrificed animals, eyes were fixed for 1 hr at 
4°C on a rotator in 4% paraformaldehyde (PFA). Eyes were then washed three times with 
PBS and retinas were dissected. Retinas were permeabilized overnight at 4°C in 1% BSA 
and 0.5% Triton X-100 in 1X PBS and subsequently washed three times for 30 min each 
in PBLEC (1X PBS, 1% Triton X-100, 0.1 mM CaCl2, 0.1 mM MgCl2, 0.1 mM McCl2, 
pH 6.8) before being incubated overnight at 4°C with rabbit anti-mouse F4/80 primary 
antibody (1:200, eBioscience, San Diego, CA) in PBLEC. After three 15 min washes in 
PBLEC and three 15 min washes in PB/2 (PBLEC diluted 1:1 in PBS), retinas were 
incubated overnight at 4°C with donkey anti-rat Alexa Fluor 594 secondary antibody 
(1:750, Invitrogen, Carlsbad, CA) and FITC-conjugated isolectin-B4 (1:250, Sigma-
Aldrich, St. Louis, MO) in PBLEC. Retinas were washed four times for 15 min each in 
PB/4 (PBLEC diluted 1:3 in PBS), once in PBS for 15 min, postfixed for 20 min in 4% 
PFA at room temperature, washed twice in PBS, flat-mounted with VectaShield 
mounting medium (Vector Labs, Burlingame, CA), and visualized using ACT-1 software 
on a Nikon ECLIPSE E800 microscope (Nikon, Inc., Melville, NY).  
 
Histology and immunofluorescence 
 Yolk sacs and extraembryonic membranes were removed from dissected embryos, 
which were then fixed overnight at 4°C in 4% PFA with rocking. Embryos were then 
washed three times with PBS, cryopreserved in 30% sucrose (in PBS) overnight at 4°C, 
and embedded in Tissue-Tek OCT Compound (Sakura Finetek USA, Inc., Torrance, CA) 
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for sectioning. For tumor analysis, tumors were dissected and fresh-frozen in Tissue-Tek 
OCT Compound for sectioning. Resultant slides were stored at -20°C until ready for use. 
 To analyze, slides were postfixed in -20°C acetone for 3 min and washed twice 
for 5 min each in 1X PBS. For hematoxylin and eosin staining, the standard protocol was 
followed [199]. For immunofluorescence, tissue sections were blocked in IHC diluent 
(3% BSA and 0.02% donkey serum in PBS) for 1 hr at room temperature, and sections 
were incubated with primary antibody in IHC diluent overnight at 4°C. Primary 
antibodies used include rat anti-mouse CD31 (1:250, BD Pharmingen, San Diego, CA), 
Cy3-conjugated mouse anti-mouse αSMA (1:1000, Sigma-Aldrich, St. Louis, MO), 
rabbit anti-mouse phosphor-histone H3 (Ser 10) (1:200, Millipore, Billerica, MA), goat 
anti-rat Jagged 1 (1:75, R&D Systems, Minneapolis, MN), goat anti-mouse VEGFR-2 
(1:100, R&D Systems, Minneapolis, MN), rabbit anti-human caspase 3 (1:100, Cell 
Signaling Technology, Danvers, MA), and rabbit anti-mouse F4/80 (1:200. eBioscience, 
San Diego, CA). Slides were then washed twice for 5 min each in PBS and incubated 
with secondary antibody in IHC diluent for 30 min at room temperature. Secondary 
antibodies used include Alexa Fluor 594 and Alexa Fluor 488 ( both at 1:1000, 
Invitrogen, Carlsbad, CA). After two 5 min washes in PBS, VectaShield with DAPI 
(Vector Labs, Burlingame, CA) was used to mount coverslips and counterstain nuclei. 
Tissue sections were visualized using ACT-1 software on a Nikon ECLIPSE E800 
microscope (Nikon, Inc., Melville, NY). Quantification was done using Image J software 
(NIH, Bethesda, MD) on five sections for each embryo of two matched sets. Positively 
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Regulation of cardiovascular development and integrity 
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Cerebral cavernous malformations (CCMs) are human vascular malformations caused by mutations in three genes of unknown 
function: KRIT1, CCM2 and PDCD10. Here we show that the heart of glass (HEG1) receptor, which in zebrafish has been linked 
to ccm gene function, is selectively expressed in endothelial cells. Heg1–/– mice showed defective integrity of the heart, blood 
vessels and lymphatic vessels. Heg1–/–; Ccm2 lacZ/+ and Ccm2 lacZ/lacZ  mice had more severe cardiovascular defects and died early 
in development owing to a failure of nascent endothelial cells to associate into patent vessels. This endothelial cell phenotype was 
shared by zebrafish embryos deficient in heg, krit1 or ccm2 and reproduced in CCM2-deficient human endothelial cells in vitro. 
Defects in the hearts of zebrafish lacking heg or ccm2, in the aortas of early mouse embryos lacking CCM2 and in the lymphatic 
vessels of neonatal mice lacking HEG1 were associated with abnormal endothelial cell junctions like those observed in human 
CCMs. Biochemical and cellular imaging analyses identified a cell-autonomous pathway in which the HEG1 receptor couples to 
KRIT1 at these cell junctions. This study identifies HEG1-CCM protein signaling as a crucial regulator of heart and vessel 
formation and integrity. 
 
 
CCMs are a common  vascular malformation,  with a prevalence of 
0.1%–0.5% in the human population1. CCMs arise primarily in the 
brain as thin-walled, dilated blood vessels that cause seizures, head- 
aches and stroke in midlife, often in association with focal hemor- 
rhage1,2. Familial CCM shows an  autosomal  dominant  pattern  of 
inheritance and is caused by loss-of-function mutations in three genes: 
KRIT1 (also known as CCM1)1,3,4, CCM2 (also known as malcalver- 
nin   and   osm)5,6    and   PDCD10  (also  known  as  CCM3)7.  The 
CCM proteins are putative adaptor proteins that interact biochemi- 
cally8–10  and  participate  in  a  signaling pathway  that  is  not  yet 
fully characterized. The mechanism by which loss of CCM protein 
signaling results in  the  development of vascular malformations  is 
not known. 
A clue to the role of CCM protein signaling in the cardiovascular 
system comes from genetic studies in zebrafish, which reveal that loss 
of krit1, ccm2 or heg (encoding the type I transmembrane  receptor 
heart of glass) results in a dilated heart phenotype early in develop- 
ment11,12. This phenotype is characterized by heart failure associated 
with enlarged cardiac chambers in which the endocardium is covered 
by a  thin  layer of myocardial cells. Expression of heg,  krit1 and 
ccm2  mRNA has been detected in  the  endocardium,  but  not  the 
myocardium, of zebrafish embryos11,12, suggesting that these proteins 
operate in an endothelial cell–autonomous signaling pathway. An 
endothelial role for this pathway is also supported by studies of 
KRIT1-deficient mice, which show lethal vascular defects at embry- 
onic day 9 (E9); however, these studies did not detect high-level Krit1 
or Ccm2 gene expression in the mouse cardiovascular system, leading 
to the proposal of cell-nonautonomous mechanisms of CCM patho- 
genesis such as a requirement for CCM protein signaling in adjacent 
neuronal cells13,14. 
Here we used mice and zebrafish lacking the HEG1 receptor and the 
CCM2 adaptor to investigate the role of this pathway in the cardio- 
vascular system. Our studies support an endothelial cell–autonomous 
mechanism in which the HEG1 receptor couples to CCM proteins to 
regulate endothelial cell-cell junctions required for the formation and 
maintenance of the heart and vessels. Complete loss of function in this 
pathway resulted in an inability of emerging endothelial cells to 
associate into a functional cardiovascular system in mouse and 
zebrafish embryos. Less-complete loss of function  permitted  heart 
and vessel development but resulted in integrity defects manifested by 
cardiac rupture,  vascular hemorrhage and lymphatic leakage. These 
cardiovascular defects arose in conjunction with abnormal endothelial 
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Figure 1 Heart and blood vessel integrity defects in HEG1-deficient 
mouse embryos and neonates. (a,b) Heg1 was selectively expressed in the 
developing cardiovascular system. Radioactive in situ hybridization revealed 
Heg1 expression in the vascular endothelium, cardiac endocardium and 
neural tube at E10.5 (a). By E14.5, Heg1 was expressed in both endothelial 
and smooth muscle cells in major arteries (b). ao, aorta; h, heart; nt, neural 
tube. (c–f) E15 Heg1–/– embryos showed deep invaginations of the 
ventricular chamber into the compact zone of the ventricular wall and 
into the septum, often associated with the presence of blood between 
the epicardial and myocardial cell layers of the heart (arrow in f). e,f show 
magnification of boxed regions in c,d. (g–i) Pulmonary hemorrhage in 
Heg1–/– neonates (h,i) but not in Heg1+/+ littermates (g) was manifested 
by the presence of erythrocytes and fibrin in alveolar air spaces. (j) Cardiac 
rupture in P4 Heg1–/– neonate. Hemopericardium (left, middle) associated 
with cardiac rupture and formation of a transmural thrombus (right) was 
observed in Heg1–/– mice. VSD, ventricular septal defect. Scale bars, 
200 mm in a–d and j (middle), 20 mm in e–i and j (right). 
 
showed cardiac defects characterized by invagination of the ventricular 
cavity into, and often through, the compact layer of ventricular 
myocardium (Fig. 1c–f ). The septal myocardium was similarly honey- 
combed by endothelial-lined extensions from the ventricular cavity 
(Fig. 1d), a defect accompanied by the presence of ventricular septal 
defects in most  late-gestation embryos. TUNEL and  Ki67 staining 
revealed that HEG1-deficient myocardial defects were not caused by 
an increase in myocardial apoptosis or a decrease in myocardial 
proliferation (Supplementary  Fig. 5 online and data not shown). 
Although most HEG1-deficient mice survived to birth, approximately 
half  died  before  weaning  as  a  result  of  pulmonary  hemorrhage 
(Fig. 1g–i). Neonatal HEG1-deficient mice also showed defective 
cardiac  integrity  manifested  by  a  blood-filled  pericardial  sac,  a 
junctions similar to those observed in human CCMs15–17 and asso- 
ciated with KRIT1 depletion in human  endothelial cells in vitro18, 
suggesting a common  mechanism  by which loss of this signaling 
pathway confers a spectrum  of vertebrate cardiovascular defects in 
developing and mature animals. Our studies indicate that the signaling 
pathway implicated  in  human  CCM regulates endothelial cell-cell 
association and suggest that agents designed to promote endothelial 
phenotype that arose as a result of rupture of the low-pressure atrial 
chamber of the heart (Fig. 1j). Cardiac or pulmonary integrity defects 
were observed in 50% of HEG1-deficient mice. These findings indicate 
that  HEG1 deficiency results in  a loss of cardiac and  pulmonary 
vascular integrity, resulting in lethality. 
cell association may be effective treatments for CCM. a 
 
RESULTS 
Heg1 is expressed in the developing cardiovascular system 
It has been unclear how CCM proteins function in cardiovascular cell 
c 
types and  whether it is loss of CCM protein  function  in cardio- 
Heg1


















vascular or other cell types that causes human  vascular disease. To 
determine whether HEG1 receptors have a direct role in regulating 
CCM protein  signaling, we cloned the mouse Heg1 gene (Supple- 
mentary Fig. 1 online) and characterized Heg1 mRNA expression in 
mice. Using in situ hybridization, we detected Heg1 expression in the 
endothelium of the developing heart and aorta and in the neural tube 
at E10.5 (Fig. 1a), and in the arterial endothelium, smooth muscle, 
endocardium of the heart and brain vasculature at E14.5 (Fig. 1b and 
Supplementary  Fig. 2 online). In contrast to Heg1, Ccm2 expression 
was low and detected primarily in the developing neural tube at E10.5 






























HEG1 deficiency results in lethal hemorrhage in mice 
To address the role of the HEG1 receptor in mammals, we generated 
HEG1-deficient mice by targeting Heg1 exon 1 in embryonic stem 
cells (Supplementary   Fig. 4  online).  In  mice with  genetic back- 
grounds  of  50%  SV129 and  50%  C57Bl/6 or  495%   C57Bl/6, 
HEG1 deficiency resulted in embryonic and postnatal lethality (Sup- 
plementary  Table 1 online). Midgestation HEG1-deficient embryos 
Figure 2 Lymphatic vessel dilatation and leakage in Heg1–/– neonatal mice. 
(a,b) HEG1-deficient neonates showed chylous ascites, manifested by the 
accumulation of white chyle in the peritoneal space. (c–f) Lymphatic 
malformations in Heg1–/– mice. Neonatal mesenteric lymphatic vessels of 
Heg1–/– mice were dilated (arrows) and leaked chyle into the intestinal wall 
and peritoneum. (g,h) Immunostaining for LYVE1 confirmed the lymphatic 
identity of the dilated mesenteric vessels (arrows). SMA, a-smooth muscle 
actin. Scale bars, 100 mm. 
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Cranial Caudal Figure 3 Heg1–/–; Ccm2 lacZ/+ mouse embryos do 
not establish a patent blood vascular network. 
Transverse sections of E9 Heg1+/–; Ccm2 +/+ 
(control) and two Heg1–/–; Ccm2 lacZ/+ embryos at 
three levels are shown. H&E staining revealed the 
presence of blood-filled dorsal aortas (DA), 
cardinal veins (CV) and branchial arch arteries 
(BAA) of normal caliber in the Heg1+/–; Ccm2 +/+ 
control embryo (top) but not in Heg1–/–; Ccm2 lacZ/+ 
littermates (bottom). Staining for Flk1 in adjacent 
sections at the level of the first two branchial 
arch arteries is shown. Flk1+ endothelial cells 
were present at the dorsal aortas, cardinal veins 
and branchial arch arteries (arrows) in Heg1–/–; 
Ccm2 lacZ/+ embryos, but these cells did not form 
vessels of normal caliber with patent lumens. AO 






HEG1 deficiency causes dilated lymphatic vessel malformations 
Neonatal mammals transport absorbed fat through the intestinal and 
mesenteric lymphatic vessels in the form of white chyle. A distinct 
phenotype observed in approximately 10% of HEG1-deficient neo- 
natal mice was the appearance of chylous ascites shortly after their first 
feeding (Fig. 2a,b).  Chylous ascites was invariably associated with 
severely dilated intestinal and mesenteric lymphatic vessels that leaked 
chyle into the intestinal wall and peritoneal space (Fig. 2c–f ). The 
dilated mesenteric lymphatic vessels were lined with endothelial cells 
that expressed the lymphatic molecular marker LYVE1 and were 
associated with smooth muscle cells typical of collecting lymphatic 
vessels (Fig. 2g,h). These findings indicate that loss of HEG1 receptors 
is associated with a loss of integrity of lymphatic vessels as well as of 
blood vessels and the heart. Because lymphatic vessels are not subject 
to  the  hemodynamic  forces generated by the  beating heart,  these 
findings further  suggest that  loss of integrity arises as an intrinsic 
defect in the heart and vessels of HEG1-deficient mice. 
 
Heg1 and Ccm2 interact genetically in mice 
Identical big-heart phenotypes arise in zebrafish embryos lacking heg, 
krit1 (also known as santa)  or ccm2 (also known as valentine), and 
gene-knockdown experiments using morpholinos have shown strong 
interactions among these genes in zebrafish12. In contrast, human 
CCMs have been linked to loss-of-function mutations in KRIT1 and 
CCM2, but not HEG1, and HEG1-deficient mice do not experience 
the early embryonic lethality reported for KRIT1-deficient mice13. To 
determine whether—and to what extent—HEG1 interacts genetically 
with CCM genes in mammals, we intercrossed Heg1+/–;  Ccm2lacZ/+ 
mice. The Ccm2lacZ  allele is predicted to be a null allele because the 
Ccm2lacZ mRNA transcript lacks the 3¢ half of the Ccm2 mRNA  (exons 
6–10,  Supplementary   Fig.  6  online),  and  Ccm2lacZ/lacZ   embryos 
experience   early   embryonic   lethality   that   phenocopies   Krit1 /  
embryos (see below and  ref. 13). In contrast  to Heg1–/–;  Ccm2+/+ 
 
Figure 4 Endothelial cells of zebrafish lacking heg or ccm2 form vessels 
that are normally patterned but not patent. (a) Fli1-GFP–transgenic, 
heg- and ccm2-morphant (MO) embryos showed dilated hearts (arrows) and 
normal vascular patterning. (b) Angiography revealed a proximal circulatory 
block in heg- and ccm2-morphant zebrafish. Fluorescent microspheres were 
distributed throughout the vasculature of control, but not heg- or ccm2- 
morphant, zebrafish after venous injection. (c) FITC-dextran was distributed 
throughout the vasculature in wild-type, but not ccm2-mutant, zebrafish 
after venous injection. Scale bars, 250 mm. 
mice, which showed no abnormalities before midgestation, both 
Heg1–/–; Ccm2lacZ/+  and Ccm2lacZ/lacZ embryos died before E10 (Sup- 
plementary Table 2 online). Heg1–/–; Ccm2lacZ/+ and Ccm2lacZ/lacZ 
embryos were indistinguishable from littermates of all other genotypes 
until E9, when the mutants  showed identical phenotypes of growth 
retardation  and marked pericardial edema despite the presence of a 
visibly normal  heartbeat (data  not  shown). Histologic examination 
revealed normal development of the ventricular chamber and bulbus 
cordis (future  right ventricle) but  aberrant  formation  of a dilated 
aortic sac (Fig. 3 and Supplementary  Fig. 7 online). Compared to 
control embryos, the paired dorsal aortas of E9 Heg1–/–; Ccm2lacZ/+ 
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P < 0.0001 
 


















Figure 5 HEG1 is required to form normal 
endothelial junctions in vivo. Dilated mesenteric 
lymphatic vessels in Heg1–/– mice had severely 
shortened endothelial junctions and gaps between 
endothelial cells. (a) Endothelial cell junctions 
were measured as the length of two overlapping 
cell membranes. Junction lengths in Heg1+/+ and 
Heg1–/– lymphatic vessels are shown divided into 








 group; 2nd, middle third of junctions in each 
group; 3rd, longest third of junctions in each 
group; mean ± s.d. for each tercile). n ¼ 66 
Heg1+/+ junctions and 123 Heg1–/– junctions. 
The data shown are from analysis of 6 vessel 
cross-sections from one animal of each genotype. 
(b) Percentage of endothelial junctions 
o1,000 nm, 1,000–2,500 nm and 42,500 nm. 
10 ∝m 500 nm 500 nm 500 nm The same junctions were analyzed in panels a and 
b. (c) Representative low-magnification (far left) 
and high-magnification images of endothelial 
cells. Asterisks indicate sites of endothelial gaps, 
normally not present in collecting mesenteric 
lymphatics; arrowheads indicate endothelial 
junction limits. Endothelial gaps were present 
in Heg1–/– but not Heg1+/+ vessels. 
10 ∝m 500 nm 500 nm 500 nm 
 
lacked luminal blood cells (Fig. 3 and Supplementary Fig. 7). Analysis 
of serial transverse sections revealed that the aortic sac did not connect 
to  a lumenized first, second or  third  branchial arch artery in the 
mutant embryos, suggesting that blood in the heart did not enter the 
dorsal aortas despite the presence of a normal heartbeat (Fig. 3 and 
Supplementary Fig. 7). When visible, the cardinal veins of E9 Heg1–/–; 
Ccm2lacZ/+   and  Ccm2lacZ/lacZ   embryos were also devoid  of blood, 
except at the point  where they connected to the sinus venosus of 
the heart (Fig. 3). In contrast to the lack of blood in the vessels, 
extravasated blood cells were frequently present in the dilated peri- 
cardial cavity (Fig. 3 and data not shown), a finding that may reflect a 
primary defect in the integrity of the heart; alternatively, this finding 
may arise from the heart beating against a closed circulatory system 
and/or from reduced embryonic viability at this point in development. 
To determine whether the lack of blood-filled vessels in E9 Heg1–/–; 
Ccm2lacZ/+  and Ccm2lacZ/lacZ  embryos is due to a lack of endothelial 
cells, we used Flk1 immunostaining  to identify endothelial cells. We 
found endothelial cells at sites where the branchial arch arteries and 
dorsal aortas are normally located, but in all Heg1–/–; Ccm2lacZ/+  and 
Ccm2lacZ/lacZ   embryos studied  these cells were not  organized into 
lumenized vessels as they were in control embryos (Fig. 3). Thus, 
circulation  in  Heg1–/–;  Ccm2lacZ/+   and  Ccm2lacZ/lacZ   embryos  was 
blocked by an inability of mutant endothelial cells to form lumenized 
vessels capable of carrying blood. These findings indicate a strong 
genetic interaction  between HEG1 receptors and the CCM protein 
signaling  pathway  during  formation  of  the  primary  vasculature 
in mammals. 
 
heg and ccm2 are required for vessel patency in zebrafish 
In contrast to E9 Heg1–/–; Ccm2lacZ/+  and Ccm2lacZ/lacZ  mouse 
embryos, zebrafish embryos  lacking heg  or  ccm2  show  primarily 
cardiac defects11,12. To determine whether HEG1 and CCM proteins 
have differing roles in cardiovascular development in zebrafish and 
mice, we examined vascular patterning and function in heg-morphant, 
ccm2-morphant and ccm2-mutant zebrafish embryos at 48 hours post 
fertilization (h.p.f.). Morpholino knockdown of heg or ccm2 in Fli1- 
GFP transgenic fish (which have GFP-labeled endothelium) resulted in 
dilated  heart  chambers  but  no  abnormalities  in  vessel patterning 
(Fig. 4a). However, we noted visually that blood cells in the hearts 
of heg- and ccm2-morphant zebrafish did not circulate despite 
detectable contraction  of the dilated heart, a finding similar to the 
circulatory block we observed in E9 Heg1–/–; Ccm2lacZ/+ and 
Ccm2lacZ/lacZ mouse embryos. 
We used angiography to functionally test the patency of the 
vasculature of heg- and ccm2-morphant zebrafish. Fluorescent beads 
injected into  the  sinus venosus of zebrafish embryos treated  with 
control morpholinos circulated throughout the body and outlined the 
developing vasculature of the head and  tail (Fig. 4b).  In contrast, 
injection of heg- or ccm2-morphant zebrafish revealed a complete or 
near-complete  circulatory  block  immediately  distal  to  the  heart 
(Fig. 4b), the same point  at which circulation was blocked in E9 
Heg1–/–;  Ccm2lacZ/+    and  Ccm2lacZ/lacZ    mouse  embryos.  We  also 
observed a complete circulatory block in all ccm2-mutant  zebrafish 
embryos injected with FITC-dextran (Fig. 4c). These findings indicate 
a conserved role for HEG1 and CCM2 in the formation of a patent 
vertebrate circulatory system. 
 
HEG1-CCM signaling regulates endothelial tube formation 
The inability of nascent endothelial cells to form patent branchial arch 
vessels in Heg1–/–; Ccm2lacZ/+  and Ccm2lacZ/lacZ  mouse embryos and 
heg- or ccm2-morphant zebrafish embryos suggested that HEG1-CCM 
protein signaling is required for endothelial cells to form lumenized 
tubes during early vascular development. To assess the role of CCM2 
in  endothelial  tube  formation,  we  used  a  fibrin  bead  assay to 
examine the ability of human umbilical vein endothelial cells 
(HUVECs)  expressing CCM2-specific or  scrambled  control  small 
hairpin  RNAs to  form  tubes19. CCM2-specific  small hairpin  RNA 
resulted in an 85%–90% reduction in CCM2 mRNA expression and 
had no effect on endothelial cell size, proliferation or migration 
(Supplementary  Fig. 7 and data not shown). Although control 
HUVECs generated multicellular structures with clearly visible mature 
lumens at 10 d, CCM2-deficient HUVECs formed branched cords 
similar to those of control cells in length but were frequently unable to 
form visible lumens (Supplementary  Fig. 7). 
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Figure 6 HEG1 receptor intracellular tails 
associate with CCM2 through KRIT1. 
a Lysate IP: anti-Flag b  Lysate 
 
IP: anti-CCM2 
(a,b) Coimmunoprecipitation of mouse HEG1 
HA-CCM2 + +     + +     + + Flag-CCM2 +     – – +     + + – – +     + 
Flag-HEG1 – + – –     + – Flag-HEG1 –     + – +     – – + – + – 
and mouse CCM2 required the HEG1 receptor 
intracellular tail. Hemagglutinin (HA)-tagged 
CCM2 or Flag-CCM2 was coexpressed with 
Flag-HEG1 or Flag-HEG1DC (a mutant lacking 
the terminal 106 amino acids of the HEG1 




–     – + Flag-HEG1C    –     – + –     + 
 
IB: anti-Flag 





C-terminal tail) in HEK293T cells. Immuno- c d Lysate 〈2b HEG1 
precipitation was done using antibodies to Flag Lysate 
〈2b HEG1 Flag-Krit1 +     –     + + +     + –     +     + 
(a) or CCM2 (b). The results shown are 
Myc-KRIT1 +     –     + + + – + HA-Ccm2 –     +     +     – +     – +     +     – 
representative of 43 independent experiments. 
(c) The HEG1 intracellular tail interacted with 
KRIT1 and CCM2. HA-tagged mouse CCM2 and 
Myc-tagged mouse KRIT1 were expressed in 












–     –     –     + –     – – –     + 
with affinity matrices containing the intracellular 
tail of either the human a2b  integrin or human 
HEG1. The HEG1 tail efficiently pulled down 
KRIT1 in the absence of CCM2, but not vice 
e f 
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versa. The results shown are representative of 
43 independent experiments. (d) HEG1 
interacted with ccm2 through krit1. Flag-tagged 
zebrafish krit1, HA-tagged zebrafish ccm2 and 
HA-tagged zebrafish ccm2-L197R were 
























assays were done using human a2b  or human HEG1 intracellular tail affinity matrices as in c. ccm2-L197R did not associate with the HEG1 tail (far right 
lane). The results shown are representative of 43 independent experiments. (e) The HEG1 tail efficiently bound endogenous KRIT1. Pull-down assays 
using a2b  or HEG1 tail affinity matrices were done using lysates from CHO cells transfected with Flag-tagged human CCM2. Endogenous KRIT1 was 
detected with monoclonal antibody to KRIT1 (top) and heterologous CCM2 with monoclonal antibody to Flag (bottom). The far right lane shows 
immunoblotting of cell lysate equivalent to 5% of the input for the pull-down assays. The results shown are representative of 43 independent experiments. 
(f) HEG1-CCM protein signaling at endothelial cell junctions. HEG1 receptors couple to KRIT1 and CCM2 through HEG1 tail–KRIT1 and KRIT1-CCM2 
interactions, respectively. KRIT1 also interacts with the junctional proteins VE-cadherin and b-catenin (b-cat) and CCM2 also interacts with CCM3. 
HEG1-CCM protein signaling is proposed to regulate junction formation and function. ECM, extracellular matrix; NPxY, NPXY amino acid sequences; 
PTB, phosphotyrosine binding domain. 
 
 
Studies of lumen formation by endothelial cells in vitro and in the 
intersegmental vessels (ISVs) of the zebrafish embryo in vivo have 
shown that endothelial cells can assemble lumenized vessels through 
the formation and fusion of intracellular vacuoles20–23. We assessed 
the  formation  of vacuole-like structures  in  the  ISVs of morphant 
and control zebrafish embryos using transgenic zebrafish expressing 
GFP-Cdc42 fusion proteins that outline the intracellular vacuoles that 
form in endothelial cells22. Endothelial vacuole-like structures formed 
normally  in  the  ISVs of  zebrafish embryos  lacking heg  or  ccm2 
(Supplementary  Fig. 7 and Supplementary  Movies 1–3 online). 
Injection  of  fluorescent  quantum   dots  into  the  dorsal  aorta  of 
morphant  zebrafish to bypass the block at the level of the branchial 
arch  arteries confirmed  that  these vessels formed  a patent  lumen 
(Supplementary   Fig. 7  and  Supplementary   Movies 4–6  online). 
These findings suggest that defects in endothelial tube formation 
observed in deficient endothelial cells do not arise because of loss of 
intracellular endothelial vacuole-like structures. 
 
HEG1-CCM signaling regulates endothelial junctions in vivo 
An ultrastructural  characteristic of human CCMs is the presence of 
abnormal endothelial cell-cell junctions and gaps between endothelial 
cells15–17, and a recent study showed a role for KRIT1 in the dynamic 
regulation  of  endothelial  cell-cell junctions  in  vitro18.  Thus,  one 
mechanism by which HEG1-CCM protein  signaling might regulate 
cardiovascular development and integrity is through regulation of 
endothelial cell association. To directly assess the role of HEG1 in 
regulating endothelial junctions in vivo, we used transmission electron 
microscopy  to  examine  cell-cell junctions  in  the  endothelium  of 
neonatal mouse lymphatic vessels. The dilated mesenteric lymphatic 
vessels of Heg1–/–  neonatal mice showed markedly shortened endo- 
thelial junctions  compared  to  vessels in  control  littermates (mean 
length of junctions,  1,769 ±  506 nm  for  Heg1–/–   versus 3,355 ± 
1,009 nm for Heg1+/+;  P ¼ 0.01; Fig. 5a,b) and were accompanied 
by endothelial gaps not present in control collecting mesenteric 
lymphatic vessels (Fig. 5c). Similarly shortened junctions were iden- 
tified in the endocardium of ccm2-morphant  zebrafish hearts (Sup- 
plementary  Fig. 8 online). Finally, analysis of the constricted, 
bloodless aortas of E9 CCM2-deficient mouse embryos also revealed 
shortened endothelial junctions despite the fact that  the caliber of 
these vessels was markedly reduced (Supplementary  Fig. 8). These 
findings indicate that defective endothelial junctions characterize both 
the dilated and constricted cardiovascular phenotypes of animals 
lacking HEG1-CCM protein signaling as well as human  CCMs. 
Notably,  the  levels of  b-catenin,  VE-cadherin and  claudin-5,  key 
components of endothelial junctions, were preserved in the lymphatic 
vessels of HEG-1 deficient mice, in the hearts and vessels of zebrafish 
embryos lacking heg or ccm2 and in CCM2-deficient HUVECs 
(Supplementary  Fig. 9 online). These findings suggest that HEG1- 
CCM protein signaling may regulate the function of these proteins 
rather than their expression. 
 
HEG1 receptors couple to CCM proteins through KRIT1 
Our findings suggest that HEG1 receptors interact with CCM proteins 
in an endothelial cell–autonomous signaling pathway: HEG1 is 
expressed in endothelial cells in zebrafish and mice; Heg1–/–; 
Ccm2lacZ/+ and Ccm2lacZ/lacZ mouse embryos and heg- and ccm2- 
morphant  zebrafish embryos show aberrant  vessel formation  at an 
early developmental time point when vessels are composed exclusively 
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of endothelial cells; and CCM2-knockdown HUVECs show defects in 
tube  formation.  In  addition,  we detected heterologously expressed 
mouse HEG1 at cell junctions in HUVECs (Supplementary  Fig. 10 
online). To determine whether HEG1 can interact with intracellular 
CCM2, we coexpressed Flag-tagged, wild-type mouse HEG1 or mouse 
HEG1 lacking most of its intracellular tail (HEG1DC) with hemag- 
glutinin-tagged mouse CCM2 in HEK293T cells and conducted 
coimmunoprecipitation  experiments with antibodies to Flag and 
CCM2. CCM2 coimmunoprecipitated  with full-length HEG1 using 
antibodies to Flag (to  pull down HEG1) or CCM2 (Fig. 6a,b). In 
contrast, although HEG1DC was expressed at the cell surface at levels 
similar to those of full-length HEG1 (Supplementary  Fig. 11 online), 
CCM2 did not coprecipitate with HEG1DC (Fig. 6a,b). 
To further define how the HEG1 intracellular tail associates with 
CCM proteins, we used affinity matrices containing the intracellular 
tail of human HEG1 or of human a2b  integrin to pull down 
hemagglutinin-tagged mouse CCM2 and Myc-tagged mouse KRIT1 
heterologously expressed in HEK293T cells. The intracellular tail of 
HEG1, but not that of a2b integrin, efficiently pulled down KRIT1 and 
both KRIT1 and CCM2 when they were coexpressed (Fig. 6c). How- 
ever, only small amounts  of CCM2 were pulled down when it was 
expressed alone (Fig. 6c), indicating that KRIT1 markedly facilitates 
CCM2 interaction with the HEG1 intracellular tail. 
To further assess the mechanism of CCM2 association with HEG1, 
we compared the ability of human HEG1 to interact with zebrafish 
krit1 coexpressed with wild-type zebrafish ccm2 or with ccm2-L197R, 
a ccm2 protein with an amino acid substitution in the phospho- 
tyrosine binding domain that blocks its binding to krit1 (ref. 8); the 
corresponding mutant allele of CCM2 has been identified as a cause of 
human  CCM6. Expression of wild-type ccm2 efficiently rescued the 
big-heart phenotype of ccm2-deficient zebrafish embryos, but expres- 
sion of ccm2-L197R did not (Supplementary  Fig. 12 online), indicat- 
ing that this amino acid substitution leads to a loss of ccm2 function 
in zebrafish and humans. As observed with the mouse proteins, the 
HEG1 receptor tail efficiently pulled down both krit1 and wild-type 
ccm2 when they were coexpressed in HEK293T cells, but only krit1 
was  efficiently pulled  down  when  ccm2-L197R was  coexpressed 
(Fig. 6d). Finally, HEG1 receptor tails also efficiently pulled down 
endogenous KRIT1 in CHO cells, despite the fact that the levels of 
endogenous KRIT1 were so low that they could not be detected in 5% 
of the input  cell lysate by immunoblotting  with the same antibody 
(Fig. 6e). These findings support a model in which HEG1 receptors 
couple to CCM proteins primarily through interaction with KRIT1 at 
endothelial cell-cell junctions (Fig. 6f). 
 
DISCUSSION 
Human  genetic studies have revealed that CCM is caused by haplo- 
insufficiency of KRIT1,  CCM2 or PDCD10,  and genetic studies in 
mice and zebrafish have implicated these proteins in cardiovascular 
development. How the loss of this signaling pathway leads to these 
diverse cardiovascular defects has not been clear. Our studies of the 
expression and  function  of HEG1 and  CCM2 support  a  mecha- 
nism in which HEG1 receptor signaling through  CCM proteins  is 
required to regulate endothelial cell-cell association during formation 
of the cardiovascular system and for its integrity thereafter. We 
identified endothelial junction  defects identical to those in human 
CCMs in the dilated hearts and vessels of zebrafish and mice deficient 
in HEG1 or CCM2, suggesting that CCM proteins regulate vertebrate 
cardiovascular development through control of endothelial cell 
association  and  that  defects  in  this  regulation  leads  to  human 
CCM pathogenesis. 
Several lines of evidence suggest that the vascular defects observed 
in  zebrafish, mice and  humans  lacking HEG1 and  CCM proteins 
reflect the  loss of an  endothelial cell signaling pathway. Although 
Ccm2 gene expression was relatively low and not  vascular specific, 
Heg1 expression was detected specifically in vascular tissues and was 
restricted to endothelial cells at the stages at which deficient mouse 
and zebrafish embryos first develop cardiovascular defects. The 
vascular defects observed in E9 Heg1–/–; Ccm2lacZ/+  and Ccm2lacZ/lacZ 
mouse embryos and  48-h.p.f. morphant  zebrafish embryos lacking 
Heg or Ccm2 arose before the appearance of other vascular cell types, 
such as pericytes or  smooth  muscle cells, in  which HEG1 might 
indirectly regulate endothelial cell function. Consistent with these 
observations, mosaic analysis in zebrafish embryos has suggested that 
krit1 functions cell autonomously during cardiovascular develop- 
ment24.  Finally, CCM2-knockdown endothelial cells were defective 
in the formation of lumenized tubes, and biochemical studies showed 
that HEG1 receptors coupled to CCM proteins such as CCM2 
primarily through the KRIT1 protein. These findings strongly support 
a conserved cell-autonomous mechanism in which HEG1 receptors 
signal through CCM proteins to regulate endothelial cells during the 
formation and function of the heart and vessels. 
Common  ultrastructural  defects in endothelial junctions  suggest 
that  the nonpatent  branchial arch arteries that  appear early in the 
development of mouse and zebrafish embryos lacking HEG1-CCM 
protein signaling, the diverse cardiovascular integrity defects in older 
HEG1-deficient mice, and the vascular defects in human CCMs can all 
be explained by varying degrees of loss of endothelial cell-cell 
association. In  our  studies, the  most  severe cardiovascular defects 
were  observed  in  48-h.p.f.  morphant   zebrafish embryos  and  E9 
Heg1–/–; Ccm2lacZ/+  and Ccm2lacZ/lacZ  mouse embryos. In these ani- 
mals, the differentiation and proliferation of early endothelial cells and 
their migration to sites of vessel formation (vessel patterning)  were 
undisturbed  (consistent with our  observation that  CCM2 deficient 
HUVECs migrated normally in vitro),  but endothelial cell assembly 
into a lumenized, patent circulatory system was blocked. Recent 
studies in zebrafish suggest that  patent  vessels arise either through 
the  coalescence of vacuoles in single endothelial cells22 (that  is, a 
mechanism within endothelial cells) or through  the circumferential 
arrangement of endothelial cells that are connected by cell-cell junc- 
tions21,23  (a mechanism between endothelial cells). Our finding that 
endothelial cell vacuolization and lumenization were preserved in the 
ISVs of zebrafish embryos lacking the HEG1-CCM protein pathway is 
most consistent with a defect in endothelial cell-cell association. 
The defects observed in the integrity of the heart, blood vessels and 
lymphatic vessels of HEG1-deficient mice also support the idea that 
impaired endothelial cell-cell association results from loss of HEG1- 
CCM protein signaling. The dilated, leaky lymphatic vessels of HEG1- 
deficient mice recapitulated many of the key structural and functional 
defects observed in human CCMs and heg-deficient zebrafish hearts, 
including shortened endothelial cell junctions, abnormal coverage of 
endothelial cells by adjacent cell types such as pericytes or cardio- 
myocytes, and vessel leakage and rupture.  In addition, we observed 
dilated  lymphatic  vessels in  Heg1+/–;  Ccm2lacZ/+   mice  but  not  in 
Heg1+/–   or  Ccm2lacZ/+   mice (data  not  shown),  a result consistent 
with a genetic link between HEG1 and CCM2 in the formation of 
CCM-like dilated vessels and in early vessel formation  in embryos. 
Finally, KRIT1 was recently found  to  localize at  and  functionally 
regulate endothelial cell junctions18, and we found that heterologously 
expressed HEG1 receptors  similarly colocalized with  b-catenin  at 
endothelial  junctions.   Thus,  a  unifying  mechanism   to   explain 
these diverse vascular phenotypes is one in which HEG1 signaling 
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through  CCM proteins is required for endothelial cells to associate 
with  each  other  to  create  and  maintain  the  vertebrate  cardio- 
vascular system. 
A final question with important therapeutic implications is whether 
and how these studies advance our understanding  of human  CCM 
pathogenesis. Although molecular and genetic pathways are frequently 
postulated to link embryonic cardiovascular development and adult 
cardiovascular disease states, such links are often tenuous. It is there- 
fore noteworthy that our studies of HEG1-CCM signaling in develop- 
ing mice and zebrafish support conservation of the role of this 
pathway in both development and disease. Our findings suggest that 
the primary role of HEG1-CCM signaling is to control the association 
of endothelial cells to create and maintain cardiovascular structures. 
Thus, CCMs are predicted to be a disease of defective endothelial 
association, and agents that  positively regulate endothelial junction 
formation  might  provide a means of stabilizing human  CCMs or 
preventing their de novo formation. Alternatively, activation of HEG1- 
CCM signaling might provide a means of treating vascular diseases 
characterized by vascular leakage or defective vessel integrity, such as 
sepsis. Studies to define better the components and in vivo role of this 
signaling pathway may therefore identify new strategies for treating 
inherited and acquired vascular diseases. 
 
METHODS 
Mice. We generated SV/129 embryonic stem cells heterozygous for the Heg1 
allele by deleting exon 1 using recombineering-based gene-targeting techniques, 
and we microinjected the stem cells into C57Bl/6 blastocysts. We intercrossed 
F1-generation Heg1
+/–  mice (50% 129, 50% C57Bl/6) and conducted pheno- 
typic analysis on Heg1–/– and wild-type littermates. We generated Heg1+/– mice 
on  a  495%  C57Bl/6 background  by backcrossing for  5  generations. We 
generated Ccm2lacZ/+   mice from  129P2 embryonic stem cells in which an 
IRES-bGeo cassette had been inserted into Ccm2 exon 6 using a retroviral gene 
trap (Bay Genomics clone RRG051; ref. 14). We obtained Tg(Tek-cre)12Flv and 
Gt(ROSA)26Sor transgenic mice from Jackson Research Laboratories. Unless 
otherwise specified, we maintained all mice on a mixed genetic background. 
The University of Pennsylvania Institutional Animal Care and Use Committee 
approved all animal protocols. Genotyping primer sequences are available in 
Supplementary  Methods online. 
 
In situ hybridization and immunostaining. Primer sequences used to generate 
Heg1 and Ccm2 in situ probes are available in Supplementary  Methods. We 
carried out radioactive in situ hybridization, immunostaining and TUNEL 
staining on paraformaldehyde-fixed, paraffin-embedded sections. Detailed 
protocols  are  available at  http://www.med.upenn.edu/mcrc/histology_core/. 
We used the following antibodies for immunostaining of tissue sections: rabbit 
monoclonal antibody to Ki67 (1:250; Vector Laboratories), mouse monoclonal 
antibody  to  a-smooth  muscle actin (1:100; 1A4, Sigma), rabbit  polyclonal 
antibody to LYVE1 (1:2,000; ref. 25), mouse monoclonal antibody to b-catenin 
(1:100; BD Transduction),  rat monoclonal antibody to Flk1 (1:50; Phar- 
Mingen) and rabbit polyclonal antibody to claudin-5 (1:50; Zymed). 
 
Zebrafish studies. We maintained and bred Tuebingen long-fin wild-type 
zebrafish and Tg(fli1a:EGFP)y1 (ref. 26), Tg(kdr:EGFP) (ref. 27), 
Tg(fli1a:EGFP-cdc42)y48  (ref. 22) and ccm2hi296aTg  (ref. 28) mutant  zebrafish. 
We injected antisense morpholino oligonucleotides (Gene Tools) that interfere 
with the splicing of ccm2 and heg11,12 into the yolks of one-cell-stage embryos at 
a dose of 5 ng. To rescue the big-heart phenotype caused by the ccm2 
morpholino,  we first injected the one-cell-stage embryos with 5 ng of the 
ccm2 morpholino and then injected half of those embryos with 100 pg of cRNA 
encoding ccm2 or ccm2-L197R. We carried out microangiography of zebrafish 
embryos as described29. We injected red fluorescent (580 and 605 nm) 0.02-mm 
carboxylate-modified FluoSphere beads (Invitrogen)  or 10 mg ml–1  70-kDa 
FITC-dextran (Sigma) into the sinus venosus of 48-h.p.f. zebrafish embryos. 
We mounted the embryos laterally in 2% methylcellulose and acquired images 
using an Olympus MVX10 microscope. 
Immunoprecipitation and immunoblotting. We subcloned full-length mouse 
HEG1  without   endogenous  signal  peptide  (amino   acids  38–1,313)  and 
C-terminally truncated  HEG1 (amino  acids 38–1,207) into  pcDNA3.1 with 
a human  interleukin-1 signal peptide, an N-terminal  Flag epitope and a C- 
terminal v5 epitope (see Supplementary Fig. 1b). We cloned His6-recombinant 
human HEG1 intracellular tail containing an in vivo biotinylation peptide tag at 
the N terminus into pET15b as previously described for integrin intracellular-tail 
model proteins30. We expressed and purified tail proteins from Escherichia coli31. 
For coimmunoprecipitation studies, we transfected plasmids driving expres- 
sion of Flag-tagged full-length and truncated mouse HEG1 and hemagglutinin- 
tagged mouse CCM2 into HEK293T cells. After 48 h, we incubated the cells for 
10 min in lysis buffer (50 mM Tris-HCl, 150 mM NaCl, 25 mM EDTA, 1% 
NP-40, 0.5% sodium deoxycholate, PhosStop (Roche) and complete protease 
inhibitor  (Roche), pH 8) drawn through  a 25-gauge needle and cleared by 
centrifugation. We conducted Flag immunoprecipitation  with 2 mg ml–1 anti- 
body to Flag (M2, Sigma) and CCM2 immunoprecipitation  with polyclonal 
antibody to CCM2 (2055, see Supplemental  Methods)  for 42  h and then 
incubated with protein G–agarose (Invitrogen) for 1 h. We detected proteins 
using the following antibodies: mouse monoclonal antibody to Flag (1:500; M2, 
Sigma), mouse monoclonal antibody to hemagglutinin (1:2,000; Abcam) and 
horseradish peroxidase–conjugated goat antibody to mouse IgG (1:5,000; 
Jackson ImmunoResearch). 
For affinity matrix pull-down assays, we transfected HEK293T and CHO 
cells with plasmids driving expression of Myc-tagged mouse KRIT1, hemag- 
glutinin-tagged mouse CCM2, Flag-tagged zebrafish krit1, hemagglutinin- 
tagged  zebrafish  ccm2,  hemagglutinin-tagged  zebrafish  ccm2-L197R and 
Flag-tagged mouse CCM2. We incubated the cells for 10 min in lysis buffer 
(25 mM HEPES (pH 7.4), 100 mM NaCl, 0.5% NP-40 and complete protease 
inhibitor  (Roche)). After clarification, we incubated  350 mg of lysate with 
10 mg of immobilized human HEG1 tail overnight. We detected proteins using 
the following antibodies: mouse monoclonal antibody to Flag (1:2,000; M2, 
Sigma), mouse monoclonal antibody to Myc (1:2,000; Abcam), mouse mono- 
clonal antibody to hemagglutinin (1:2,000; Abcam), polyclonal antibody to 
KRIT1 (1:1,000; 6832, ref. 18), horseradish peroxidase–conjugated goat anti- 
body  to  mouse  IgG (1:5,000; Jackson ImmunoResearch)  and  horseradish 
peroxidase–conjugated donkey antibody to rabbit IgG (1:5,000; Jackson 
ImmunoResearch). We carried out all steps at 4 1C. 
 
Electron microscopy and cell-cell junction  quantitation. We fixed neonatal 
mouse gut mesentery, 48-h.p.f. zebrafish embryos and E9.5 mouse embryos 
overnight, embedded them  in  Polybed 812 (Polysciences), sectioned them, 
stained them and examined them with a JEOL 1010 electron microscope fitted 
with a Hamamatsu digital camera. We imaged all identifiable endocardial cell- 
cell junctions from six Heg1+/+ and five Heg1–/– lymphatic vessel cross-sections 
(66 and 123 junctions, respectively), and we quantitated junction lengths using 
ImageJ. We similarly imaged and  quantitated  endothelial cell-cell junctions 
from three control and four ccm2 morpholino–injected zebrafish atria cross- 
sections  (88  and  107  junctions,  respectively) and  four  Ccm2+/+   and  six 
Ccm2lacz/lacz  mouse dorsal aorta cross-sections (128 and 107 junctions, 
respectively). We ordered the junctions by length and determined the mean 
junction length for each tercile. We also calculated the percentage of junctions 
o1,000  nm,  1,000–2,500 nm  and  42,500  nm.  Lastly, we calculated the 
overall mean junction length from the mean junction lengths for each heart 
or vessel cross-section. 
 
Statistics. We calculated  P values using an unpaired two-tailed Student t test or 
w2  analysis as indicated. 
 
Note: Supplementary information  is available on the Nature Medicine website. 
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